≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Disorders of mineral metabolism

DOID EFO Endpoint Browser PheWeb

E4_MINERAL_MET

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E83
  • Cause of death: ICD-10 — E83

2 out of 7 registries used, show all original rules.

3782

4. Check minimum number of events

None

3782

5. Include endpoints

3857

6. Filter based on genotype QC (FinnGen only)

3712

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E70-E90
Name in latin
Perturbationes metabolismi mineralium

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 20513 11800 8560
Only index persons 17898 10452 7446
Unadjusted period prevalence (%)
Whole population 0.30 0.34 0.24
Only index persons 0.34 0.38 0.28
Median age at first event (years)
Whole population 64.04 65.92 61.47
Only index persons 63.59 65.28 61.23

-FinnGen-

Key figures

All Female Male
Number of individuals 3712 2109 1603
Unadjusted period prevalence (%) 0.74 0.75 0.74
Median age at first event (years) 63.22 62.25 64.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3857
Matched controls
38570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E86
ICD-10 Finland
Volume depletion
62.2
321.0
178
30
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
1661.4
312.6
300
*
E83.50
ICD-10 Finland
Hypercalcemia
447.7
307.7
1689
67
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
25.8
307.7
408
176
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
22.9
307.7
261
122
N17.9
ICD-10 Finland
Acute renal failure, unspecified
8.9
307.7
425
528
E87.6
ICD-10 Finland
Hypokalaemia
24.9
307.7
373
165
106
Kela drug reimbursment
Hypoparathyroidism
161.4
307.7
199
13
A12AA04
ATC
calcium carbonate; oral
23.6
307.7
297
136
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
27.7
307.7
307
120
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
36.0
307.7
287
86
E83.1
ICD-10 Finland
Disorders of iron metabolism
285.6
307.7
643
27
A11CC03
ATC
alfacalcidol; systemic
30.8
307.7
620
238
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
23.3
307.7
263
121
E21.0
ICD-10 Finland
Primary hyperparathyroidism
20.1
307.7
438
244
BAA60
NOMESCO Finland
Total thyroidectomy
14.5
307.7
320
239
E83.51
ICD-10 Finland
Hypocalcemia
849.2
307.7
909
14
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.5
306.1
543
942
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
260.0
1921
9296
TPH00
NOMESCO Finland
Phlebotomy
43.6
259.8
155
37
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
11.9
248.3
258
231
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
2330.7
240.0
230
*
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
41.5
238.6
144
36
A11CC02
ATC
dihydrotachysterol; oral
86.9
223.8
118
14
C03CA01
ATC
furosemide; systemic
2.9
217.0
1543
7145
E83.58
ICD-10 Finland
Idiopathic hypercalciuria
561.2
216.4
213
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.7
215.6
562
1361
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
10.7
207.2
231
229
321
Kela drug reimbursment
Paricalcitol and cinacalcet
23.9
201.8
145
63
H05BX01
ATC
cinacalcet; oral
23.5
197.9
143
63
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
183.5
703
2237
JN4AD
NOMESCO Finland
Body CT examination
3.4
178.5
774
2662
E87.5
ICD-10 Finland
Hyperkalaemia
24.8
176.7
125
52
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
5.6
168.1
340
659
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
167.9
2214
13435
E21.2
ICD-10 Finland
Other hyperparathyroidism
34.0
166.6
106
32
E83.39
ICD-10 Finland
Other disorder of phosphorus metabolism
1702.0
163.7
158
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.5
159.3
426
1044
N18.8
ICD-10 Finland
Other chronic renal failure
8.4
158.1
211
264
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
13.1
156.1
151
120
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
150.2
943
3970
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
149.3
873
3538
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
149.1
772
2925
N19
ICD-10 Finland
Unspecified kidney failure
5.9
148.3
278
501
TK800
NOMESCO Finland
Hemodialysis
8.4
146.2
194
241
N02AA05
ATC
oxycodone; systemic
2.7
145.0
1008
4463
M05BX04
ATC
denosumab; parenteral
3.9
143.1
468
1327
SPAT1074
SPAT
Venesection
22.5
140.3
103
47
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
23.8
139.4
100
43
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
137.9
1399
7373
M04AA01
ATC
allopurinol; systemic
3.0
137.6
708
2664
B03XA02
ATC
darbepoetin alfa; parenteral
7.5
132.1
194
271
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.9
130.7
142
135
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
11.3
128.7
136
124
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
128.4
399
1088
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
126.9
393
1069
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
14.7
126.5
114
80
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
123.7
606
2209
104
Kela drug reimbursment
Thyroid insufficiency
3.7
122.8
429
1268
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
11.9
122.5
125
108
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
121.8
723
2926
AA1AD
NOMESCO Finland
CT of head and brain
2.3
121.5
1322
7105
V03AE01
ATC
polystyrene sulfonate; oral
11.7
120.2
124
109
TPH00, ,
SPAT
29.9
119.3
79
27
127
Kela drug reimbursment
Transplant complication
9.2
117.2
144
162
H03AA01
ATC
levothyroxine sodium; systemic
2.4
116.2
1102
5565
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.9
115.6
112
89
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
114.4
530
1866
WW500
NOMESCO Finland
Blood transfusion
4.5
109.3
284
676
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
109.2
1006
4998
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
15.1
108.6
96
65
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.6
107.5
756
3315
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
105.8
223
446
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
104.7
1075
5579
BBA20
NOMESCO Finland
Exploration of parathyroid gland
29.2
98.9
66
23
Z94.0
ICD-10 Finland
Kidney transplant status
10.8
98.2
107
102
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
16.7
97.9
82
50
L04AD02
ATC
tacrolimus; systemic
10.8
97.3
106
101
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
96.9
538
2085
Z51.5
ICD-10 Finland
Palliative care
2.9
96.2
510
1928
R53
ICD-10 Finland
Malaise and fatigue
2.2
95.0
1094
5914
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
94.7
643
2759
L04AA06
ATC
mycophenolic acid; systemic
6.8
94.4
150
228
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
19.6
93.9
73
38
XW000
NOMESCO Finland
Bone marrow biopsy
4.1
93.5
266
677
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
13.4
93.1
88
67
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
25.4
92.9
65
26
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.3
92.9
192
377
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
34.6
91.6
58
17
A02BC02
ATC
pantoprazole; systemic
2.1
91.0
2793
21375
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
89.2
1605
10177
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
88.7
1119
6240
3025
Kela drug reimbursment
Calcium carbonate
17.3
88.6
73
43
ZX120
NOMESCO Finland
Intravenous
2.9
88.5
477
1815
Z49.0
ICD-10 Finland
Preparatory care for dialysis
10.8
88.4
96
91
N17.8
ICD-10 Finland
Other acute renal failure
9.0
87.9
109
124
H02AB06
ATC
prednisolone; systemic
1.9
86.8
1984
13607
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.3
86.5
178
348
E83.59
ICD-10 Finland
Other disorders of calcium metabolism
857.2
85.9
84
*
137
Kela drug reimbursment
Uraemia requiring dialysis
11.2
85.1
90
82
196
Kela drug reimbursment
Paricalcitol and cinacalcet
15.9
83.9
72
46
SPAT1262
SPAT
Handing over of treatment supplies
2.3
83.7
771
3780
N18.0
ICD-10 Finland
End-stage renal disease
9.9
83.3
96
99
R50.9
ICD-10 Finland
Fever, unspecified
2.3
81.6
712
3407
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.4
81.0
119
166
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.2
80.6
220
542
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
80.2
525
2201
B99
ICPC
Blood/lymph/spleen disease other
13.7
79.3
74
55
J01MA12
ATC
levofloxacin; systemic
2.2
77.7
835
4346
C08CA01
ATC
amlodipine; oral
1.9
77.6
1576
10277
WZC30
NOMESCO Finland
Teaching
2.2
76.9
790
4037
V03AE02
ATC
sevelamer; oral
14.6
76.8
69
48
R11
ICD-10 Finland
Nausea and vomiting
2.8
76.0
416
1591
C90.0
ICD-10 Finland
Multiple myeloma
7.6
76.0
108
145
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
75.9
183
409
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
10.4
75.7
84
82
A41.9
ICD-10 Finland
Sepsis, unspecified
4.1
75.7
214
541
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
75.6
998
5609
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
36.6
75.2
47
13
B05DB
ATC
Hypertonic solutions
12.6
74.4
73
59
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
74.3
956
5317
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
74.3
262
773
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
74.1
493
2080
V03AE03
ATC
lanthanum carbonate; oral
19.0
73.6
58
31
A10AB05
ATC
insulin aspart; parenteral
3.0
73.5
349
1234
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
15.5
73.5
64
42
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.7
72.3
116
178
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
6.7
71.4
114
174
H02AB09
ATC
hydrocortisone; systemic
5.2
70.5
148
294
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
8.6
69.1
89
106
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
7.6
69.1
99
134
N02AX02
ATC
tramadol; systemic, rectal
1.8
69.1
1731
11929
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.6
68.9
239
697
C07AB07
ATC
bisoprolol; oral
1.8
67.9
1885
13373
205
Kela drug reimbursment
Chronic hypertension
1.9
67.6
1050
6210
A10AE04
ATC
insulin glargine; parenteral
2.7
66.7
405
1630
B05DA
ATC
Isotonic solutions
10.6
65.7
72
69
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
11.1
65.1
69
63
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
65.1
566
2686
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
64.9
958
5557
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
64.6
442
1884
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
3.7
64.6
214
605
153
Kela drug reimbursment
Lenalidomid
10.3
64.4
72
71
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.7
63.8
151
332
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
115.4
63.0
68
6
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
62.6
1045
6303
ZXD05
NOMESCO Finland
Urgent procedure
1.9
62.3
1139
7073
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
8.8
62.1
78
90
Z49.2
ICD-10 Finland
Other dialysis
10.2
62.0
70
70
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
60.8
1025
6195
TK810
NOMESCO Finland
Hemofiltration
13.8
60.5
56
41
R06.0
ICD-10 Finland
Dyspnoea
1.9
60.2
1088
6719
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
60.2
733
3961
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.3
60.0
241
771
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
9.5
59.9
71
76
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
12.8
59.8
58
46
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.5
59.7
150
346
E20.8
ICD-10 Finland
Other hypoparathyroidism
307.1
59.5
60
*
WX402
NOMESCO Finland
General anaesthesia
1.9
59.3
919
5395
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
59.1
222
681
L04AX04
ATC
lenalidomide; oral
9.6
58.7
69
73
H03BB01
ATC
carbimazole; oral
3.6
58.4
200
578
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
13.7
57.9
54
40
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.3
57.0
220
686
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
10.0
56.9
65
66
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
6.5
56.2
92
144
B01AB10
ATC
tinzaparin; parenteral
2.2
55.9
507
2439
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.0
55.9
253
868
A04AA01
ATC
ondansetron; systemic, rectal
2.4
55.9
408
1787
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
55.7
933
5602
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
55.5
1630
11535
UJF32
NOMESCO Finland
Coloscopy
1.8
55.4
1072
6732
J01MA02
ATC
ciprofloxacin; systemic
1.7
54.7
1508
10474
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.6
54.7
183
520
E83.9
ICD-10 Finland
Disorder of mineral metabolism, unspecified
+∞
54.3
52
*
R4190
NOMESCO Finland
Nutritional therapy
3.4
54.1
206
637
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
54.0
584
3009
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
20.7
54.0
41
20
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.8
54.0
289
1087
329
Kela drug reimbursment
Lenalidomide
10.9
54.0
58
54
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
4.4
53.8
139
328
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.0
53.7
117
240
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
5.8
53.6
99
175
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
53.5
2315
18098
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
11.6
53.4
55
48
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
18.1
53.4
43
24
KH1AD
NOMESCO Finland
CT of urinary organs
3.4
52.4
199
614
N16.3*E83.50
ICD-10 Finland
Nefrocalcinosis NEC
269.5
52.2
53
*
A10BH05
ATC
linagliptin; oral
3.1
51.2
227
769
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
15.9
51.2
44
28
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.0
51.1
111
227
WW200
NOMESCO Finland
Immunization
4.0
50.5
146
375
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.7
50.0
163
455
B03XA01
ATC
erythropoietin; parenteral
7.8
49.3
68
88
M10.9
ICD-10 Finland
Gout, unspecified
2.6
49.2
309
1259
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
49.1
518
2637
E61.2
ICD-10 Finland
Magnesium deficiency
107.5
48.9
53
5
C03DA01
ATC
spironolactone; oral
2.1
48.9
489
2440
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
48.8
316
1306
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
15.7
48.6
42
27
JN4BD
NOMESCO Finland
Extensive body CT
2.2
48.3
461
2257
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.1
48.3
215
730
A10AC01
ATC
insulin (human); parenteral
2.6
48.2
294
1180
A06AD11
ATC
lactulose; oral
2.0
48.0
597
3227
M14.5*E83.1
ICD-10 Finland
Arthropathy in haemochromatosis
+∞
48.0
46
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
16.8
47.9
40
24
N02BE01
ATC
paracetamol; systemic, rectal
2.1
47.3
3440
30619
A12AA06
ATC
calcium lactate gluconate; oral
68.3
47.2
54
8
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.4
47.1
351
1548
L28
ICPC
Limited function/disability (L)
1.9
47.0
774
4591
H02AB02
ATC
dexamethasone; systemic
2.1
47.0
528
2750
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.8
47.0
145
390
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
46.6
221
778
SPAT1254
SPAT
Administration of medicine
2.0
46.1
587
3197
B01AB05
ATC
enoxaparin; parenteral
1.7
46.1
1222
8310
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
7.9
46.0
63
81
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
45.9
1351
9438
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
45.2
626
3506
V03AG01
ATC
sodium cellulose phosphate; systemic
65.8
45.2
52
8
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.7
44.8
83
147
N03AX16
ATC
[U] pregabalin
1.8
44.8
882
5514
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.8
44.8
236
879
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
44.7
416
2013
130
Kela drug reimbursment
Malignant tumour
2.2
44.3
409
1974
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
43.7
667
3853
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.7
43.4
143
402
WX892
NOMESCO Finland
Monitored bed care
2.5
43.4
303
1296
ZX108
NOMESCO Finland
Inhalation
7.6
43.3
61
81
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
43.2
334
1495
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
3.8
43.1
134
362
N20.0
ICD-10 Finland
Calculus of kidney
4.0
43.1
124
317
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
11.7
43.0
44
38
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
42.9
485
2527
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.0
42.9
76
129
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
42.8
345
1573
ZX114
NOMESCO Finland
Intramuscular
5.5
42.5
82
151
SPAT1263
SPAT
Sampling
1.6
42.4
1551
11379
T90
ICPC
Diabetes non-insulin dependent
1.7
42.2
902
5759
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
15.8
41.7
36
23
A28
ICPC
Limited function/disability NOS
1.8
41.4
684
4047
C10AA05
ATC
atorvastatin; oral
1.6
41.0
1461
10626
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
4.9
40.9
91
190
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
4.5
40.7
100
227
UKC02
NOMESCO Finland
Cystoscopy
1.9
40.5
625
3616
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
40.5
199
714
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
11.8
40.3
41
35
J01DB01
ATC
cefalexin; oral
1.8
40.2
3107
27114
C02AC05
ATC
moxonidine; oral
2.9
40.1
196
701
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
40.0
652
3838
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.5
39.8
142
421
Z3231
NOMESCO Finland
Registered nurse
1.7
39.6
994
6612
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.7
39.5
125
342
C03AA03
ATC
hydrochlorothiazide; oral
2.2
39.5
360
1725
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
39.4
247
1004
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
39.0
136
397
A04
ICPC
Weakness/tiredness general
1.9
39.0
605
3503
D86.0
ICD-10 Finland
Sarcoidosis of lung
5.2
38.7
80
157
U14
ICPC
Kidney symptom/complaint
4.4
38.6
98
228
E83.0
ICD-10 Finland
Disorders of copper metabolism
+∞
38.6
37
*
N05BA04
ATC
oxazepam; oral
1.7
38.5
979
6528
N06AX11
ATC
mirtazapine; oral
1.6
38.3
1261
8964
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.5
38.1
244
1001
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
4.8
38.1
87
186
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
38.0
522
2905
C08CA13
ATC
lercanidipine; oral
1.9
37.9
573
3288
SPAT1255
SPAT
Intravenous administration of medicine
2.3
37.3
286
1274
E87.2
ICD-10 Finland
Acidosis
370.9
37.1
37
*
N05CF01
ATC
zopiclone; oral
1.6
36.7
1188
8394
C10AA01
ATC
simvastatin; oral
1.6
36.6
1360
9920
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
36.3
1183
8368
M05BA04
ATC
alendronic acid; oral
2.1
35.8
383
1951
J01FF01
ATC
clindamycin; systemic
1.6
35.6
1000
6815
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
5.7
35.6
66
117
2754A
ICD-9 Finland
Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]
+∞
35.5
34
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3.5
35.1
122
356
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
34.9
578
3407
KBV00
NOMESCO Finland
Insertion of stent into ureter
7.9
34.5
47
60
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
34.4
1279
9298
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.2
34.4
92
223
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
34.2
245
1059
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
9.6
34.2
40
42
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
34.1
423
2270
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
3.9
33.8
102
270
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
33.7
264
1186
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.4
33.5
66
124
N20.1
ICD-10 Finland
Calculus of ureter
2.8
33.5
171
626
C07AB02
ATC
metoprolol; systemic
1.7
33.5
698
4394
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
33.4
953
6505
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
33.4
446
2454
N20.9
ICD-10 Finland
Urinary calculus, unspecified
3.3
33.3
125
383
A02BC01
ATC
omeprazole; systemic
1.6
33.1
995
6877
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
3.4
32.8
118
352
SPAT1216
SPAT
Assessment of functional ability
1.8
32.7
591
3571
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.2
32.7
56
92
JN6AD
NOMESCO Finland
CT of torso and neck
3.6
32.6
108
305
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.4
32.6
236
1025
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.9
32.5
160
574
H02AB04
ATC
methylprednisolone; systemic
1.8
32.5
549
3250
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.6
32.5
194
769
B03BA03
ATC
hydroxocobalamin; parenteral
2.4
32.5
235
1020
WW300
NOMESCO Finland
Transfer of autologic stem cells
10.4
32.5
36
35
C07AG02
ATC
carvedilol; oral
2.4
32.1
227
975
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.2
32.1
86
209
RD210, ,
NOMESCO Finland
4.2
32.0
85
205
A10BA02
ATC
metformin; oral
1.6
32.0
975
6751
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
31.8
1562
12004
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
6.7
31.8
50
75
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
31.8
492
2835
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
31.7
197
796
R4110
NOMESCO Finland
Physiotherapy
1.6
31.7
981
6812
S97
ICPC
Chronic ulcer skin
2.3
31.7
258
1178
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.3
31.7
119
365
A02BC05
ATC
esomeprazole; systemic
1.5
31.6
1468
11148
ZXE00
NOMESCO Finland
One hour or less
1.5
31.4
1353
10112
WX882
NOMESCO Finland
High dependency care
3.2
31.3
127
408
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
31.3
540
3215
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
31.2
710
4566
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
31.1
242
1084
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
31.0
707
4549
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
30.9
198
813
212
Kela drug reimbursment
Gout
3.9
30.8
90
233
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
30.7
226
988
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.4
30.7
78
182
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
30.7
173
667
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
30.6
320
1614
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
30.5
337
1733
TK820
NOMESCO Finland
Peritoneal dialysis
8.6
30.5
39
46
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.1
30.5
83
204
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.8
30.5
92
244
N03AX12
ATC
[U] gabapentin; oral
1.7
30.4
590
3631
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
30.4
106
310
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
7.7
30.2
42
55
SPAT1229
SPAT
Assessment of need for aid
2.1
30.1
303
1505
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.5
30.0
102
293
N16.2*D86.8
ICD-10 Finland
Renal tubulo-interstitial disorders in sarcoidosis
304.8
29.8
30
*
ZXA10
NOMESCO Finland
Bilateral
1.7
29.8
672
4306
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.9
29.8
89
234
A10AE05
ATC
insulin detemir; parenteral
2.5
29.8
192
790
M10.3
ICD-10 Finland
Gout due to impairment of renal function
9.5
29.7
35
37
C09AA02
ATC
enalapril; systemic
1.7
29.6
676
4346
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
5.5
29.6
57
105
G72.8
ICD-10 Finland
Other specified myopathies
4.2
29.2
78
189
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.4
29.2
108
328
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
29.1
978
6900
K65.0
ICD-10 Finland
Acute peritonitis
4.9
29.0
63
129
L04AD01
ATC
ciclosporin; systemic
3.7
29.0
93
257
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
29.0
321
1652
B01AC04
ATC
clopidogrel; oral
1.8
28.9
484
2853
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
28.7
408
2285
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
28.7
558
3434
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.3
28.6
220
980
L03AA02
ATC
filgrastim; parenteral
2.8
28.5
143
519
L04AX01
ATC
azathioprine; systemic
2.5
28.5
178
722
A41.8
ICD-10 Finland
Other specified sepsis
3.7
28.4
92
256
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
28.4
319
1649
P01AB01
ATC
metronidazole; oral, rectal
1.5
28.4
1399
10691
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
28.4
780
5248
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
4.6
28.2
67
148
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
5.3
28.2
56
106
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
5.5
28.2
54
99
E20.0
ICD-10 Finland
Idiopathic hypoparathyroidism
55.4
28.1
33
6
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
28.1
137
489
J01MA14
ATC
moxifloxacin; systemic
2.0
28.1
346
1848
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.8
28.1
85
226
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.3
28.0
41
57
BBA50
NOMESCO Finland
Total parathyroidectomy
64.5
27.9
32
5
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
27.9
659
4267
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.0
27.8
307
1578
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
27.8
401
2257
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
27.7
1507
11728
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.2
27.5
73
176
KBV10
NOMESCO Finland
Removal of stent from ureter
5.6
27.5
52
94
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
5.5
27.4
53
98
E83.3
ICD-10 Finland
Disorders of phosphorus metabolism and phosphatases
+∞
27.1
26
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.0
27.1
119
401
N06AX16
ATC
venlafaxine; oral
1.8
27.1
488
2936
I50.0
ICD-10 Finland
Congestive heart failure
2.1
27.0
252
1215
A06AH03
ATC
naloxegol; oral
3.8
27.0
81
214
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
26.9
1554
12211
A46
ICD-10 Finland
Erysipelas
1.7
26.9
540
3348
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.1
26.9
36
45
A04AA02
ATC
granisetron; systemic, transdermal
2.1
26.9
271
1347
TGC00
NOMESCO Finland
Bronchial lavation
3.0
26.8
120
409
E83.5
ICD-10 Finland
Disorders of calcium metabolism
272.9
26.7
27
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.5
26.7
92
267
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
26.7
278
1398
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
26.7
177
738
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
26.6
509
3113
A10BB12
ATC
glimepiride; oral
2.2
26.6
229
1070
A07AA09
ATC
vancomycin; oral
4.1
26.5
72
177
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
26.4
639
4159
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
26.4
315
1664
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.8
26.4
462
2756
K70.1
ICD-10 Finland
Alcoholic hepatitis
7.6
26.3
37
49
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.9
26.2
127
452
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.5
26.1
91
266
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
26.1
2590
22461
E83.30
ICD-10 Finland
Acid phosphatase deficiency
+∞
26.1
25
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.2
26.0
70
171
SPAT1234
SPAT
Support of social functional capacity
2.3
25.9
205
924
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
25.8
343
1878
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
25.5
466
2811
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
7.3
25.4
37
51
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.7
25.3
139
529
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
25.2
25.2
35
14
G47.3
ICD-10 Finland
Sleep apnoea
1.6
25.2
798
5530
WX002
NOMESCO Finland
Sedation and analgesia
1.6
25.2
674
4493
WVA20
NOMESCO Finland
Medicine administration
2.9
25.1
120
424
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
25.1
531
3335
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.0
25.1
71
180
ZX112
NOMESCO Finland
Subcutaneous
3.2
25.0
100
319
L95
ICPC
Osteoporosis
2.3
24.9
184
806
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
6.0
24.6
43
72
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
7.5
24.6
35
47
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
24.4
264
1346
Z31.5
ICD-10 Finland
Genetic counselling
2.2
24.3
203
936
K92.1
ICD-10 Finland
Melaena
2.2
24.3
203
937
N30.0
ICD-10 Finland
Acute cystitis
1.6
24.2
596
3889
Z2446
NOMESCO Finland
Social worker
2.1
24.1
232
1132
E66.8
ICD-10 Finland
Other obesity
2.3
24.0
186
831
NHQ40
NOMESCO Finland
Amputation of toe
4.2
24.0
64
155
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.1
24.0
101
332
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
24.0
1831
15033
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
87.3
23.7
26
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
23.6
307
1667
E0000UV, ,
ATC
1.4
23.6
1478
11705
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
3.0
23.6
102
341
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.8
23.5
72
193
SPAT1310
SPAT
Counselling related to known health issue
1.5
23.4
1114
8383
197
Kela drug reimbursment
Sunitinib
7.9
23.4
32
41
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
4.8
23.4
52
109
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
23.4
494
3099
R60.9
ICD-10 Finland
Oedema, unspecified
2.1
23.4
216
1038
N18
ICD-10 Finland
Chronic kidney disease
4.5
23.3
56
125
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
3.7
23.2
74
204
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
5.3
23.2
46
87
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
22.8
1004
7433
H02AB07
ATC
prednisone; oral
1.7
22.8
480
3006
ED1AA
NOMESCO Finland
Mandibular X-ray examination
5.6
22.7
43
78
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
22.6
361
2091
R79.0
ICD-10 Finland
Abnormal level of blood mineral
26.0
22.6
31
12
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
22.6
173
770
R60.0
ICD-10 Finland
Localized oedema
1.7
22.6
456
2825
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.1
22.5
230
1149
R31
ICD-10 Finland
Unspecified haematuria
1.8
22.3
355
2054
C01DA14
ATC
isosorbide mononitrate; oral
1.7
22.3
434
2660
WX872
NOMESCO Finland
Intensive care
2.3
22.3
176
793
R13
ICD-10 Finland
Dysphagia
2.0
22.2
270
1433
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
22.0
235
1193
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.0
22.0
62
157
F10.24
ICD-10 Finland
Alcohol depence active use
3.8
21.8
65
171
C08CA02
ATC
felodipine; oral
1.8
21.8
330
1881
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
21.8
458
2866
KAE12
NOMESCO Finland
Retrograde ureteronephroscopic lithotripsy in pelvis of kidney
5.6
21.8
41
74
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.3
21.7
170
763
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.4
21.7
54
124
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.8
21.7
106
380
R33
ICD-10 Finland
Retention of urine
1.9
21.6
270
1446
WF004
NOMESCO Finland
Palliative radiotherapy
2.9
21.5
103
365
N06AX21
ATC
duloxetine; oral
1.7
21.5
414
2531
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.2
21.4
83
260
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
21.4
681
4706
A12BA01
ATC
potassium chloride; oral
2.4
21.3
151
649
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
21.3
626
4249
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
17.5
21.3
33
19
K08.3
ICD-10 Finland
Retained dental root
1.9
21.2
290
1600
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.3
21.1
54
127
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
21.0
195
939
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
8.1
20.9
28
35
A07AA11
ATC
rifaximin; oral
8.1
20.9
28
35
E83.8
ICD-10 Finland
Other disorders of mineral metabolism
+∞
20.8
20
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.6
20.8
518
3380
AN1
HP
Coronary angiography
1.8
20.8
303
1706
M81.8
ICD-10 Finland
Other osteoporosis
4.1
20.8
56
137
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.8
20.8
101
361
K76.9
ICD-10 Finland
Liver disease, unspecified
3.6
20.6
68
192
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
20.6
127
512
UJF92
NOMESCO Finland
Capsular endoscopy
3.0
20.6
93
319
OAB50, ,
SPAT
1.8
20.5
300
1691
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
20.5
346
2036
N03AX14
ATC
levetiracetam; systemic
2.7
20.5
108
403
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.0
20.4
89
299
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
25.6
20.4
28
11
Z3226
NOMESCO Finland
Physiotherapist
1.6
20.4
590
3989
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.6
20.3
48
106
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
3.9
20.2
59
153
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.0
20.2
56
140
R42
ICD-10 Finland
Dizziness and giddiness
1.5
20.1
779
5603
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
4.5
20.1
48
107
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.0
20.0
87
292
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
4.0
20.0
56
141
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.0
20.0
56
141
N05AH04
ATC
quetiapine; oral
1.6
20.0
578
3905
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.5
20.0
125
508
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
4.9
19.9
43
88
SPAT1172
SPAT
Guidance concerning hydration
3.0
19.9
89
304
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.6
19.8
65
183
H3603, E103,
ICD-10 Finland
6.1
19.8
34
56
A10BH01
ATC
sitagliptin; oral
1.8
19.8
315
1822
XF402
NOMESCO Finland
ECG with work load test
1.8
19.7
317
1839
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
19.7
270
1491
K92.0
ICD-10 Finland
Haematemesis
2.8
19.6
97
350
A01
ICPC
Pain general/multiple sites
1.7
19.6
359
2163
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
7.8
19.5
27
35
T99
ICPC
Endocr/metab/nutrit disease other
3.3
19.4
71
215
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.9
19.3
89
309
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
19.2
376
2305
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
19.2
137
591
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.4
19.2
136
585
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
5.3
19.2
38
72
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
19.2
443
2836
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.3
19.2
148
661
R55
ICD-10 Finland
Syncope and collapse
1.7
19.1
363
2209
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
18.9
113
449
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.8
18.9
58
156
KA3EB
NOMESCO Finland
Antegrade pyelography
6.2
18.9
32
52
WX725
NOMESCO Finland
Noninvasive ventilation
2.0
18.9
204
1039
L04AA01
ATC
[U] ciclosporin
3.6
18.9
62
175
M10.0
ICD-10 Finland
Idiopathic gout
2.4
18.8
124
516
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.8
18.8
57
152
R06AE07
ATC
cetirizine; oral
1.4
18.8
1490
12145
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.9
18.7
254
1398
3AC01, ,
NOMESCO Finland
4.4
18.7
47
109
192
Kela drug reimbursment
Fulvestrant
5.3
18.7
37
70
L02BA03
ATC
fulvestrant; parenteral
4.7
18.7
43
93
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
18.6
895
6700
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
6.1
18.6
32
53
SPAT1301
SPAT
No procedures
1.4
18.6
1065
8226
H02AA02
ATC
fludrocortisone; oral
5.0
18.5
39
78
M54.5
ICD-10 Finland
Low back pain
1.4
18.5
1246
9884
JAH00
NOMESCO Finland
Laparotomy
2.6
18.5
110
436
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
18.5
200
1020
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
18.5
162
763
A02BC03
ATC
lansoprazole; oral
1.4
18.4
963
7317
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
18.4
327
1952
B28
ICPC
Limited function/disability (B)
6.4
18.4
30
47
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
18.3
643
4526
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
18.3
1329
10671
132
Kela drug reimbursment
Sarcoidosis
5.0
18.3
39
79
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.4
18.3
120
499
C08DB01
ATC
diltiazem; oral
2.1
18.3
171
826
N06AB10
ATC
escitalopram; oral
1.5
18.2
636
4470
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
18.1
346
2107
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
18.0
1321
10616
E87.8
ICD-10 Finland
Other disorders of electrolyte and fluid balance, not elsewhere classified
52.8
17.9
21
*
EP1DS
NOMESCO Finland
PET-MRI of neck metabolism
33.0
17.9
23
7
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.3
17.9
132
578
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
3.2
17.9
69
216
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
17.9
242
1331
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
6.7
17.8
28
42
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.9
17.8
235
1282
K70.4
ICD-10 Finland
Alcoholic hepatic failure
7.0
17.8
27
39
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
3.4
17.8
63
187
C09CA01
ATC
losartan; oral
1.4
17.8
898
6775
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
17.7
146
670
KAC10
NOMESCO Finland
Total nephrectomy with capsule
4.6
17.7
41
89
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
17.7
223
1199
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
17.6
679
4867
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
17.6
236
1294
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.0
17.5
76
255
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.0
17.5
196
1011
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
17.5
304
1802
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.9
17.4
240
1327
SPAT1211
SPAT
Application of soft bandage
1.7
17.4
307
1828
1502
Kela drug reimbursment
Cabozantinib
7.8
17.4
24
31
3012
Kela drug reimbursment
Cabozantinib
7.8
17.4
24
31
SPAT1260
SPAT
Consultation of another employee
1.5
17.4
589
4110
WX730
NOMESCO Finland
Conventional respirator
3.5
17.4
60
175
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.7
17.4
93
350
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
17.4
637
4519
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.9
17.3
81
284
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
17.3
262
1493
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
17.3
289
1696
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
13.9
17.2
29
21
R03AC02
ATC
salbutamol; inhalant
1.3
17.2
1869
15910
N06AB04
ATC
citalopram; systemic
1.5
17.2
671
4818
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
17.2
599
4204
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
2.8
17.1
84
302
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
5.8
17.1
31
54
T89
ICPC
Diabetes insulin dependent
2.3
17.1
126
552
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
17.1
642
4575
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
17.0
199
1042
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.5
17.0
57
163
A10AB04
ATC
insulin lispro; parenteral
2.7
17.0
93
354
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
7.5
17.0
24
32
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
16.9
371
2341
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
16.9
739
5421
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
3.6
16.9
56
159
A05AA02
ATC
ursodeoxycholic acid; oral
3.1
16.9
71
234
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
16.9
245
1377
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
25.7
16.9
23
9
Z71.8
ICD-10 Finland
Other specified counselling
1.4
16.9
1102
8672
394
Kela drug reimbursment
Palbociclib
5.0
16.9
36
73
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.0
16.9
175
879
B01AF02
ATC
apixaban; oral
1.6
16.9
448
2963
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
14.1
16.8
28
20
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.9
16.7
76
262
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
3.8
16.7
51
137
R80
ICD-10 Finland
Isolated proteinuria
5.0
16.7
35
70
F05.9
ICD-10 Finland
Delirium, unspecified
2.8
16.6
80
285
1501
Kela drug reimbursment
Palbociclib
4.8
16.6
37
78
B81
ICPC
Anaemia vit B12/folate deficiency
2.2
16.5
137
632
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
16.4
982
7609
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
16.4
124
549
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.9
16.4
228
1264
105
Kela drug reimbursment
Adrenal cortical hypofunction
20.1
16.4
24
12
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
6.1
16.4
28
46
N05CD07
ATC
temazepam; oral
1.6
16.3
376
2403
C09AA05
ATC
ramipril; oral
1.4
16.3
771
5737
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.8
16.2
48
126
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.3
16.2
60
183
N02BF02
ATC
pregabalin; oral
1.8
16.2
236
1328
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.9
16.2
74
256
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
6.5
16.2
26
40
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.8
16.2
49
131
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
3.2
16.1
64
204
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
6.8
16.1
25
37
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.2
16.1
138
644
K59.1
ICD-10 Finland
Functional diarrhoea
1.9
16.0
199
1064
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.2
16.0
138
646
L03AA13
ATC
pegfilgrastim; parenteral
2.0
15.9
172
877
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
15.9
981
7637
Z94.4
ICD-10 Finland
Liver transplant status
6.4
15.8
26
41
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
4.2
15.8
42
102
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
15.8
135
630
XPX08
NOMESCO Finland
Intraoperative flow measurement
4.9
15.7
34
70
ZXA00
NOMESCO Finland
Right side
1.4
15.6
852
6492
K29.8
ICD-10 Finland
Duodenitis
4.5
15.6
38
86
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
12.9
15.6
27
21
E20.1
ICD-10 Finland
Pseudohypoparathyroidism
+∞
15.6
15
*
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.6
15.6
36
78
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
15.6
200
1081
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.4
15.6
55
163
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.0
15.5
162
816
A07AA02
ATC
nystatin; oral
1.9
15.5
206
1127
124
Kela drug reimbursment
Inborn metabolic disorders
160.6
15.5
16
*
PC5DE
NOMESCO Finland
Ultrasound of kidney circulation with Doppler technic
6.2
15.5
26
42
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.3
15.4
58
179
WX704
NOMESCO Finland
Intubation
1.7
15.4
269
1597
B80
ICPC
Iron deficiency anaemia
2.5
15.4
92
367
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
15.3
324
2025
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
5.2
15.3
31
60
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
15.3
286
1731
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
15.3
269
1601
N07BB01
ATC
disulfiram; oral
2.1
15.3
136
645
JFB00
NOMESCO Finland
Partial resection of small intestine
3.1
15.3
64
211
WX202
NOMESCO Finland
Supraclavicular plexus blockade
3.1
15.3
64
211
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.1
15.2
63
206
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.5
15.2
29
53
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.0
15.2
68
233
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.1
15.2
144
700
J01EA01
ATC
trimethoprim; systemic
1.4
15.2
834
6362
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
15.1
209
1157
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.7
15.1
263
1560
R52.9
ICD-10 Finland
Pain, unspecified
1.6
15.1
342
2176
D64.8
ICD-10 Finland
Other specified anaemias
2.9
15.1
68
234
C07AA05
ATC
propranolol; systemic
1.4
15.1
638
4645
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
45.2
15.1
18
*
S18
ICPC
Laceration/cut
1.3
15.0
1662
14090
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
4.8
14.9
33
69
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
6.5
14.9
24
37
A10AE06
ATC
insulin degludec; parenteral
2.4
14.9
106
458
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.1
14.9
40
98
C09BA02
ATC
enalapril and diuretics; systemic
1.7
14.9
255
1506
A02BA02
ATC
ranitidine; systemic
1.5
14.8
616
4466
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.0
14.8
65
220
C10AA04
ATC
fluvastatin; oral
1.8
14.8
237
1373
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.6
14.7
84
327
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
16.5
14.7
23
14
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
14.7
455
3109
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.5
14.7
93
381
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.0
14.7
64
216
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
14.6
234
1355
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
14.6
211
1185
GD6AD
NOMESCO Finland
CT of chest and neck
5.1
14.6
30
59
M79.6
ICD-10 Finland
Pain in limb
1.3
14.5
1491
12489
M10
ICD-10 Finland
Gout
2.0
14.5
150
753
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.9
14.5
171
899
JN4CD
NOMESCO Finland
Very extensive body CT
2.1
14.5
135
652
XKD00
NOMESCO Finland
Uroflowmetry
1.5
14.5
512
3597
R02
ICPC
Shortness of breath/dyspnoea
1.5
14.5
442
3012
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.9
14.4
65
224
R5110, ,
SPAT
1.7
14.3
294
1823
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.1
14.3
58
188
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.9
14.2
179
962
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
4.6
14.2
33
72
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
14.2
432
2940
AA1AA
NOMESCO Finland
Head X-ray examination
3.9
14.2
41
106
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.1
14.2
132
637
C10AC01
ATC
colestyramine; oral
2.3
14.2
101
437
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.5
14.2
47
134
A10AB01
ATC
insulin (human); parenteral
2.4
14.1
94
394
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
5.7
14.1
26
46
KBT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of ureter
6.4
14.1
23
36
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
14.1
422
2863
ZXA05
NOMESCO Finland
Left side
1.4
14.1
771
5869
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
14.0
226
1311
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
4.9
14.0
30
61
J02AC01
ATC
fluconazole; systemic
1.3
14.0
1250
10252
A10AD05
ATC
insulin aspart; parenteral
3.1
14.0
57
185
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
4.6
14.0
33
73
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.2
14.0
123
581
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.5
14.0
85
342
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
10.1
13.9
27
27
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.6
13.9
45
126
J01CA04
ATC
amoxicillin; systemic
1.3
13.9
2892
26602
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.7
13.9
76
290
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
15.8
13.9
22
14
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.9
13.9
64
223
WPA13
NOMESCO Finland
Palliative consultation
4.9
13.8
30
62
WPB10
NOMESCO Finland
Making a convalescent care decision
4.9
13.8
30
62
5BA08, ,
NOMESCO Finland
4.9
13.8
30
62
B01AA03
ATC
warfarin; systemic
1.4
13.8
570
4127
SPAT1097
SPAT
Recording of ECG
1.5
13.7
467
3253
K70.0
ICD-10 Finland
Alcoholic fatty liver
4.1
13.7
37
91
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
13.7
179
974
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.2
13.7
120
566
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.9
13.7
39
100
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.0
13.7
58
193
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.7
13.6
74
282
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
4.9
13.6
29
59
XX2RW, ,
NOMESCO Finland
3.0
13.5
58
194
SPAT1167
SPAT
Insertion of urinary catheter
2.3
13.5
101
446
TPX15
NOMESCO Finland
Removal of vascular injection port
5.4
13.5
26
48
I81
ICD-10 Finland
Portal vein thrombosis
5.9
13.5
24
41
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
5.9
13.5
24
41
N06AX26
ATC
vortioxetine; oral
1.7
13.5
228
1341
D10
ICPC
Vomiting
1.9
13.5
167
893
C75.0
ICD-10 Finland
Malignant neoplasm: Parathyroid gland
140.5
13.5
14
*
JFF13
NOMESCO Finland
Terminal enterostomy
10.1
13.4
26
26
R41.0
ICD-10 Finland
Disorientation, unspecified
2.3
13.4
100
441
L17
ICPC
Foot/toe symptom/complaint
1.3
13.4
1019
8158
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.2
13.3
106
481
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
4.4
13.3
33
76
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
13.3
263
1615
JJA20
NOMESCO Finland
Open biopsy of liver
6.3
13.3
22
35
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.3
13.3
48
145
D07AA02
ATC
hydrocortisone; topical
1.5
13.2
433
2991
SPAT1104
SPAT
Monitoring of emergency patient
1.8
13.2
217
1266
K86.1
ICD-10 Finland
Other chronic pancreatitis
3.9
13.2
38
98
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
13.2
149
772
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.7
13.2
259
1588
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
3.5
13.2
44
126
SPAT1153
SPAT
Removal of sutures
1.3
13.1
1083
8768
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
13.1
228
1353
B07.9
ICD-10 Finland
Verruca simplex
2.1
13.1
125
610
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
13.1
186
1040
N02BF01
ATC
gabapentin; oral
1.6
13.1
348
2299
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
5.5
13.0
25
46
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
13.0
1477
12485
J01CA08
ATC
pivmecillinam; oral
1.3
12.9
1295
10763
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
12.9
235
1411
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
6.1
12.9
22
36
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
12.9
1075
8711
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.0
12.9
27
54
SPAT1240
SPAT
Therapeutic discussion
1.6
12.9
298
1905
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
4.4
12.9
32
74
J01CF05
ATC
flucloxacillin; systemic
1.7
12.8
227
1353
GD1UN
NOMESCO Finland
Lung circulation SPECT
4.9
12.8
28
58
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
4.1
12.8
35
87
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.1
12.8
113
535
J01AA02
ATC
doxycycline; systemic
1.3
12.8
2754
25261
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.1
12.7
125
617
SAA04
NOMESCO Finland
Special examination of mouth
1.8
12.7
174
962
N05BA02
ATC
chlordiazepoxide; systemic
2.4
12.7
84
352
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
12.7
907
7186
R51.80
ICD-10 Finland
Headache
1.5
12.6
474
3365
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
12.6
1199
9890
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
15.5
12.6
20
13
XG410
NOMESCO Finland
Flow-volume spirometry
2.0
12.5
131
661
ZY010
NOMESCO Finland
Hospital outpatient
1.9
12.5
154
822
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
12.5
394
2699
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
12.5
164
894
EBA10
NOMESCO Finland
Operative extraction of tooth
1.5
12.5
376
2553
L01CA04
ATC
vinorelbine; systemic
3.4
12.5
43
126
WX720
NOMESCO Finland
Own respiration
1.9
12.5
156
838
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
24.4
12.4
17
7
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.2
12.4
107
502
M81.5
ICD-10 Finland
Idiopathic osteoporosis
3.6
12.4
40
112
ZX121
NOMESCO Finland
Central venous catheter
5.6
12.4
23
41
R63.4
ICD-10 Finland
Abnormal weight loss
2.0
12.4
139
719
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
12.4
192
1102
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
4.4
12.4
30
68
M48.0
ICD-10 Finland
Spinal stenosis
1.5
12.3
403
2782
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
4.6
12.3
29
64
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
4.7
12.3
28
60
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.6
12.3
68
261
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
4.1
12.3
33
81
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
5.4
12.3
24
45
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
12.3
110
524
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
4.2
12.2
32
77
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.7
12.2
38
104
R10.0
ICD-10 Finland
Acute abdomen
2.1
12.2
109
519
G04CA02
ATC
tamsulosin; oral
1.4
12.2
719
5527
N03AX09
ATC
lamotrigine; oral
2.0
12.1
135
697
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
12.1
40
114
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
12.1
220
1322
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.1
12.1
49
159
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.9
12.1
35
91
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.3
12.1
93
417
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.2
12.0
105
495
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
12.0
199
1164
R52.2
ICD-10 Finland
Other chronic pain
2.0
12.0
124
623
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
12.0
171
957
W19
ICD-10 Finland
Unspecified fall
1.6
12.0
317
2090
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
5.2
12.0
24
46
C10AB05
ATC
fenofibrate; oral
2.9
12.0
56
197
P15
ICPC
Chronic alcohol abuse
2.2
12.0
95
431
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.1
12.0
118
583
B04
ICPC
Blood symptom/complaint
4.2
12.0
31
74
L04AX06
ATC
pomalidomide; oral
10.1
12.0
23
23
A29
ICPC
General symptom/complaint other
1.5
11.9
442
3129
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
3.4
11.9
42
125
J94.8
ICD-10 Finland
Other specified pleural conditions
2.7
11.9
61
226
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
11.9
236
1452
R03BB04
ATC
tiotropium bromide; inhalant
1.6
11.9
312
2055
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.9
11.9
145
773
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
2.9
11.9
53
182
N20.2
ICD-10 Finland
Calculus of kidney with calculus of ureter
4.1
11.8
32
79
A12AA12
ATC
[U] calcium acetate
11.7
11.8
21
18
L01XE04
ATC
[U] sunitinib
11.7
11.8
21
18
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.9
11.8
54
188
A10BH02
ATC
vildagliptin; oral
2.7
11.8
64
244
A79
ICPC
Malignancy NOS
2.6
11.7
66
256
1507
Kela drug reimbursment
Pomalidomide
10.5
11.7
22
21
C09CA03
ATC
valsartan; oral
1.6
11.7
298
1949
C09DA06
ATC
candesartan and diuretics; oral
1.6
11.7
244
1521
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
11.7
1508
12909
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.8
11.6
173
981
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
11.6
167
937
N05BA01
ATC
diazepam; systemic, rectal
1.5
11.6
397
2765
WZA10
NOMESCO Finland
Extensive medical or dental certificate
2.9
11.6
52
179
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.1
11.6
31
76
WX199
NOMESCO Finland
Other local analgesia
2.0
11.6
117
584
2522
FHL
Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)
22.9
11.6
16
7
K83.1
ICD-10 Finland
Obstruction of bile duct
2.7
11.5
59
218
G72.9
ICD-10 Finland
Myopathy, unspecified
3.7
11.5
35
94
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.6
11.5
285
1850
A03
ICPC
Fever
1.4
11.5
515
3774
I95.9
ICD-10 Finland
Hypotension, unspecified
2.9
11.5
53
185
C10AX09
ATC
ezetimibe; oral
1.5
11.5
448
3203
2754B
ICD-9 Finland
Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCURIA]
+∞
11.5
11
*
WX204
NOMESCO Finland
Axillary plexus blockaced
2.0
11.4
121
614
E87.3
ICD-10 Finland
Alkalosis
120.4
11.4
12
*
E31.00
ICD-10 Finland
APECED syndrome
120.4
11.4
12
*
I50
ICD-10 Finland
Heart failure
2.2
11.4
91
414
J01DA01
ATC
[U] cefalexin
1.3
11.4
2049
18230
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.8
11.4
56
203
ZX095
NOMESCO Finland
Combined chemoradiotherapy
3.9
11.4
33
86
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.3
11.3
88
396
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.7
11.3
60
226
C08CA05
ATC
nifedipine; systemic
1.8
11.3
183
1064
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
15.1
11.3
18
12
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.8
11.3
34
91
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
11.3
132
694
SPAT1312
SPAT
General health counselling
1.3
11.3
1024
8371
393
Kela drug reimbursment
Pomalidomide
8.9
11.2
23
26
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
9.6
11.2
22
23
K65.9
ICD-10 Finland
Peritonitis, unspecified
9.6
11.2
22
23
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.1
11.2
106
516
H3600, E113,
ICD-10 Finland
3.3
11.2
41
125
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.9
11.2
143
774
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
4.5
11.2
27
61
E46
ICD-10 Finland
Unspecified protein-energy malnutrition
17.1
11.2
17
10
TGD00
NOMESCO Finland
Needle biopsy of lung
4.6
11.2
26
57
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
4.6
11.2
26
57
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.1
11.1
46
151
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.2
11.1
96
451
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
25.1
11.1
15
6
H05BX02
ATC
paricalcitol; systemic
25.1
11.1
15
6
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.9
11.1
140
755
A10AA01, ,
ATC
2.6
11.1
64
252
B37.08
ICD-10 Finland
Other candidal stomatitis
3.3
11.1
40
121
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
5.3
11.1
22
42
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
5.3
11.1
22
42
N06AB06
ATC
sertraline; oral
1.5
11.0
341
2327
K72.9
ICD-10 Finland
Hepatic failure, unspecified
4.3
11.0
28
66
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
5.7
11.0
20
35
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
5.7
11.0
20
35
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
11.0
221
1365
G41.9
ICD-10 Finland
Status epilepticus, unspecified
4.8
10.9
24
50
UKB02
NOMESCO Finland
Retrograde ureteroscopy
3.4
10.9
39
117
BB1AN
NOMESCO Finland
Parathyroid gland isotope imaging, 1 isotope
43.4
10.9
13
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.1
10.9
99
475
160
Kela drug reimbursment
exenatide
2.6
10.9
59
225
Z71.9
ICD-10 Finland
Counselling, unspecified
1.6
10.9
242
1533
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
10.8
206
1253
C10AA03
ATC
pravastatin; oral
1.7
10.8
192
1146
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
10.8
498
3668
UJD02
NOMESCO Finland
Gastroscopy
1.9
10.8
144
791
Z50.1
ICD-10 Finland
Other physical therapy
1.8
10.8
167
960
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
4.3
10.8
27
63
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
10.6
10.8
20
19
B74
ICPC
Malignant neoplasm blood other
8.8
10.7
22
25
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.6
10.7
35
99
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.2
10.7
92
432
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
2.9
10.7
49
171
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
10.7
248
1587
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.6
10.7
62
245
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
10.7
196
1182
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.5
10.7
63
251
E20
ICD-10 Finland
Hypoparathyroidism
60.2
10.6
12
*
T29
ICPC
Endocr/metab/nutr sympt/compl other
2.4
10.6
70
294
WX722
NOMESCO Finland
PEEP
1.8
10.6
145
803
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.1
10.6
42
135
C09CA06
ATC
candesartan; oral
1.3
10.5
769
6089
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
4.2
10.5
27
64
YNB10
NOMESCO Finland
Collection of stem cells for transplant
11.2
10.5
19
17
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
3.2
10.5
40
125
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.6
10.5
59
229
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
10.5
95
455
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.1
10.5
102
502
207
Kela drug reimbursment
Chronic arrhythmias
1.4
10.5
486
3581
NF3AA
NOMESCO Finland
Femur X-ray examination
2.3
10.5
81
364
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.6
10.5
61
241
SPAT1325
SPAT
Vaccination
1.3
10.5
1078
8939
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
4.8
10.5
23
48
NGQ20
NOMESCO Finland
Amputation of lower leg
4.8
10.5
23
48
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
3.6
10.5
34
96
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
2.8
10.4
52
190
E85.9
ICD-10 Finland
Amyloidosis, unspecified
110.3
10.4
11
*
N16.3
ICD-10 Finland
Renal tubulo-interstitial disorders in metabolic diseases
+∞
10.4
10
*
2753A
ICD-9 Finland
Disorders of mineral metabolism, Disorders of phosphorus metabolism[HYPOPHOSPHATHAEMIA FAMILIARIS]
+∞
10.4
10
*
B05XA09
ATC
sodium phosphate; parenteral
+∞
10.4
10
*
N05AN01
ATC
lithium; oral
2.3
10.4
74
321
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
10.4
1824
16108
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.2
10.4
41
131
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.7
10.4
32
87
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.3
10.4
75
328
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.2
10.4
89
418
168
Kela drug reimbursment
Axitinib
32.6
10.3
13
*
S76
ICPC
Skin infection other
1.7
10.3
176
1040
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.5
10.3
34
97
K06.18
ICD-10 Finland
Another gingival hyperplasia
5.1
10.3
21
41
R07.3
ICD-10 Finland
Other chest pain
1.5
10.3
315
2145
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.0
10.3
110
561
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.0
10.3
112
575
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.9
10.3
128
688
TPH04, ,
SPAT
3.0
10.2
44
148
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
4.6
10.2
24
53
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.9
10.2
129
696
I25.2
ICD-10 Finland
Old myocardial infarction
1.8
10.2
151
856
JAH01
NOMESCO Finland
Laparoscopy
1.9
10.2
130
704
C03BA11
ATC
indapamide; oral
2.2
10.2
87
408
C02EA02, ,
ATC
1.9
10.1
124
662
K59.0
ICD-10 Finland
Constipation
1.7
10.1
176
1045
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.4
10.1
35
103
EBA00
NOMESCO Finland
Extraction of tooth
1.3
10.1
1176
9893
H04AA01
ATC
glucagon; nasal, parenteral
2.6
10.1
57
222
M25.5
ICD-10 Finland
Pain in joint
1.3
10.1
1066
8863
SPAT1252
SPAT
Overall medication plan or its review
1.6
10.1
208
1293
A10BK01
ATC
dapagliflozin; oral
1.6
10.1
230
1466
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
10.1
232
1482
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
4.3
10.0
25
58
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
8.4
10.0
21
25
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
8.4
10.0
21
25
Z73.6
ICD-10 Finland
Limitation of activities due to disability
3.8
10.0
30
80
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
3.8
10.0
30
80
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.6
10.0
233
1492
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
10.0
505
3775
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
4.8
10.0
22
46
UJC01
NOMESCO Finland
Scopy of lower throat
3.2
10.0
39
124
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
4.6
10.0
23
50
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
4.6
10.0
23
50
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.5
9.9
59
236
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.0
9.9
43
146
M79.7
ICD-10 Finland
Fibromyalgia
2.0
9.8
107
549
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
9.8
422
3067
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.7
9.8
164
963
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.5
9.8
59
237
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
9.8
159
926
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.4
9.8
67
286
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
9.8
264
1749
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.7
9.8
167
987
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
9.8
285
1920
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.4
9.8
24
55
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.0
9.8
96
475
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
2.1
9.8
89
428
N05CF02
ATC
zolpidem; oral
1.4
9.8
529
4000
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
4.5
9.8
23
51
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.5
9.8
32
91
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
9.7
317
2186
XF404
NOMESCO Finland
Ambulatory ECG
1.6
9.7
245
1598
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
2.8
9.7
47
169
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.8
9.7
47
169
J01FA06
ATC
roxithromycin; oral
1.3
9.7
1271
10830
A10AB06
ATC
insulin glulisine; parenteral
3.5
9.7
33
96
SPAT1125
SPAT
Stoma care and guidance
2.6
9.7
55
215
A10AD01
ATC
insulin (human); parenteral
2.7
9.7
51
192
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.5
9.7
271
1811
E21.4
ICD-10 Finland
Other specified disorders of parathyroid gland
55.1
9.6
11
*
E87.7
ICD-10 Finland
Fluid overload
55.1
9.6
11
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
5.3
9.6
19
36
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.8
9.6
133
739
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.8
9.6
144
820
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
9.6
101
513
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
3.9
9.6
27
69
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.4
9.6
34
102
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
4.4
9.5
23
52
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
9.5
249
1638
Z93.2
ICD-10 Finland
Ileostomy status
4.8
9.5
21
44
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.6
9.5
55
217
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
4.6
9.5
22
48
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.7
9.5
186
1141
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
9.5
225
1447
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
15.0
9.5
15
10
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
4.0
9.5
26
65
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.0
9.5
93
460
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
3.1
9.5
38
123
L29.9
ICD-10 Finland
Pruritus, unspecified
2.1
9.4
90
441
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
9.4
146
840
E55.0
ICD-10 Finland
Rickets, active
100.3
9.4
10
*
BBA99
NOMESCO Finland
Other operations on parathyroid gland
100.3
9.4
10
*
WVA20, ,
SPAT
1.9
9.4
117
629
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.2
9.4
76
349
PG5ST
NOMESCO Finland
Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance
+∞
9.4
9
*
2750A
ICD-9 Finland
Disorders of mineral metabolism, Disorders of iron metabolism[HAEMOCHROMATOSIS]
+∞
9.4
9
*
M14.5
ICD-10 Finland
Arthropathies in other endocrine, nutritional and metabolic disorders
+∞
9.4
9
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
9.4
332
2329
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
12.4
9.3
16
13
R04.0
ICD-10 Finland
Epistaxis
1.6
9.3
236
1541
N06AA09
ATC
amitriptyline; systemic
1.5
9.3
290
1982
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
9.3
129
718
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.9
9.3
42
146
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.8
9.3
44
157
U04
ICPC
Incontinence urine
1.6
9.3
187
1157
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.7
9.2
165
988
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
9.2
417
3058
TAB00
NOMESCO Finland
Lumbar puncture
1.8
9.2
136
772
SPAT1279
SPAT
Preparation of immediate hospitalisation
3.2
9.2
36
115
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
9.2
307
2129
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.8
9.1
122
671
H25.8
ICD-10 Finland
Other senile cataract
1.4
9.1
364
2611
S06.0
ICD-10 Finland
Concussion
1.5
9.1
319
2232
D86
ICD-10 Finland
Sarcoidosis
7.7
9.1
20
26
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
4.3
9.1
23
54
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
9.1
149
871
H3600, E103,
ICD-10 Finland
3.6
9.1
29
81
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.7
9.1
160
955
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
4.6
9.1
21
46
ZY000
NOMESCO Finland
Hospital inpatient
2.9
9.0
42
148
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.2
9.0
73
335
M01AB01
ATC
indometacin; systemic, rectal
1.6
9.0
219
1418
NFQ20
NOMESCO Finland
Amputation of femur
3.7
9.0
28
77
C09CA07
ATC
telmisartan; oral
1.6
9.0
226
1475
K83.0
ICD-10 Finland
Cholangitis
2.5
9.0
52
206
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.5
8.9
54
218
UDC00
NOMESCO Finland
Ear microscopy
1.6
8.9
232
1525
SBB10
NOMESCO Finland
Dental impressions
1.6
8.9
198
1256
K12.10
ICD-10 Finland
Stomatitis NOS
3.7
8.9
27
73
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
3.7
8.9
27
73
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.0
8.9
38
128
D01
ICPC
Abdominal pain/cramps general
1.4
8.9
366
2642
PJA10
NOMESCO Finland
Exploration of lymph nodes
2.7
8.9
47
178
Z01.2
ICD-10 Finland
Dental examination
1.2
8.9
1510
13217
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
8.8
249
1666
WVA30, ,
SPAT
1.6
8.8
217
1408
GBB00
NOMESCO Finland
Tracheostomy
2.8
8.8
42
150
N06AX12
ATC
bupropion; oral
1.6
8.8
189
1188
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.1
8.8
81
392
RS221, ,
NOMESCO Finland
2.7
8.8
46
173
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
2.3
8.8
62
269
N25.0
ICD-10 Finland
Renal osteodystrophy
10.7
8.8
16
15
F32
ICD-10 Finland
Depressive episode
1.7
8.8
143
836
A10BK03
ATC
empagliflozin; oral
1.5
8.7
296
2058
K56.7
ICD-10 Finland
Ileus, unspecified
2.4
8.7
57
239
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.4
8.7
57
239
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
8.7
650
5152
K20
ICD-10 Finland
Oesophagitis
2.3
8.7
61
264
G44.2
ICD-10 Finland
Tension-type headache
1.4
8.7
391
2866
N06AB03
ATC
fluoxetine; oral
1.4
8.7
354
2550
Z00.0
ICD-10 Finland
General medical examination
1.3
8.7
601
4714
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
4.2
8.6
22
52
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
3.1
8.6
34
109
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
7.6
8.6
19
25
J01XX08
ATC
linezolid; systemic
3.4
8.6
30
89
F05.8
ICD-10 Finland
Other delirium
3.3
8.6
31
94
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.1
8.6
83
409
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
2.9
8.6
39
136
ZX120, ,
SPAT
2.6
8.6
48
187
N04BC05
ATC
pramipexole; oral
1.5
8.5
239
1597
WF099
NOMESCO Finland
Other radiotherapy
3.6
8.5
27
75
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
8.5
128
730
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.2
8.5
72
337
D12
ICPC
Constipation
1.8
8.5
117
650
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.1
8.5
81
397
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.7
8.5
165
1011
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.7
8.5
139
813
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.6
8.5
47
182
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
8.5
95
494
N26
ICD-10 Finland
Unspecified contracted kidney
20.1
8.5
12
6
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
8.4
921
7661
J86.9
ICD-10 Finland
Pyothorax without fistula
3.0
8.4
35
116
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
90.3
8.4
9
*
BB1AQ
NOMESCO Finland
Parathyroidgland SPECT with low dose CT
90.3
8.4
9
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
8.4
77
372
K02.1
ICD-10 Finland
Caries of dentine
1.2
8.4
1917
17257
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
4.3
8.4
21
49
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.3
8.4
21
49
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
8.4
410
3047
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.8
8.4
112
617
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.1
8.4
73
346
M05BA07
ATC
risedronic acid; oral
1.9
8.4
97
510
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
12.8
8.4
14
11
158
Kela drug reimbursment
Everolimus
12.8
8.4
14
11
K07
ICPC
Swollen ankles/oedema
1.7
8.3
147
878
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
6.7
8.3
20
30
I95.1
ICD-10 Finland
Orthostatic hypotension
1.9
8.3
108
589
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.4
8.3
57
244
8010/3-C75.0
ICD-O-3
Carcinoma, NOS, of parathyroid gland
+∞
8.3
8
*
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
1.9
8.3
96
504
C08CA10
ATC
nilvadipine; oral
2.3
8.3
59
257
M86.1
ICD-10 Finland
Other acute osteomyelitis
8.5
8.3
17
20
L60.0
ICD-10 Finland
Ingrowing nail
1.7
8.3
144
857
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
3.6
8.3
26
72
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
3.1
8.3
34
112
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
3.1
8.3
34
112
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
8.2
138
813
I20.00
ICD-10 Finland
Unstable angina
2.2
8.2
67
309
L01EX07
ATC
cabozantinib; oral
7.1
8.2
19
27
C07AB03
ATC
atenolol; systemic
1.6
8.2
164
1012
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
2.8
8.2
40
145
WX290
NOMESCO Finland
Other blockage of nerve
1.2
8.2
1467
12874
WX212
NOMESCO Finland
Femoral plexus blockade
2.0
8.2
80
396
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
3.2
8.2
31
97
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
14.5
8.2
13
9
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
14.5
8.2
13
9
BB1BN
NOMESCO Finland
Parathyroid gland isotope imaging, 2 isotopes
14.5
8.2
13
9
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
8.2
219
1450
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.7
8.1
129
748
I50.1
ICD-10 Finland
Left ventricular failure
1.7
8.1
129
748
A06AC51
ATC
ispaghula, combinations; oral
1.7
8.1
144
862
P01BA02
ATC
hydroxychloroquine; oral
1.5
8.1
255
1747
288
Kela drug reimbursment
Febuxostat
4.8
8.1
18
38
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
8.1
416
3116
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
8.1
721
5845
25200
ICD-8 Finland
Diseases of parathyroid gland, Hyperparathyroidism
33.4
8.1
10
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
3.0
8.1
35
119
ZX100, ,
SPAT
17.2
8.1
12
7
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
3.4
8.1
28
83
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
1.9
8.1
96
510
SPAT1238
SPAT
Brief therapy
2.5
8.0
49
199
A10BX07
ATC
[U] liraglutide
2.9
8.0
37
130
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
8.0
728
5914
E03
ICD-10 Finland
Other hypothyroidism
1.6
8.0
179
1136
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.3
8.0
56
242
J01MA06
ATC
norfloxacin; oral
1.4
8.0
390
2895
B01AB04
ATC
dalteparin; parenteral
1.7
8.0
153
934
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
3.6
8.0
25
69
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.8
8.0
38
136
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.2
8.0
63
287
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
1.8
8.0
105
576
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.4
8.0
51
212
N28.1
ICD-10 Finland
Cyst of kidney
2.4
8.0
50
206
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
7.2
7.9
18
25
L01EF01
ATC
palbociclib; oral
4.3
7.9
20
47
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
4.3
7.9
20
47
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.7
7.9
136
807
WF002
NOMESCO Finland
Radical radiotherapy
1.6
7.9
179
1141
E66.0
ICD-10 Finland
Obesity due to excess calories
3.0
7.9
33
110
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.0
7.9
33
110
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.7
7.9
125
726
F34.1
ICD-10 Finland
Dysthymia
1.9
7.9
100
543
D11
ICPC
Diarrhoea
1.4
7.8
339
2467
S01.0
ICD-10 Finland
Open wound of scalp
1.5
7.8
240
1636
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
6.1
7.8
20
33
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
3.1
7.8
31
100
B82
ICPC
Anaemia other/unspecified
2.0
7.8
86
445
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.8
7.8
38
138
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.3
7.8
54
233
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
3.2
7.8
29
90
7151
FHL
Kidney transplantation
10.8
7.8
14
13
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.0
7.8
80
404
ZX080
NOMESCO Finland
Image guided radiotherapy
2.0
7.8
75
370
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
7.7
848
7047
XQ800
NOMESCO Finland
Prick test
1.5
7.7
202
1331
A10BJ02
ATC
liraglutide; parenteral
2.0
7.7
76
378
XG466
NOMESCO Finland
Sleep oxymetry
1.9
7.7
89
468
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.1
7.7
72
351
R00.2
ICD-10 Finland
Palpitations
1.5
7.7
232
1576
SXC03
NOMESCO Finland
Other oral or dental procedure
2.8
7.7
38
139
R18
ICD-10 Finland
Ascites
2.2
7.7
65
305
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.2
7.7
63
292
NF1DA
NOMESCO Finland
X-ray of hips
2.0
7.7
76
379
K29.2
ICD-10 Finland
Alcoholic gastritis
7.4
7.7
17
23
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.4
7.6
48
198
L29.8
ICD-10 Finland
Other pruritus
2.5
7.6
47
192
E000003, ,
ATC
1.7
7.6
122
710
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.7
7.6
125
733
TQW99
NOMESCO Finland
Other minor procedure on skin
1.6
7.6
154
955
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.1
7.6
66
313
Z2221
NOMESCO Finland
Medical doctor
1.3
7.6
788
6506
A10BX02
ATC
repaglinide; oral
2.7
7.6
39
146
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.2
7.6
59
268
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
8.9
7.5
15
17
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.1
7.5
64
301
I20.09
ICD-10 Finland
Unstable angina
1.7
7.5
134
804
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
7.5
1150
9911
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
7.5
1067
9124
WX610
NOMESCO Finland
Patient controlled analgesia
3.3
7.5
27
82
D07AB08
ATC
desonide; topical
1.4
7.5
319
2315
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
7.5
81
417
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.9
7.4
96
524
SBA00
NOMESCO Finland
Microbiological examinations
2.0
7.4
80
411
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.2
7.4
61
283
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
2.2
7.4
61
283
2521A
ICD-9 Finland
Disorders of parathyroid gland, Hypoparathyroidism
80.3
7.4
8
*
C02CA01
ATC
prazosin; oral
2.4
7.4
47
195
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
6.5
7.4
18
28
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
7.4
447
3435
4CJ01, ,
NOMESCO Finland
13.4
7.4
12
9
NK6AN
NOMESCO Finland
Total body bone isotope imaging
1.9
7.4
93
504
K85.8
ICD-10 Finland
Other acute pancreatitis
3.3
7.4
27
83
RS220, ,
NOMESCO Finland
2.6
7.4
40
154
A07EA06
ATC
budesonide; oral, local oral
1.8
7.4
109
621
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
4.0
7.3
20
50
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.9
7.3
33
115
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.7
7.3
127
757
2581B
ICD-9 Finland
Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]
+∞
7.3
7
*
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
+∞
7.3
7
*
27340
ICD-8 Finland
Other and unspecified congenital disorders of metabolism, Other disorders involving metabolism of minerals
+∞
7.3
7
*
N07BA03
ATC
varenicline; oral
1.7
7.3
131
788
E000001, ,
ATC
1.3
7.3
577
4603
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.4
7.3
306
2216
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
6.8
7.3
17
25
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.2
7.3
60
279
L02BG06
ATC
exemestane; oral
2.2
7.3
60
279
N18
ICPC
Paralysis/weakness
2.2
7.3
60
279
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
9.4
7.3
14
15
M03BX02
ATC
tizanidine; oral
1.2
7.3
2025
18474
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
7.3
547
4335
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.4
7.2
45
185
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.9
7.2
92
500
JJC00
NOMESCO Finland
Allogenic transplantation of liver
6.2
7.2
18
29
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
15.8
7.2
11
7
3XA02, ,
NOMESCO Finland
15.8
7.2
11
7
K55.8
ICD-10 Finland
Other vascular disorders of intestine
4.3
7.2
18
42
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
7.2
204
1369
J01MA01
ATC
ofloxacin; systemic
1.5
7.2
239
1658
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.2
7.2
54
242
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
7.2
119
701
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
2.9
7.2
32
111
N21.0
ICD-10 Finland
Calculus in bladder
2.8
7.2
34
122
M81.4
ICD-10 Finland
Drug-induced osteoporosis
3.9
7.2
20
51
WX213
NOMESCO Finland
Lower leg blockade
3.1
7.2
29
95
4039A
ICD-9 Finland
Hypertensive renal disease, Unspecified
30.1
7.1
9
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
30.1
7.1
9
*
M821, E2109,
ICD-10 Finland
30.1
7.1
9
*
L94.2
ICD-10 Finland
Calcinosis cutis
20.0
7.1
10
5
KAS40
NOMESCO Finland
Excision of transplanted kidney
20.0
7.1
10
5
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.7
7.1
127
763
A10BX04
ATC
[U] exenatide
2.9
7.1
31
106
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.8
7.1
96
532
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.4
7.1
24
70
JFH10
NOMESCO Finland
Total colectomy and ileostomy
6.6
7.1
17
26
E44.0
ICD-10 Finland
Moderate protein-energy malnutrition
7.9
7.1
15
19
Z83.4
ICD-10 Finland
Family history of other endocrine, nutritional and metabolic diseases
7.9
7.1
15
19
XF612
NOMESCO Finland
Measurement of central venous pressure
7.9
7.1
15
19
L02
ICPC
Back symptom/complaint
1.4
7.1
294
2125
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
4.1
7.1
19
47
L14
ICPC
Leg/thigh symptom/complaint
1.5
7.1
253
1780
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
4.2
7.0
18
43
S72.2
ICD-10 Finland
Subtrochanteric fracture
3.1
7.0
28
91
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
3.1
7.0
28
91
198
Kela drug reimbursment
Sorafenib
7.0
7.0
16
23
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
2.7
7.0
36
135
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
7.0
525
4159
NH1AD
NOMESCO Finland
Ankle and foot CT
2.0
7.0
71
358
TQW80
NOMESCO Finland
Local dermatologic skincare
1.9
7.0
84
449
A10BJ06
ATC
semaglutide; parenteral
1.6
7.0
138
852
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
2.3
7.0
48
207
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
3.4
7.0
24
71
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.6
7.0
37
141
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.3
7.0
25
76
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
4.4
7.0
17
39
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.1
7.0
64
311
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
2.2
6.9
57
265
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
3.7
6.9
21
57
L03
ICPC
Low back symptom/complaint
1.2
6.9
912
7728
A02BC04
ATC
rabeprazole; oral
1.4
6.9
256
1813
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.6
6.9
146
917
WX320
NOMESCO Finland
Spinalanesthesy
1.3
6.9
772
6424
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
4.0
6.9
19
48
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.2
6.9
53
240
D07AC01
ATC
betamethasone; topical
1.2
6.9
1169
10167
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
2.5
6.8
39
154
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.2
6.8
26
82
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
3.4
6.8
23
67
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.5
6.8
194
1303
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
1.7
6.8
126
764
R06.5
ICD-10 Finland
Mouth breathing
1.4
6.8
256
1817
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
6.8
785
6551
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
2.7
6.8
35
131
NG1DA
NOMESCO Finland
X-ray of knees
2.1
6.8
62
300
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
6.8
98
554
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.2
6.8
53
241
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.2
6.8
57
267
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
3.8
6.8
20
53
-54
ICPC
Repair/fix-suture/cast/prosth device
2.0
6.8
68
341
P16
ICPC
Acute alcohol abuse
2.4
6.8
46
197
M05BX06
ATC
romosozumab; parenteral
10.9
6.8
12
11
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
10.9
6.8
12
11
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
9.3
6.8
13
14
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.6
6.8
132
812
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.4
6.8
290
2108
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.0
6.8
74
383
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
3.0
6.8
28
93
C10AA02
ATC
lovastatin; oral
1.8
6.8
90
497
322
Kela drug reimbursment
Sunitinib
6.1
6.8
17
28
G63.8*N18.8
ICD-10 Finland
Uraemic neuropathy
40.1
6.8
8
*
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
6.8
360
2713
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
6.7
202
1372
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.2
6.7
55
255
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
4.3
6.7
17
40
K86.3
ICD-10 Finland
Pseudocyst of pancreas
4.3
6.7
17
40
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.2
6.7
52
236
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
6.7
335
2498
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
6.7
110
646
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
1.8
6.7
89
491
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.8
6.7
101
579
L01XE33
ATC
[U] palbociclib
3.9
6.7
19
49
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.6
6.7
130
799
G62.8
ICD-10 Finland
Other specified polyneuropathies
2.7
6.7
33
121
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.3
6.7
48
211
UJF02
NOMESCO Finland
Peroral enteroscopy
3.4
6.7
23
68
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.9
6.7
29
99
T92
ICPC
Gout
2.0
6.7
64
316
R4130
NOMESCO Finland
Speech therapy
1.9
6.7
74
385
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
22.5
6.7
9
*
361
Kela drug reimbursment
Axitinib
22.5
6.7
9
*
ECB20
NOMESCO Finland
Oral alveoplasty
2.5
6.7
39
156
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.1
6.6
59
283
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
6.6
2408
22414
K85
ICD-10 Finland
Acute pancreatitis
2.3
6.6
49
218
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.3
6.6
45
193
C07AB05
ATC
betaxolol; oral
2.0
6.6
70
358
P03
ICPC
Feeling depressed
1.4
6.6
256
1827
K02.9
ICD-10 Finland
Dental caries, unspecified
2.2
6.6
51
231
6BA02, ,
NOMESCO Finland
6.4
6.6
16
25
A10AA02, ,
ATC
2.0
6.6
72
372
PG1UT
NOMESCO Finland
Percutaneous aspiration throbectomy
4.0
6.6
18
45
U02
ICPC
Urinary frequency/urgency
1.3
6.6
447
3489
R4120
NOMESCO Finland
Occupational therapy
1.5
6.6
173
1142
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
1.8
6.6
97
552
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
5.9
6.6
17
29
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
2.3
6.6
47
206
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
3.6
6.6
21
59
C03DB01
ATC
amiloride; oral
12.3
6.6
11
9
JA3FT
NOMESCO Finland
Exchange abdominal catheter with radiological guidance
12.3
6.6
11
9
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
2.9
6.6
29
100
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.8
6.6
94
531
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
8.7
6.5
13
15
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
4.2
6.5
17
41
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.0
6.5
70
360
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
1.9
6.5
73
381
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
6.5
282
2054
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.0
6.5
65
326
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
6.8
6.5
15
22
B04AB02, ,
ATC
2.5
6.5
39
158
R04.2
ICD-10 Finland
Haemoptysis
1.8
6.5
99
570
R94.5
ICD-10 Finland
Abnormal results of liver function studies
2.3
6.5
45
195
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.9
6.5
74
389
V03AA01, ,
ATC
2.3
6.5
44
189
FN2AB
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon
2.4
6.5
43
183
K90.0
ICD-10 Finland
Coeliac disease
1.8
6.5
84
461
A99
ICPC
Disease/condition unspecnature/site
1.4
6.4
310
2298
U05
ICPC
Urination problems other
1.6
6.4
161
1052
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
1.8
6.4
87
483
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.6
6.4
139
878
PB1BT
NOMESCO Finland
Extensive upper extremity artery PTA
70.0
6.4
7
*
25219
ICD-8 Finland
Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD
70.0
6.4
7
*
J20
ICD-10 Finland
Acute bronchitis
1.4
6.4
299
2205
S70.0
ICD-10 Finland
Contusion of hip
1.7
6.4
115
693
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
2.7
6.4
33
124
M02AA10
ATC
ketoprofen; topical
1.3
6.4
484
3836
3079, ,
Kela drug reimbursment
14.3
6.4
10
7
L01XE26
ATC
[U] cabozantinib
14.3
6.4
10
7
R21
ICPC
Throat symptom/complaint
1.3
6.4
577
4678
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.7
6.4
109
648
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
2.6
6.4
35
136
M16.5
ICD-10 Finland
Other post-traumatic coxarthrosis
4.1
6.3
17
42
K86.2
ICD-10 Finland
Cyst of pancreas
2.4
6.3
40
166
C09DA03
ATC
valsartan and diuretics; oral
1.6
6.3
137
866
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.7
6.3
111
665
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
6.3
257
1852
K05.31
ICD-10 Finland
Periodontitis pronounced
1.4
6.3
333
2506
B37.8
ICD-10 Finland
Candidiasis of other sites
5.2
6.3
18
35
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
6.3
415
3227
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
2.9
6.3
28
97
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.0
6.3
61
303
D21
ICPC
Swallowing problem
2.2
6.3
48
217
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
9.3
6.3
12
13
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.8
6.3
95
546
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.6
6.3
133
837
M43.1
ICD-10 Finland
Spondylolisthesis
1.7
6.3
120
736
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.0
6.3
65
331
2759X
ICD-9 Finland
Disorders of mineral metabolism, Unspecified disorder of mineral metabolism
+∞
6.2
6
*
E83
ICD-10 Finland
Disorders of mineral metabolism
+∞
6.2
6
*
JJ1RG, ,
NOMESCO Finland
+∞
6.2
6
*
E67.3
ICD-10 Finland
Hypervitaminosis D
+∞
6.2
6
*
26510
ICD-8 Finland
Vitamin D deficiency, Rickets, late effect
+∞
6.2
6
*
L01XE17
ATC
[U] axitinib
+∞
6.2
6
*
M821, E8358,
ICD-10 Finland
+∞
6.2
6
*
N16.2
ICD-10 Finland
Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism
+∞
6.2
6
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
6.2
6
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.2
6.2
49
224
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
1.8
6.2
90
510
V03AC03
ATC
deferasirox; oral
26.7
6.2
8
*
PC6DE, ,
NOMESCO Finland
26.7
6.2
8
*
M82.1
ICD-10 Finland
Osteoporosis in endocrine disorders
26.7
6.2
8
*
ZZA00
NOMESCO Finland
Split skin graft
1.8
6.2
82
452
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
1.8
6.2
85
474
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.7
6.2
105
623
K29.7
ICD-10 Finland
Gastritis, unspecified
1.7
6.2
103
608
E, ,
ICD-9 Finland
3.7
6.2
19
52
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
3.1
6.2
25
82
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.0
6.2
62
312
WX419
NOMESCO Finland
Other general anesthesy
2.7
6.2
31
115
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.7
6.2
31
115
SPAT1247
SPAT
Outpatient detoxication and monitoring
5.0
6.2
18
36
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
4.0
6.2
17
43
N05AH03
ATC
olanzapine; systemic
1.5
6.2
169
1128
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.2
2195
20332
JMA10
NOMESCO Finland
Transabdominal total splenectomy
3.5
6.2
20
57
D07AC13
ATC
mometasone; topical
1.2
6.2
875
7461
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
5.3
6.1
17
32
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
3.2
6.1
23
72
XQ858, ,
SPAT
3.2
6.1
23
72
R25.1
ICD-10 Finland
Tremor, unspecified
1.8
6.1
93
535
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
3.3
6.1
22
67
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.5
6.1
172
1154
GD1LA
NOMESCO Finland
GD
2.4
6.1
40
169
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
7.7
6.1
13
17
R81
ICPC
Pneumonia
1.7
6.1
113
687
C02LM02, ,
ATC
2.4
6.1
38
157
J96.0
ICD-10 Finland
Acute respiratory failure
2.5
6.1
37
151
C08CA03
ATC
isradipine; systemic
2.5
6.1
36
145
M15.3
ICD-10 Finland
Secondary multiple arthrosis
4.1
6.1
16
39
SPAT1281
SPAT
Other administrative function
1.4
6.1
216
1519
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
12.5
6.1
10
8
E79.0
ICD-10 Finland
Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
12.5
6.1
10
8
J45.8
ICD-10 Finland
Mixed asthma
1.8
6.1
86
485
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.2
6.1
47
214
IGY02, ,
SPAT
2.3
6.1
41
176
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.0
6.1
65
335
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
2.4
6.0
40
170
G93.4
ICD-10 Finland
Encephalopathy, unspecified
6.7
6.0
14
21
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
1.8
6.0
82
457
NH3CG
NOMESCO Finland
Extensive MRI of foot
3.2
6.0
23
73
J37.0
ICD-10 Finland
Chronic laryngitis
1.7
6.0
96
561

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Calcium [Moles/time] in 24 hour Urine
14637-3 [3010838]
2.0e+00
3.5e+00
5.8e+00
1.0e+50
6.0e+00
4.4e+00
3.3e+00
cases:2.37%
controls:0.34%
cases:3.55%
controls:0.12%
cases:5.00%
controls:0.02%
cases:0.16%
controls:0.00%
cases:4.94%
controls:0.01%
cases:8.57%
controls:0.12%
cases:9.98%
controls:0.41%
90
128
3712
37859
135
44
3668
37948
190
6
3613
37986
6
0
3797
37992
185
5
3557
37868
281
43
2998
36232
247
118
2227
28900
alfacalcidol; oral, parenteral
A11CC03 [21600818]
2.9e+00
3.0e+00
4.3e+00
—
4.8e+00
4.0e+00
3.8e+00
cases:3.31%
controls:0.19%
cases:3.34%
controls:0.17%
cases:2.37%
controls:0.03%
—
—
cases:7.08%
controls:0.06%
cases:9.18%
controls:0.18%
cases:9.58%
controls:0.24%
126
73
3676
37914
127
63
3676
37929
90
13
3713
37979
—
265
23
3477
37850
301
65
2978
36210
237
70
2237
28948
Nephrology
39 [38004479]
2.0e+00
2.3e+00
2.7e+00
5.4e+00
3.4e+00
2.9e+00
2.4e+00
cases:5.65%
controls:0.81%
cases:6.00%
controls:0.62%
cases:3.05%
controls:0.21%
cases:5.60%
controls:0.03%
cases:5.93%
controls:0.20%
cases:9.79%
controls:0.61%
cases:9.82%
controls:0.98%
215
308
3587
37679
228
235
3575
37757
116
79
3687
37913
213
10
3590
37982
222
76
3520
37797
321
220
2958
36055
243
283
2231
28735
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
7.9e-01
1.8e+00
3.7e+00
6.3e+00
4.0e+00
2.3e+00
1.5e+00
cases:24.15%
controls:12.63%
cases:30.00%
controls:6.64%
cases:28.48%
controls:0.98%
cases:20.75%
controls:0.05%
cases:37.15%
controls:1.04%
cases:42.30%
controls:6.62%
cases:48.91%
controls:16.91%
918
4796
2884
33191
1141
2522
2662
35470
1083
374
2720
37618
789
18
3014
37974
1390
393
2352
37480
1387
2401
1892
33874
1210
4908
1264
24110
Hemodialysis
TK800 [2001305768]
2.2e+00
2.5e+00
2.6e+00
4.0e+00
3.1e+00
3.2e+00
2.8e+00
cases:1.37%
controls:0.15%
cases:1.26%
controls:0.10%
cases:0.63%
controls:0.05%
cases:0.71%
controls:0.01%
cases:0.86%
controls:0.04%
cases:1.86%
controls:0.07%
cases:2.43%
controls:0.16%
52
56
3750
37931
48
39
3755
37953
24
18
3779
37974
27
5
3776
37987
32
15
3710
37858
61
27
3218
36248
60
46
2414
28972
pH of Serum or Plasma
2753-2 [3018418]
8.0e-01
1.8e+00
3.7e+00
6.1e+00
4.1e+00
2.3e+00
1.6e+00
cases:14.31%
controls:6.95%
cases:18.54%
controls:3.56%
cases:17.78%
controls:0.55%
cases:11.86%
controls:0.03%
cases:24.45%
controls:0.54%
cases:27.69%
controls:3.60%
cases:32.82%
controls:9.28%
544
2639
3258
35348
705
1353
3098
36639
676
208
3127
37784
451
11
3352
37981
915
204
2827
37669
908
1306
2371
34969
812
2694
1662
26324
cinacalcet; oral
H05BX01 [21602792]
3.1e+00
3.1e+00
2.9e+00
—
4.3e+00
3.8e+00
3.1e+00
cases:0.95%
controls:0.04%
cases:1.08%
controls:0.05%
cases:0.39%
controls:0.02%
—
—
cases:1.15%
controls:0.02%
cases:2.44%
controls:0.06%
cases:1.78%
controls:0.08%
36
16
3766
37971
41
19
3762
37973
15
8
3788
37984
—
43
6
3699
37867
80
20
3199
36255
44
23
2430
28995
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
7.6e-01
1.7e+00
3.6e+00
6.5e+00
4.0e+00
2.3e+00
1.5e+00
cases:21.80%
controls:11.50%
cases:25.43%
controls:5.80%
cases:23.88%
controls:0.86%
cases:18.62%
controls:0.03%
cases:31.96%
controls:0.87%
cases:36.41%
controls:5.68%
cases:42.40%
controls:14.31%
829
4368
2973
33619
967
2204
2836
35788
908
327
2895
37665
708
13
3095
37979
1196
329
2546
37544
1194
2060
2085
34215
1049
4152
1425
24866
Chronic kidney disease, unspecified
N18.9 [45553438]
2.0e+00
2.3e+00
2.8e+00
5.2e+00
3.1e+00
2.7e+00
2.0e+00
cases:4.42%
controls:0.59%
cases:4.05%
controls:0.41%
cases:1.68%
controls:0.11%
cases:2.37%
controls:0.01%
cases:2.73%
controls:0.12%
cases:5.73%
controls:0.42%
cases:6.91%
controls:0.98%
168
225
3634
37762
154
154
3649
37838
64
41
3739
37951
90
5
3713
37987
102
46
3640
37827
188
151
3091
36124
171
285
2303
28733
Primary hyperparathyroidism
E21.0 [45571667]
1.9e+00
2.6e+00
4.4e+00
1.0e+50
4.1e+00
3.8e+00
3.3e+00
cases:0.87%
controls:0.14%
cases:1.60%
controls:0.12%
cases:1.03%
controls:0.01%
cases:1.13%
controls:0.00%
cases:2.14%
controls:0.04%
cases:5.70%
controls:0.13%
cases:7.24%
controls:0.30%
33
52
3769
37935
61
45
3742
37947
39
5
3764
37987
43
0
3760
37992
80
14
3662
37859
187
48
3092
36227
179
87
2295
28931
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
1.7e+00
2.8e+00
4.4e+00
—
5.1e+00
3.4e+00
2.5e+00
cases:7.60%
controls:1.53%
cases:11.23%
controls:0.79%
cases:11.04%
controls:0.15%
—
—
cases:17.56%
controls:0.12%
cases:19.37%
controls:0.79%
cases:21.95%
controls:2.24%
289
580
3513
37407
427
302
3376
37690
420
56
3383
37936
—
657
47
3085
37826
635
286
2644
35989
543
651
1931
28367
Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]
1.6e+00
2.5e+00
4.6e+00
1.0e+50
5.3e+00
3.2e+00
2.5e+00
cases:1.55%
controls:0.31%
cases:2.58%
controls:0.22%
cases:2.73%
controls:0.03%
cases:0.55%
controls:0.00%
cases:4.20%
controls:0.02%
cases:4.85%
controls:0.21%
cases:5.70%
controls:0.48%
59
119
3743
37868
98
82
3705
37910
104
11
3699
37981
21
0
3782
37992
157
8
3585
37865
159
76
3120
36199
141
140
2333
28878
calcium carbonate; oral
A12AA04 [21600863]
2.6e+00
2.9e+00
3.3e+00
—
4.0e+00
3.7e+00
3.2e+00
cases:2.84%
controls:0.22%
cases:2.63%
controls:0.15%
cases:1.13%
controls:0.04%
—
—
cases:2.78%
controls:0.05%
cases:6.01%
controls:0.16%
cases:7.76%
controls:0.33%
108
83
3694
37904
100
58
3703
37934
43
16
3760
37976
—
104
20
3638
37853
197
57
3082
36218
192
97
2282
28921
calcium carbonate
A02AC01 [21600065]
2.6e+00
2.9e+00
3.3e+00
—
4.0e+00
3.7e+00
3.2e+00
cases:2.84%
controls:0.22%
cases:2.63%
controls:0.15%
cases:1.13%
controls:0.04%
—
—
cases:2.78%
controls:0.05%
cases:6.01%
controls:0.16%
cases:7.76%
controls:0.33%
108
83
3694
37904
100
58
3703
37934
43
16
3760
37976
—
104
20
3638
37853
197
57
3082
36218
192
97
2282
28921
Other primary hyperparathyroidism
E21.09 [2000501463]
2.2e+00
3.1e+00
—
1.0e+50
4.8e+00
5.2e+00
4.2e+00
cases:1.47%
controls:0.17%
cases:1.58%
controls:0.07%
—
—
cases:1.08%
controls:0.00%
cases:1.98%
controls:0.02%
cases:6.74%
controls:0.04%
cases:7.15%
controls:0.12%
56
65
3746
37922
60
27
3743
37965
—
41
0
3762
37992
74
6
3668
37867
221
14
3058
36261
177
34
2297
28984
Internal Medicine
11 [38004456]
8.5e-01
1.4e+00
2.5e+00
7.5e+00
3.3e+00
2.2e+00
1.4e+00
cases:34.90%
controls:18.69%
cases:24.19%
controls:6.97%
cases:10.89%
controls:1.02%
cases:42.73%
controls:0.04%
cases:21.78%
controls:1.00%
cases:38.91%
controls:6.45%
cases:42.64%
controls:15.77%
1327
7099
2475
30888
920
2647
2883
35345
414
387
3389
37605
1625
15
2178
37977
815
380
2927
37493
1276
2340
2003
33935
1055
4577
1419
24441
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.2e+00
2.4e+00
3.8e+00
3.3e+00
3.6e+00
2.4e+00
1.7e+00
cases:8.42%
controls:2.74%
cases:14.04%
controls:1.47%
cases:7.10%
controls:0.17%
cases:0.37%
controls:0.01%
cases:5.91%
controls:0.18%
cases:15.58%
controls:1.59%
cases:19.81%
controls:4.40%
320
1039
3482
36948
534
558
3269
37434
270
66
3533
37926
14
5
3789
37987
221
68
3521
37805
511
577
2768
35698
490
1276
1984
27742
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.1e+00
2.3e+00
3.8e+00
3.4e+00
3.5e+00
2.4e+00
1.6e+00
cases:8.71%
controls:3.06%
cases:14.36%
controls:1.59%
cases:7.28%
controls:0.18%
cases:0.39%
controls:0.01%
cases:5.93%
controls:0.18%
cases:15.77%
controls:1.74%
cases:20.33%
controls:4.79%
331
1162
3471
36825
546
605
3257
37387
277
69
3526
37923
15
5
3788
37987
222
70
3520
37803
517
631
2762
35644
503
1389
1971
27629
Metastasis
OMOP4998856 [36769180]
1.8e+00
2.2e+00
2.6e+00
5.2e+00
3.0e+00
2.1e+00
1.2e+00
cases:1.26%
controls:0.20%
cases:2.16%
controls:0.25%
cases:1.92%
controls:0.14%
cases:2.24%
controls:0.01%
cases:2.51%
controls:0.13%
cases:1.95%
controls:0.25%
cases:1.25%
controls:0.38%
48
77
3754
37910
82
96
3721
37896
73
53
3730
37939
85
5
3718
37987
94
50
3648
37823
64
92
3215
36183
31
111
2443
28907
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
1.9e+00
2.2e+00
2.6e+00
5.2e+00
2.9e+00
2.1e+00
1.2e+00
cases:1.26%
controls:0.20%
cases:2.16%
controls:0.25%
cases:1.92%
controls:0.14%
cases:2.24%
controls:0.01%
cases:2.41%
controls:0.13%
cases:1.95%
controls:0.25%
cases:1.21%
controls:0.37%
48
75
3754
37912
82
96
3721
37896
73
53
3730
37939
85
5
3718
37987
90
50
3652
37823
64
91
3215
36184
30
108
2444
28910
Extracorporeal dialysis
Z49.1 [45537649]
2.9e+00
2.8e+00
2.8e+00
—
3.1e+00
3.2e+00
2.9e+00
cases:1.18%
controls:0.06%
cases:1.08%
controls:0.06%
cases:0.66%
controls:0.04%
—
—
cases:0.91%
controls:0.04%
cases:1.52%
controls:0.06%
cases:1.86%
controls:0.11%
45
24
3757
37963
41
24
3762
37968
25
16
3778
37976
—
34
15
3708
37858
50
22
3229
36253
46
31
2428
28987
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
9.5e-01
2.0e+00
4.4e+00
—
5.7e+00
2.9e+00
1.9e+00
cases:1.55%
controls:0.61%
cases:1.45%
controls:0.21%
cases:1.60%
controls:0.02%
—
—
cases:3.63%
controls:0.01%
cases:3.26%
controls:0.18%
cases:3.35%
controls:0.50%
59
230
3743
37757
55
79
3748
37913
61
8
3742
37984
—
136
5
3606
37868
107
64
3172
36211
83
146
2391
28872
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.4e+00
2.2e+00
3.8e+00
—
4.7e+00
2.9e+00
2.1e+00
cases:10.07%
controls:2.64%
cases:11.18%
controls:1.41%
cases:10.52%
controls:0.26%
—
—
cases:20.58%
controls:0.24%
cases:19.82%
controls:1.34%
cases:21.87%
controls:3.35%
383
1004
3419
36983
425
537
3378
37455
400
100
3403
37892
—
770
92
2972
37781
650
485
2629
35790
541
971
1933
28047
Nontoxic multinodular goitre
E04.2 [45576425]
1.4e+00
2.9e+00
4.2e+00
—
4.4e+00
2.6e+00
1.4e+00
cases:1.37%
controls:0.34%
cases:2.24%
controls:0.12%
cases:1.74%
controls:0.03%
—
—
cases:1.31%
controls:0.02%
cases:1.71%
controls:0.12%
cases:1.37%
controls:0.34%
52
131
3750
37856
85
46
3718
37946
66
10
3737
37982
—
49
6
3693
37867
56
45
3223
36230
34
99
2440
28919
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
7.0e-01
1.4e+00
3.2e+00
5.0e+00
3.6e+00
1.8e+00
1.2e+00
cases:18.20%
controls:9.99%
cases:18.49%
controls:5.24%
cases:11.46%
controls:0.54%
cases:2.71%
controls:0.02%
cases:18.52%
controls:0.59%
cases:26.20%
controls:5.63%
cases:39.33%
controls:16.01%
692
3795
3110
34192
703
1991
3100
36001
436
206
3367
37786
103
7
3700
37985
693
223
3049
37650
859
2043
2420
34232
973
4645
1501
24373
Hyperparathyroidism, unspecified
E21.3 [45581360]
2.8e+00
3.1e+00
3.4e+00
1.0e+50
—
4.2e+00
3.3e+00
cases:0.87%
controls:0.06%
cases:1.03%
controls:0.04%
cases:0.39%
controls:0.01%
cases:1.42%
controls:0.00%
—
—
cases:2.96%
controls:0.04%
cases:2.99%
controls:0.11%
33
21
3769
37966
39
17
3764
37975
15
5
3788
37987
54
0
3749
37992
—
97
16
3182
36259
74
32
2400
28986
Hypertension secondary to other renal disorders
I15.1 [45557535]
2.9e+00
2.6e+00
2.8e+00
—
2.9e+00
2.9e+00
2.7e+00
cases:0.79%
controls:0.04%
cases:0.63%
controls:0.05%
cases:0.32%
controls:0.02%
—
—
cases:0.40%
controls:0.02%
cases:0.98%
controls:0.06%
cases:1.33%
controls:0.09%
30
17
3772
37970
24
18
3779
37974
12
7
3791
37985
—
15
8
3727
37865
32
20
3247
36255
33
27
2441
28991
methoxy polyethylene glycol-epoetin beta; parenteral
B03XA03 [21601135]
2.9e+00
2.8e+00
2.8e+00
—
2.5e+00
3.2e+00
2.5e+00
cases:0.79%
controls:0.04%
cases:0.66%
controls:0.04%
cases:0.29%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.91%
controls:0.04%
cases:0.77%
controls:0.06%
30
17
3772
37970
25
16
3778
37976
11
7
3792
37985
—
7
6
3735
37867
30
13
3249
36262
19
18
2455
29000
Papillary carcinoma of the thyroid gland (thyroid gland)
C73.91 [2000501197]
2.1e+00
2.8e+00
4.6e+00
1.0e+50
—
3.6e+00
3.6e+00
cases:0.89%
controls:0.12%
cases:1.39%
controls:0.09%
cases:1.79%
controls:0.02%
cases:0.89%
controls:0.00%
—
—
cases:3.17%
controls:0.09%
cases:4.12%
controls:0.12%
34
44
3768
37943
53
34
3750
37958
68
7
3735
37985
34
0
3769
37992
—
104
33
3175
36242
102
34
2372
28984
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
9.5e-01
1.9e+00
4.2e+00
1.0e+50
5.1e+00
2.6e+00
1.8e+00
cases:2.37%
controls:0.93%
cases:2.21%
controls:0.34%
cases:2.21%
controls:0.03%
cases:0.26%
controls:0.00%
cases:4.62%
controls:0.03%
cases:3.96%
controls:0.29%
cases:4.77%
controls:0.86%
90
353
3712
37634
84
131
3719
37861
84
13
3719
37979
10
0
3793
37992
173
11
3569
37862
130
106
3149
36169
118
249
2356
28769
Bacteria identified in Blood by Culture
600-7 [3023368]
7.5e-01
1.5e+00
2.7e+00
5.9e+00
3.1e+00
1.5e+00
8.8e-01
cases:10.63%
controls:5.34%
cases:9.76%
controls:2.41%
cases:4.58%
controls:0.33%
cases:4.79%
controls:0.01%
cases:7.40%
controls:0.34%
cases:10.13%
controls:2.41%
cases:15.84%
controls:7.25%
404
2029
3398
35958
371
917
3432
37075
174
125
3629
37867
182
5
3621
37987
277
130
3465
37743
332
876
2947
35399
392
2105
2082
26913
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
5.8e-01
1.5e+00
2.9e+00
5.5e+00
3.2e+00
1.6e+00
1.1e+00
cases:13.41%
controls:8.01%
cases:14.44%
controls:3.67%
cases:9.76%
controls:0.62%
cases:3.58%
controls:0.02%
cases:11.68%
controls:0.53%
cases:16.80%
controls:3.75%
cases:25.42%
controls:10.05%
510
3041
3292
34946
549
1394
3254
36598
371
236
3432
37756
136
6
3667
37986
437
200
3305
37673
551
1361
2728
34914
629
2916
1845
26102
Hematology
82 [38004501]
1.2e+00
1.6e+00
2.1e+00
5.2e+00
2.5e+00
2.0e+00
1.6e+00
cases:3.79%
controls:1.18%
cases:3.84%
controls:0.84%
cases:2.45%
controls:0.30%
cases:2.87%
controls:0.02%
cases:3.96%
controls:0.33%
cases:6.13%
controls:0.84%
cases:6.67%
controls:1.36%
144
448
3658
37539
146
318
3657
37674
93
113
3710
37879
109
6
3694
37986
148
126
3594
37747
201
305
3078
35970
165
396
2309
28622
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.2e+00
2.1e+00
3.6e+00
—
4.8e+00
2.8e+00
1.8e+00
cases:8.86%
controls:2.96%
cases:9.86%
controls:1.33%
cases:7.60%
controls:0.22%
—
—
cases:22.72%
controls:0.23%
cases:18.08%
controls:1.28%
cases:17.46%
controls:3.50%
337
1125
3465
36862
375
506
3428
37486
289
84
3514
37908
—
850
89
2892
37784
593
463
2686
35812
432
1016
2042
28002
Emergency Room and Inpatient Visit
ERIP [262]
6.6e-01
1.4e+00
2.5e+00
6.9e+00
2.8e+00
1.3e+00
6.6e-01
cases:10.21%
controls:5.55%
cases:11.44%
controls:3.05%
cases:5.26%
controls:0.45%
cases:16.12%
controls:0.02%
cases:8.42%
controls:0.55%
cases:11.38%
controls:3.50%
cases:19.32%
controls:10.97%
388
2109
3414
35878
435
1159
3368
36833
200
171
3603
37821
613
7
3190
37985
315
210
3427
37663
373
1268
2906
35007
478
3184
1996
25834
Endocrinology
46 [38004485]
1.5e+00
2.2e+00
2.7e+00
—
3.9e+00
3.5e+00
2.6e+00
cases:10.39%
controls:2.59%
cases:11.31%
controls:1.43%
cases:3.87%
controls:0.27%
—
—
cases:12.56%
controls:0.30%
cases:30.65%
controls:1.34%
cases:27.81%
controls:2.92%
395
985
3407
37002
430
542
3373
37450
147
103
3656
37889
—
470
112
3272
37761
1005
486
2274
35789
688
847
1786
28171
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
1.7e+00
2.1e+00
3.9e+00
1.0e+50
4.6e+00
2.3e+00
1.7e+00
cases:2.58%
controls:0.49%
cases:2.39%
controls:0.31%
cases:1.95%
controls:0.04%
cases:0.39%
controls:0.00%
cases:5.00%
controls:0.05%
cases:3.05%
controls:0.31%
cases:3.72%
controls:0.70%
98
186
3704
37801
91
116
3712
37876
74
16
3729
37976
15
0
3788
37992
187
20
3555
37853
100
112
3179
36163
92
203
2382
28815
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
1.7e+00
2.2e+00
3.7e+00
1.0e+50
4.5e+00
2.3e+00
1.8e+00
cases:2.13%
controls:0.39%
cases:1.87%
controls:0.21%
cases:1.39%
controls:0.03%
cases:0.34%
controls:0.00%
cases:3.98%
controls:0.05%
cases:2.32%
controls:0.23%
cases:2.75%
controls:0.47%
81
148
3721
37839
71
79
3732
37913
53
13
3750
37979
13
0
3790
37992
149
18
3593
37855
76
85
3203
36190
68
136
2406
28882
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
1.7e+00
2.1e+00
3.9e+00
1.0e+50
4.6e+00
2.3e+00
1.6e+00
cases:2.60%
controls:0.51%
cases:2.76%
controls:0.35%
cases:2.34%
controls:0.05%
cases:0.55%
controls:0.00%
cases:5.83%
controls:0.06%
cases:3.23%
controls:0.34%
cases:4.00%
controls:0.80%
99
194
3703
37793
105
132
3698
37860
89
18
3714
37974
21
0
3782
37992
218
23
3524
37850
106
124
3173
36151
99
233
2375
28785
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
1.6e+00
2.1e+00
3.9e+00
1.0e+50
4.6e+00
2.3e+00
1.6e+00
cases:2.58%
controls:0.51%
cases:2.76%
controls:0.35%
cases:2.29%
controls:0.05%
cases:0.55%
controls:0.00%
cases:5.77%
controls:0.06%
cases:3.23%
controls:0.34%
cases:3.96%
controls:0.80%
98
194
3704
37793
105
133
3698
37859
87
18
3716
37974
21
0
3782
37992
216
23
3526
37850
106
123
3173
36152
98
233
2376
28785
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
7.3e-01
1.5e+00
3.0e+00
4.6e+00
3.4e+00
1.7e+00
1.1e+00
cases:20.38%
controls:10.98%
cases:21.56%
controls:5.79%
cases:15.51%
controls:0.92%
cases:4.39%
controls:0.04%
cases:19.91%
controls:0.85%
cases:25.65%
controls:5.80%
cases:34.60%
controls:14.40%
775
4170
3027
33817
820
2199
2983
35793
590
348
3213
37644
167
17
3636
37975
745
321
2997
37552
841
2104
2438
34171
856
4180
1618
24838
lenalidomide; oral
L04AX04 [21603930]
2.4e+00
2.6e+00
2.7e+00
—
2.6e+00
3.1e+00
2.5e+00
cases:0.47%
controls:0.04%
cases:0.55%
controls:0.04%
cases:0.39%
controls:0.03%
—
—
cases:0.32%
controls:0.02%
cases:1.19%
controls:0.06%
cases:1.13%
controls:0.09%
18
17
3784
37970
21
15
3782
37977
15
10
3788
37982
—
12
9
3730
37864
39
20
3240
36255
28
26
2446
28992
Thyrotoxicosis with diffuse goitre
E05.0 [45600628]
1.8e+00
2.7e+00
3.7e+00
1.0e+50
3.2e+00
2.8e+00
1.7e+00
cases:1.76%
controls:0.31%
cases:2.10%
controls:0.14%
cases:1.74%
controls:0.04%
cases:0.79%
controls:0.00%
cases:1.15%
controls:0.05%
cases:1.80%
controls:0.12%
cases:1.25%
controls:0.22%
67
116
3735
37871
80
54
3723
37938
66
16
3737
37976
30
0
3773
37992
43
18
3699
37855
59
42
3220
36233
31
65
2443
28953
Other chronic renal failure
N18.8 [45534123]
2.1e+00
2.5e+00
2.4e+00
—
3.4e+00
3.0e+00
2.6e+00
cases:1.89%
controls:0.23%
cases:1.39%
controls:0.12%
cases:0.37%
controls:0.03%
—
—
cases:0.99%
controls:0.03%
cases:2.07%
controls:0.11%
cases:3.31%
controls:0.27%
72
89
3730
37898
53
44
3750
37948
14
13
3789
37979
—
37
13
3705
37860
68
40
3211
36235
82
77
2392
28941
darbepoetin alfa; parenteral
B03XA02 [21601134]
2.3e+00
2.9e+00
2.5e+00
—
2.6e+00
3.1e+00
2.2e+00
cases:1.53%
controls:0.16%
cases:1.81%
controls:0.10%
cases:0.68%
controls:0.06%
—
—
cases:0.67%
controls:0.05%
cases:2.59%
controls:0.12%
cases:2.30%
controls:0.25%
58
59
3744
37928
69
39
3734
37953
26
22
3777
37970
—
25
18
3717
37855
85
45
3194
36230
57
72
2417
28946
magnesium hydroxide; oral
A02AA04 [21600052]
1.5e+00
2.1e+00
2.5e+00
—
4.1e+00
3.1e+00
2.2e+00
cases:1.66%
controls:0.38%
cases:1.89%
controls:0.23%
cases:1.03%
controls:0.09%
—
—
cases:4.60%
controls:0.08%
cases:5.37%
controls:0.25%
cases:4.53%
controls:0.51%
63
143
3739
37844
72
86
3731
37906
39
33
3764
37959
—
172
29
3570
37844
176
90
3103
36185
112
147
2362
28871
magnesium hydroxide; oral
G04BX01 [21602658]
1.5e+00
2.1e+00
2.5e+00
—
4.1e+00
3.1e+00
2.2e+00
cases:1.66%
controls:0.38%
cases:1.89%
controls:0.23%
cases:1.03%
controls:0.09%
—
—
cases:4.60%
controls:0.08%
cases:5.37%
controls:0.25%
cases:4.53%
controls:0.51%
63
143
3739
37844
72
86
3731
37906
39
33
3764
37959
—
172
29
3570
37844
176
90
3103
36185
112
147
2362
28871
Gas panel - Central venous blood
97535-9 [1616796]
1.5e+00
1.9e+00
3.6e+00
1.0e+50
4.3e+00
2.5e+00
1.8e+00
cases:1.42%
controls:0.33%
cases:1.21%
controls:0.18%
cases:0.66%
controls:0.02%
cases:0.58%
controls:0.00%
cases:1.95%
controls:0.03%
cases:1.89%
controls:0.16%
cases:2.75%
controls:0.45%
54
126
3748
37861
46
70
3757
37922
25
7
3778
37985
22
0
3781
37992
73
10
3669
37863
62
59
3217
36216
68
131
2406
28887
Thorax X-ray examination
GD1AA [2001303617]
7.8e-01
1.5e+00
2.2e+00
6.1e+00
2.3e+00
1.6e+00
1.1e+00
cases:19.07%
controls:9.74%
cases:13.46%
controls:3.43%
cases:4.00%
controls:0.45%
cases:7.42%
controls:0.02%
cases:3.90%
controls:0.41%
cases:14.03%
controls:3.18%
cases:22.76%
controls:9.32%
725
3699
3077
34288
512
1305
3291
36687
152
172
3651
37820
282
7
3521
37985
146
155
3596
37718
460
1153
2819
35122
563
2704
1911
26314
Inpatient Hospital
21 [8717]
6.4e-01
1.2e+00
2.3e+00
6.4e+00
2.6e+00
1.4e+00
8.7e-01
cases:41.32%
controls:27.08%
cases:21.27%
controls:7.86%
cases:10.31%
controls:1.15%
cases:20.98%
controls:0.04%
cases:12.83%
controls:1.06%
cases:23.33%
controls:6.67%
cases:32.09%
controls:16.54%
1571
10288
2231
27699
809
2988
2994
35004
392
438
3411
37554
798
17
3005
37975
480
402
3262
37471
765
2419
2514
33856
794
4800
1680
24218
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.2e+00
2.4e+00
3.8e+00
—
3.6e+00
2.5e+00
1.7e+00
cases:8.10%
controls:2.51%
cases:13.20%
controls:1.37%
cases:6.86%
controls:0.16%
—
—
cases:5.72%
controls:0.16%
cases:15.16%
controls:1.43%
cases:19.12%
controls:4.01%
308
955
3494
37032
502
521
3301
37471
261
60
3542
37932
—
214
62
3528
37811
497
520
2782
35755
473
1165
2001
27853
Multiple myeloma
C90.0 [45600562]
2.2e+00
2.2e+00
2.4e+00
—
3.3e+00
3.0e+00
2.2e+00
cases:0.82%
controls:0.09%
cases:0.95%
controls:0.11%
cases:0.84%
controls:0.08%
—
—
cases:2.19%
controls:0.08%
cases:2.13%
controls:0.11%
cases:1.66%
controls:0.18%
31
36
3771
37951
36
42
3767
37950
32
30
3771
37962
—
82
32
3660
37841
70
40
3209
36235
41
53
2433
28965
Emergency Room Visit
ER [9203]
6.8e-01
1.2e+00
2.2e+00
6.7e+00
2.2e+00
1.3e+00
8.3e-01
cases:47.90%
controls:31.77%
cases:26.90%
controls:9.56%
cases:10.12%
controls:1.23%
cases:24.43%
controls:0.04%
cases:10.26%
controls:1.24%
cases:25.04%
controls:8.64%
cases:41.84%
controls:23.84%
1821
12069
1981
25918
1023
3633
2780
34359
385
468
3418
37524
929
15
2874
37977
384
471
3358
37402
821
3133
2458
33142
1035
6919
1439
22099
Volume of 24 hour Urine
3167-4 [3012565]
1.9e+00
1.9e+00
1.0e+50
—
4.0e+00
3.8e+00
3.5e+00
cases:0.60%
controls:0.09%
cases:0.26%
controls:0.04%
cases:0.76%
controls:0.00%
—
—
cases:0.72%
controls:0.01%
cases:1.10%
controls:0.02%
cases:1.86%
controls:0.06%
23
33
3779
37954
10
15
3793
37977
29
0
3774
37992
—
27
5
3715
37868
36
9
3243
36266
46
17
2428
29001
Kidney transplant status
Z94.0 [45566477]
2.0e+00
2.1e+00
2.7e+00
1.0e+50
2.9e+00
2.5e+00
2.8e+00
cases:1.00%
controls:0.14%
cases:1.21%
controls:0.15%
cases:0.92%
controls:0.06%
cases:0.92%
controls:0.00%
cases:0.99%
controls:0.05%
cases:1.77%
controls:0.15%
cases:2.63%
controls:0.17%
38
52
3764
37935
46
56
3757
37936
35
24
3768
37968
35
0
3768
37992
37
20
3705
37853
58
54
3221
36221
65
49
2409
28969
Unspecified kidney failure
N19 [45601718]
1.6e+00
2.4e+00
3.5e+00
—
3.1e+00
2.6e+00
1.8e+00
cases:1.13%
controls:0.24%
cases:1.18%
controls:0.11%
cases:0.87%
controls:0.03%
—
—
cases:0.91%
controls:0.04%
cases:1.80%
controls:0.13%
cases:2.30%
controls:0.40%
43
90
3759
37897
45
43
3758
37949
33
10
3770
37982
—
34
16
3708
37857
59
47
3220
36228
57
117
2417
28901
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
6.9e-01
1.4e+00
2.5e+00
5.3e+00
2.7e+00
1.4e+00
8.9e-01
cases:23.30%
controls:13.26%
cases:24.01%
controls:7.39%
cases:16.49%
controls:1.52%
cases:8.07%
controls:0.04%
cases:18.36%
controls:1.46%
cases:23.79%
controls:7.20%
cases:33.35%
controls:17.08%
886
5037
2916
32950
913
2807
2890
35185
627
579
3176
37413
307
17
3496
37975
687
552
3055
37321
780
2613
2499
33662
825
4955
1649
24063
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.3e-01
1.4e+00
2.7e+00
5.5e+00
2.6e+00
1.2e+00
7.3e-01
cases:13.02%
controls:7.37%
cases:10.91%
controls:2.87%
cases:5.31%
controls:0.36%
cases:3.68%
controls:0.02%
cases:5.42%
controls:0.41%
cases:9.36%
controls:2.98%
cases:17.70%
controls:9.38%
495
2800
3307
35187
415
1089
3388
36903
202
136
3601
37856
140
6
3663
37986
203
154
3539
37719
307
1082
2972
35193
438
2722
2036
26296
pH of Blood
11558-4 [3010421]
1.2e+00
1.9e+00
4.0e+00
1.0e+50
4.1e+00
2.2e+00
1.5e+00
cases:1.66%
controls:0.51%
cases:1.39%
controls:0.22%
cases:0.82%
controls:0.02%
cases:1.10%
controls:0.00%
cases:2.35%
controls:0.04%
cases:2.17%
controls:0.23%
cases:3.27%
controls:0.73%
63
194
3739
37793
53
84
3750
37908
31
6
3772
37986
42
0
3761
37992
88
15
3654
37858
71
85
3208
36190
81
212
2393
28806
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1.7e+00
2.4e+00
2.8e+00
—
4.3e+00
2.1e+00
1.5e+00
cases:1.26%
controls:0.23%
cases:1.26%
controls:0.11%
cases:0.58%
controls:0.04%
—
—
cases:1.52%
controls:0.02%
cases:1.28%
controls:0.15%
cases:1.98%
controls:0.44%
48
89
3754
37898
48
42
3755
37950
22
14
3781
37978
—
57
8
3685
37865
42
56
3237
36219
49
127
2425
28891
Oxygen saturation in Capillary blood
2709-4 [3021901]
1.6e+00
2.1e+00
2.9e+00
1.0e+50
4.5e+00
2.2e+00
1.5e+00
cases:0.97%
controls:0.19%
cases:1.00%
controls:0.13%
cases:0.45%
controls:0.02%
cases:0.55%
controls:0.00%
cases:1.60%
controls:0.02%
cases:1.43%
controls:0.16%
cases:2.26%
controls:0.51%
37
73
3765
37914
38
48
3765
37944
17
9
3786
37983
21
0
3782
37992
60
7
3682
37866
47
59
3232
36216
56
149
2418
28869
Blood transfusion
WW500 [2001310603]
1.6e+00
2.4e+00
3.2e+00
1.0e+50
3.3e+00
2.7e+00
1.6e+00
cases:1.39%
controls:0.28%
cases:1.39%
controls:0.12%
cases:0.71%
controls:0.03%
cases:1.13%
controls:0.00%
cases:1.07%
controls:0.04%
cases:2.01%
controls:0.14%
cases:1.54%
controls:0.33%
53
105
3749
37882
53
47
3750
37945
27
11
3776
37981
43
0
3760
37992
40
15
3702
37858
66
51
3213
36224
38
95
2436
28923
Radiotherapy of metastasis
WF049 [2001310705]
1.7e+00
2.4e+00
3.2e+00
—
4.0e+00
2.4e+00
1.0e+00
cases:0.74%
controls:0.13%
cases:1.39%
controls:0.12%
cases:0.66%
controls:0.03%
—
—
cases:1.18%
controls:0.02%
cases:1.46%
controls:0.14%
cases:0.93%
controls:0.34%
28
51
3774
37936
53
47
3750
37945
25
10
3778
37982
—
44
8
3698
37865
48
49
3231
36226
23
98
2451
28920
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
1.4e+00
1.7e+00
3.6e+00
1.0e+50
4.4e+00
2.1e+00
1.6e+00
cases:1.13%
controls:0.29%
cases:0.84%
controls:0.16%
cases:0.58%
controls:0.02%
cases:0.76%
controls:0.00%
cases:1.52%
controls:0.02%
cases:1.31%
controls:0.16%
cases:2.14%
controls:0.45%
43
112
3759
37875
32
60
3771
37932
22
6
3781
37986
29
0
3774
37992
57
7
3685
37866
43
58
3236
36217
53
130
2421
28888
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
1.3e+00
2.2e+00
3.2e+00
1.0e+50
4.3e+00
2.2e+00
1.4e+00
cases:1.47%
controls:0.39%
cases:1.37%
controls:0.16%
cases:0.39%
controls:0.02%
cases:0.24%
controls:0.00%
cases:1.36%
controls:0.02%
cases:1.71%
controls:0.18%
cases:2.59%
controls:0.65%
56
149
3746
37838
52
59
3751
37933
15
6
3788
37986
9
0
3794
37992
51
7
3691
37866
56
67
3223
36208
64
189
2410
28829
Gastroenterology
10 [38004455]
7.8e-01
1.3e+00
1.7e+00
5.7e+00
2.4e+00
1.8e+00
1.1e+00
cases:11.86%
controls:5.81%
cases:8.36%
controls:2.53%
cases:2.26%
controls:0.44%
cases:5.84%
controls:0.02%
cases:4.94%
controls:0.47%
cases:13.27%
controls:2.49%
cases:17.54%
controls:6.54%
451
2207
3351
35780
318
961
3485
37031
86
168
3717
37824
222
8
3581
37984
185
177
3557
37696
435
905
2844
35370
434
1899
2040
27119
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
1.2e+00
1.7e+00
3.9e+00
—
4.2e+00
2.1e+00
1.4e+00
cases:2.13%
controls:0.63%
cases:2.08%
controls:0.40%
cases:1.66%
controls:0.03%
—
—
cases:3.23%
controls:0.05%
cases:2.65%
controls:0.32%
cases:3.48%
controls:0.85%
81
238
3721
37749
79
152
3724
37840
63
13
3740
37979
—
121
19
3621
37854
87
117
3192
36158
86
246
2388
28772
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
1.2e+00
1.7e+00
3.8e+00
—
4.2e+00
2.2e+00
1.4e+00
cases:1.89%
controls:0.55%
cases:2.05%
controls:0.39%
cases:1.55%
controls:0.03%
—
—
cases:3.07%
controls:0.05%
cases:2.53%
controls:0.29%
cases:3.15%
controls:0.78%
72
210
3730
37777
78
148
3725
37844
59
13
3744
37979
—
115
18
3627
37855
83
105
3196
36170
78
227
2396
28791
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
5.0e-01
1.1e+00
2.5e+00
5.9e+00
2.6e+00
1.3e+00
6.5e-01
cases:23.17%
controls:15.41%
cases:19.56%
controls:7.17%
cases:10.60%
controls:0.92%
cases:10.65%
controls:0.03%
cases:10.88%
controls:0.94%
cases:20.74%
controls:6.79%
cases:31.49%
controls:19.29%
881
5855
2921
32132
744
2723
3059
35269
403
349
3400
37643
405
13
3398
37979
407
356
3335
37517
680
2463
2599
33812
779
5597
1695
23421
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.3e+00
1.8e+00
3.3e+00
—
4.4e+00
2.3e+00
1.4e+00
cases:2.76%
controls:0.74%
cases:2.24%
controls:0.38%
cases:0.92%
controls:0.03%
—
—
cases:1.90%
controls:0.02%
cases:2.96%
controls:0.31%
cases:4.16%
controls:1.05%
105
281
3697
37706
85
145
3718
37847
35
13
3768
37979
—
71
9
3671
37864
97
114
3182
36161
103
304
2371
28714
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
1.3e+00
1.7e+00
3.8e+00
—
4.2e+00
2.1e+00
1.4e+00
cases:2.29%
controls:0.66%
cases:2.26%
controls:0.41%
cases:1.79%
controls:0.04%
—
—
cases:3.58%
controls:0.06%
cases:2.81%
controls:0.35%
cases:3.72%
controls:0.95%
87
249
3715
37738
86
157
3717
37835
68
16
3735
37976
—
134
21
3608
37852
92
128
3187
36147
92
275
2382
28743
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.3e+00
1.9e+00
3.7e+00
—
4.2e+00
2.0e+00
1.4e+00
cases:4.45%
controls:1.30%
cases:4.10%
controls:0.66%
cases:3.31%
controls:0.08%
—
—
cases:6.52%
controls:0.10%
cases:4.33%
controls:0.61%
cases:5.74%
controls:1.51%
169
494
3633
37493
156
249
3647
37743
126
32
3677
37960
—
244
38
3498
37835
142
223
3137
36052
142
438
2332
28580
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
1.3e+00
1.7e+00
3.7e+00
—
4.3e+00
2.0e+00
1.4e+00
cases:2.16%
controls:0.62%
cases:1.97%
controls:0.37%
cases:1.60%
controls:0.04%
—
—
cases:2.97%
controls:0.04%
cases:2.26%
controls:0.31%
cases:3.15%
controls:0.77%
82
234
3720
37753
75
142
3728
37850
61
15
3742
37977
—
111
15
3631
37858
74
114
3205
36161
78
223
2396
28795
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
5.7e-01
1.1e+00
2.6e+00
6.0e+00
2.6e+00
1.1e+00
6.0e-01
cases:15.41%
controls:9.34%
cases:11.18%
controls:4.07%
cases:5.65%
controls:0.46%
cases:7.13%
controls:0.02%
cases:6.36%
controls:0.53%
cases:11.13%
controls:4.20%
cases:20.78%
controls:12.59%
586
3549
3216
34438
425
1548
3378
36444
215
176
3588
37816
271
7
3532
37985
238
199
3504
37674
365
1523
2914
34752
514
3653
1960
25365
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
1.3e+00
1.7e+00
3.8e+00
—
4.2e+00
2.1e+00
1.4e+00
cases:2.29%
controls:0.66%
cases:2.26%
controls:0.41%
cases:1.79%
controls:0.04%
—
—
cases:3.61%
controls:0.06%
cases:2.81%
controls:0.36%
cases:3.72%
controls:0.95%
87
249
3715
37738
86
157
3717
37835
68
16
3735
37976
—
135
21
3607
37852
92
130
3187
36145
92
276
2382
28742
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
1.3e+00
1.7e+00
3.8e+00
—
4.2e+00
2.1e+00
1.4e+00
cases:2.29%
controls:0.65%
cases:2.26%
controls:0.41%
cases:1.79%
controls:0.04%
—
—
cases:3.55%
controls:0.06%
cases:2.81%
controls:0.36%
cases:3.72%
controls:0.95%
87
248
3715
37739
86
156
3717
37836
68
16
3735
37976
—
133
21
3609
37852
92
130
3187
36145
92
275
2382
28743
Bone marrow biopsy
XW000 [2001310618]
1.5e+00
2.0e+00
3.2e+00
—
3.6e+00
2.5e+00
1.5e+00
cases:1.68%
controls:0.38%
cases:1.03%
controls:0.13%
cases:0.32%
controls:0.01%
—
—
cases:0.59%
controls:0.02%
cases:1.28%
controls:0.10%
cases:1.58%
controls:0.34%
64
143
3738
37844
39
51
3764
37941
12
5
3791
37987
—
22
6
3720
37867
42
37
3237
36238
39
100
2435
28918
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
5.0e-01
1.1e+00
2.5e+00
5.7e+00
2.8e+00
1.1e+00
7.9e-01
cases:10.31%
controls:6.52%
cases:7.31%
controls:2.65%
cases:3.21%
controls:0.28%
cases:3.92%
controls:0.01%
cases:4.52%
controls:0.29%
cases:7.01%
controls:2.48%
cases:16.33%
controls:8.16%
392
2476
3410
35511
278
1006
3525
36986
122
108
3681
37884
149
5
3654
37987
169
111
3573
37762
230
901
3049
35374
404
2367
2070
26651
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
1.2e+00
1.6e+00
3.7e+00
—
4.2e+00
2.1e+00
1.5e+00
cases:1.63%
controls:0.51%
cases:1.66%
controls:0.34%
cases:1.31%
controls:0.03%
—
—
cases:2.49%
controls:0.04%
cases:1.89%
controls:0.23%
cases:2.71%
controls:0.60%
62
192
3740
37795
63
128
3740
37864
50
12
3753
37980
—
93
14
3649
37859
62
85
3217
36190
67
174
2407
28844
Fatty (change of) liver, not elsewhere classified
K76.0 [45601189]
1.3e+00
2.7e+00
3.4e+00
1.0e+50
2.9e+00
2.5e+00
1.6e+00
cases:0.76%
controls:0.21%
cases:0.82%
controls:0.06%
cases:0.39%
controls:0.01%
cases:0.74%
controls:0.00%
cases:0.43%
controls:0.02%
cases:1.13%
controls:0.09%
cases:1.17%
controls:0.24%
29
79
3773
37908
31
22
3772
37970
15
5
3788
37987
28
0
3775
37992
16
9
3726
37864
37
33
3242
36242
29
70
2445
28948
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
9.0e-01
1.9e+00
3.8e+00
—
3.8e+00
2.3e+00
1.6e+00
cases:4.42%
controls:1.85%
cases:5.65%
controls:0.87%
cases:4.65%
controls:0.11%
—
—
cases:7.22%
controls:0.17%
cases:8.54%
controls:0.90%
cases:10.15%
controls:2.22%
168
701
3634
37286
215
329
3588
37663
177
43
3626
37949
—
270
65
3472
37808
280
326
2999
35949
251
645
2223
28373
Outpatient Hospital
22 [8756]
6.0e-01
1.1e+00
2.3e+00
5.4e+00
2.4e+00
1.5e+00
9.1e-01
cases:34.35%
controls:22.38%
cases:16.20%
controls:6.01%
cases:7.07%
controls:0.78%
cases:8.23%
controls:0.04%
cases:7.08%
controls:0.71%
cases:18.24%
controls:4.54%
cases:25.95%
controls:12.33%
1306
8501
2496
29486
616
2282
3187
35710
269
296
3534
37696
313
15
3490
37977
265
270
3477
37603
598
1648
2681
34627
642
3579
1832
25439
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
5.5e-01
1.2e+00
2.4e+00
5.5e+00
2.7e+00
1.2e+00
7.2e-01
cases:14.52%
controls:8.92%
cases:12.15%
controls:4.17%
cases:5.89%
controls:0.59%
cases:4.44%
controls:0.02%
cases:7.48%
controls:0.57%
cases:12.81%
controls:4.13%
cases:21.06%
controls:11.45%
552
3388
3250
34599
462
1586
3341
36406
224
225
3579
37767
169
7
3634
37985
280
215
3462
37658
420
1498
2859
34777
521
3323
1953
25695
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.4e+00
1.9e+00
3.1e+00
—
3.8e+00
2.3e+00
1.7e+00
cases:6.39%
controls:1.63%
cases:6.15%
controls:0.98%
cases:4.05%
controls:0.20%
—
—
cases:7.30%
controls:0.18%
cases:8.75%
controls:0.92%
cases:10.59%
controls:2.13%
243
620
3559
37367
234
373
3569
37619
154
75
3649
37917
—
273
67
3469
37806
287
333
2992
35942
262
619
2212
28399
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
1.4e+00
1.9e+00
2.9e+00
—
4.3e+00
2.2e+00
1.5e+00
cases:1.29%
controls:0.31%
cases:1.21%
controls:0.18%
cases:0.55%
controls:0.03%
—
—
cases:1.76%
controls:0.02%
cases:1.77%
controls:0.20%
cases:2.55%
controls:0.61%
49
119
3753
37868
46
69
3757
37923
21
12
3782
37980
—
66
9
3676
37864
58
72
3221
36203
63
176
2411
28842
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.4e-01
1.3e+00
2.6e+00
4.8e+00
2.6e+00
1.4e+00
9.3e-01
cases:35.85%
controls:24.66%
cases:39.23%
controls:14.87%
cases:28.58%
controls:2.83%
cases:10.97%
controls:0.10%
cases:27.74%
controls:2.79%
cases:40.96%
controls:14.56%
cases:52.83%
controls:30.61%
1363
9367
2439
28620
1492
5649
2311
32343
1087
1076
2716
36916
417
39
3386
37953
1038
1058
2704
36815
1343
5280
1936
30995
1307
8881
1167
20137
Acute renal failure, unspecified
N17.9 [45567829]
2.3e+00
2.9e+00
4.1e+00
—
—
3.1e+00
1.9e+00
cases:1.50%
controls:0.16%
cases:1.50%
controls:0.09%
cases:1.26%
controls:0.02%
—
—
—
—
cases:2.50%
controls:0.12%
cases:2.26%
controls:0.35%
57
60
3745
37927
57
33
3746
37959
48
8
3755
37984
—
—
82
44
3197
36231
56
102
2418
28916
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
1.2e+00
1.6e+00
3.6e+00
—
4.3e+00
2.1e+00
1.5e+00
cases:1.50%
controls:0.47%
cases:1.53%
controls:0.33%
cases:1.26%
controls:0.03%
—
—
cases:2.41%
controls:0.03%
cases:1.77%
controls:0.23%
cases:2.55%
controls:0.60%
57
180
3745
37807
58
124
3745
37868
48
13
3755
37979
—
90
13
3652
37860
58
83
3221
36192
63
173
2411
28845
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
1.1e+00
1.5e+00
3.7e+00
—
4.2e+00
2.1e+00
1.4e+00
cases:1.42%
controls:0.46%
cases:1.45%
controls:0.31%
cases:1.21%
controls:0.03%
—
—
cases:2.32%
controls:0.03%
cases:1.62%
controls:0.21%
cases:2.18%
controls:0.54%
54
176
3748
37811
55
118
3748
37874
46
11
3757
37981
—
87
13
3655
37860
53
75
3226
36200
54
158
2420
28860
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.3e+00
1.9e+00
3.4e+00
—
3.5e+00
2.3e+00
1.8e+00
cases:1.89%
controls:0.54%
cases:1.87%
controls:0.29%
cases:1.05%
controls:0.04%
—
—
cases:1.28%
controls:0.04%
cases:3.02%
controls:0.30%
cases:3.96%
controls:0.67%
72
207
3730
37780
71
111
3732
37881
40
14
3763
37978
—
48
15
3694
37858
99
110
3180
36165
98
194
2376
28824
Chronic kidney disease
N18 [45582391]
2.5e+00
2.4e+00
2.5e+00
—
2.0e+00
2.6e+00
2.2e+00
cases:2.10%
controls:0.17%
cases:0.97%
controls:0.09%
cases:0.16%
controls:0.01%
—
—
cases:0.19%
controls:0.03%
cases:1.16%
controls:0.09%
cases:1.86%
controls:0.21%
80
66
3722
37921
37
34
3766
37958
6
5
3797
37987
—
7
10
3735
37863
38
32
3241
36243
46
62
2428
28956
Other disorders resulting from impaired renal tubular function
N25.8 [45582397]
3.1e+00
3.8e+00
—
1.0e+50
—
3.5e+00
3.6e+00
cases:1.18%
controls:0.06%
cases:0.84%
controls:0.02%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.85%
controls:0.02%
cases:1.41%
controls:0.04%
45
21
3757
37966
32
7
3771
37985
—
9
0
3794
37992
—
28
9
3251
36266
35
11
2439
29007
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E11.2 [2000503133]
1.7e+00
2.1e+00
2.6e+00
1.0e+50
3.1e+00
2.4e+00
2.2e+00
cases:0.68%
controls:0.13%
cases:0.63%
controls:0.08%
cases:0.29%
controls:0.02%
cases:0.29%
controls:0.00%
cases:0.35%
controls:0.02%
cases:0.82%
controls:0.07%
cases:1.29%
controls:0.15%
26
48
3776
37939
24
30
3779
37962
11
8
3792
37984
11
0
3792
37992
13
6
3729
37867
27
27
3252
36248
32
43
2442
28975
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
5.2e-01
1.2e+00
2.8e+00
4.7e+00
2.6e+00
1.5e+00
8.2e-01
cases:12.44%
controls:7.77%
cases:9.39%
controls:3.14%
cases:5.63%
controls:0.37%
cases:1.42%
controls:0.01%
cases:4.86%
controls:0.39%
cases:9.88%
controls:2.36%
cases:16.09%
controls:7.78%
473
2952
3329
35035
357
1193
3446
36799
214
142
3589
37850
54
5
3749
37987
182
147
3560
37726
324
855
2955
35420
398
2259
2076
26759
Hypokalaemia
E87.6 [45537991]
2.8e+00
4.3e+00
—
1.0e+50
1.0e+50
4.1e+00
2.8e+00
cases:0.97%
controls:0.06%
cases:1.29%
controls:0.02%
—
—
cases:4.55%
controls:0.00%
cases:1.95%
controls:0.00%
cases:1.86%
controls:0.03%
cases:2.14%
controls:0.13%
37
22
3765
37965
49
7
3754
37985
—
173
0
3630
37992
73
0
3669
37873
61
11
3218
36264
53
39
2421
28979
Excision of lesion of parathyroid gland
BBA30 [2001300785]
1.7e+00
3.1e+00
—
—
—
5.3e+00
3.9e+00
cases:0.39%
controls:0.07%
cases:0.47%
controls:0.02%
—
—
—
—
—
—
cases:3.81%
controls:0.02%
cases:2.75%
controls:0.06%
15
28
3787
37959
18
8
3785
37984
—
—
—
125
7
3154
36268
68
17
2406
29001
Thyroglobulin [Mass/volume] in Serum or Plasma
3013-0 [3036535]
1.7e+00
1.9e+00
—
—
4.0e+00
3.3e+00
3.1e+00
cases:0.58%
controls:0.11%
cases:0.50%
controls:0.08%
—
—
—
—
cases:0.99%
controls:0.02%
cases:2.29%
controls:0.09%
cases:3.27%
controls:0.15%
22
41
3780
37946
19
29
3784
37963
—
—
37
7
3705
37866
75
31
3204
36244
81
44
2393
28974
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1.6e+00
2.0e+00
2.9e+00
1.0e+50
4.0e+00
2.2e+00
1.3e+00
cases:1.47%
controls:0.30%
cases:1.34%
controls:0.19%
cases:0.74%
controls:0.04%
cases:0.82%
controls:0.00%
cases:2.14%
controls:0.04%
cases:2.20%
controls:0.24%
cases:3.31%
controls:0.93%
56
113
3746
37874
51
73
3752
37919
28
16
3775
37976
31
0
3772
37992
80
15
3662
37858
72
88
3207
36187
82
269
2392
28749
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
1.2e+00
1.7e+00
3.4e+00
1.0e+50
3.9e+00
2.0e+00
1.7e+00
cases:1.45%
controls:0.44%
cases:1.03%
controls:0.19%
cases:0.39%
controls:0.01%
cases:0.74%
controls:0.00%
cases:1.31%
controls:0.03%
cases:1.13%
controls:0.15%
cases:1.94%
controls:0.35%
55
169
3747
37818
39
71
3764
37921
15
5
3788
37987
28
0
3775
37992
49
10
3693
37863
37
56
3242
36219
48
103
2426
28915
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
8.1e-01
1.5e+00
2.6e+00
3.5e+00
3.0e+00
1.5e+00
9.9e-01
cases:11.44%
controls:5.42%
cases:11.36%
controls:2.68%
cases:3.68%
controls:0.28%
cases:0.53%
controls:0.02%
cases:5.42%
controls:0.29%
cases:11.01%
controls:2.77%
cases:18.59%
controls:7.81%
435
2060
3367
35927
432
1019
3371
36973
140
106
3663
37886
20
6
3783
37986
203
108
3539
37765
361
1004
2918
35271
460
2267
2014
26751
Other transplanted organ and tissue status
Z94.8 [45600381]
2.1e+00
1.9e+00
2.3e+00
—
2.3e+00
2.8e+00
2.5e+00
cases:0.34%
controls:0.04%
cases:0.24%
controls:0.03%
cases:0.21%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.52%
controls:0.03%
cases:0.77%
controls:0.06%
13
16
3789
37971
9
13
3794
37979
8
8
3795
37984
—
7
7
3735
37866
17
12
3262
36263
19
18
2455
29000
Base excess in Blood by calculation
11555-0 [3012501]
1.2e+00
1.7e+00
3.4e+00
1.0e+50
3.9e+00
2.0e+00
1.7e+00
cases:1.45%
controls:0.44%
cases:1.03%
controls:0.19%
cases:0.39%
controls:0.01%
cases:0.74%
controls:0.00%
cases:1.31%
controls:0.03%
cases:1.13%
controls:0.15%
cases:1.94%
controls:0.36%
55
169
3747
37818
39
71
3764
37921
15
5
3788
37987
28
0
3775
37992
49
10
3693
37863
37
56
3242
36219
48
104
2426
28914
Reticulocyte production index
31111-8 [3000012]
1.4e+00
1.9e+00
3.2e+00
—
3.9e+00
2.2e+00
1.3e+00
cases:0.95%
controls:0.24%
cases:0.82%
controls:0.12%
cases:0.32%
controls:0.01%
—
—
cases:1.02%
controls:0.02%
cases:1.10%
controls:0.13%
cases:1.54%
controls:0.40%
36
92
3766
37895
31
45
3772
37947
12
5
3791
37987
—
38
8
3704
37865
36
46
3243
36229
38
117
2436
28901
Leukocytes [#/volume] in Urine
30405-5 [3018095]
5.4e-01
1.1e+00
2.3e+00
5.8e+00
2.5e+00
1.1e+00
6.0e-01
cases:13.15%
controls:8.14%
cases:11.67%
controls:4.32%
cases:5.60%
controls:0.62%
cases:4.29%
controls:0.01%
cases:7.06%
controls:0.63%
cases:12.44%
controls:4.51%
cases:20.78%
controls:12.61%
500
3091
3302
34896
444
1642
3359
36350
213
234
3590
37758
163
5
3640
37987
264
239
3478
37634
408
1637
2871
34638
514
3660
1960
25358
Thyrotoxicosis with toxic multinodular goitre
E05.2 [45600629]
1.7e+00
3.3e+00
3.5e+00
1.0e+50
2.8e+00
2.6e+00
1.4e+00
cases:0.39%
controls:0.07%
cases:0.82%
controls:0.03%
cases:0.58%
controls:0.02%
cases:0.32%
controls:0.00%
cases:0.35%
controls:0.02%
cases:0.61%
controls:0.05%
cases:0.36%
controls:0.09%
15
28
3787
37959
31
11
3772
37981
22
7
3781
37985
12
0
3791
37992
13
8
3729
37865
20
17
3259
36258
9
26
2465
28992
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
1.3e+00
1.8e+00
3.3e+00
—
3.6e+00
2.3e+00
1.6e+00
cases:0.97%
controls:0.26%
cases:0.97%
controls:0.16%
cases:0.47%
controls:0.02%
—
—
cases:0.83%
controls:0.02%
cases:1.49%
controls:0.15%
cases:1.90%
controls:0.40%
37
99
3765
37888
37
59
3766
37933
18
7
3785
37985
—
31
9
3711
37864
49
55
3230
36220
47
116
2427
28902
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
1.2e+00
1.8e+00
3.5e+00
—
4.1e+00
2.0e+00
1.3e+00
cases:4.68%
controls:1.49%
cases:4.73%
controls:0.79%
cases:3.55%
controls:0.11%
—
—
cases:6.87%
controls:0.12%
cases:5.28%
controls:0.76%
cases:6.51%
controls:1.92%
178
567
3624
37420
180
301
3623
37691
135
42
3668
37950
—
257
47
3485
37826
173
275
3106
36000
161
556
2313
28462
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.2e+00
1.7e+00
3.4e+00
1.0e+50
3.8e+00
2.0e+00
1.7e+00
cases:1.45%
controls:0.45%
cases:1.03%
controls:0.19%
cases:0.39%
controls:0.01%
cases:0.74%
controls:0.00%
cases:1.31%
controls:0.03%
cases:1.13%
controls:0.16%
cases:1.94%
controls:0.37%
55
171
3747
37816
39
72
3764
37920
15
5
3788
37987
28
0
3775
37992
49
11
3693
37862
37
58
3242
36217
48
106
2426
28912
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
1.4e+00
1.5e+00
3.9e+00
—
3.6e+00
1.9e+00
1.4e+00
cases:1.47%
controls:0.37%
cases:0.92%
controls:0.20%
cases:0.63%
controls:0.01%
—
—
cases:0.86%
controls:0.02%
cases:1.28%
controls:0.20%
cases:2.06%
controls:0.49%
56
141
3746
37846
35
76
3768
37916
24
5
3779
37987
—
32
9
3710
37864
42
71
3237
36204
51
143
2423
28875
Neck ultrasound examination
EP1AE [2001302284]
1.2e+00
2.3e+00
2.2e+00
1.0e+50
3.0e+00
2.8e+00
2.1e+00
cases:2.08%
controls:0.66%
cases:1.97%
controls:0.20%
cases:0.26%
controls:0.03%
cases:0.55%
controls:0.00%
cases:0.53%
controls:0.03%
cases:2.93%
controls:0.18%
cases:3.60%
controls:0.47%
79
252
3723
37735
75
77
3728
37915
10
11
3793
37981
21
0
3782
37992
20
10
3722
37863
96
64
3183
36211
89
135
2385
28883
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
6.8e-01
1.5e+00
2.9e+00
3.3e+00
2.6e+00
1.6e+00
9.8e-01
cases:17.46%
controls:9.65%
cases:21.90%
controls:5.68%
cases:10.75%
controls:0.67%
cases:0.63%
controls:0.02%
cases:8.82%
controls:0.68%
cases:23.30%
controls:6.00%
cases:33.14%
controls:15.67%
664
3667
3138
34320
833
2159
2970
35833
409
254
3394
37738
24
9
3779
37983
330
258
3412
37615
764
2176
2515
34099
820
4547
1654
24471
Office Visit
OMOP4822458 [581477]
7.0e-01
1.1e+00
2.0e+00
4.4e+00
2.6e+00
1.6e+00
1.1e+00
cases:14.41%
controls:7.69%
cases:5.81%
controls:1.98%
cases:1.95%
controls:0.27%
cases:1.10%
controls:0.01%
cases:3.26%
controls:0.26%
cases:7.78%
controls:1.63%
cases:12.41%
controls:4.38%
548
2923
3254
35064
221
752
3582
37240
74
102
3729
37890
42
5
3761
37987
122
99
3620
37774
255
591
3024
35684
307
1272
2167
27746
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.4e+00
2.0e+00
2.2e+00
—
3.3e+00
2.7e+00
2.0e+00
cases:0.95%
controls:0.23%
cases:1.05%
controls:0.14%
cases:0.37%
controls:0.04%
—
—
cases:0.83%
controls:0.03%
cases:1.52%
controls:0.11%
cases:2.30%
controls:0.33%
36
88
3766
37899
40
53
3763
37939
14
15
3789
37977
—
31
12
3711
37861
50
39
3229
36236
57
97
2417
28921
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.1e+00
1.8e+00
3.1e+00
—
4.3e+00
2.1e+00
1.2e+00
cases:3.52%
controls:1.16%
cases:2.66%
controls:0.46%
cases:1.03%
controls:0.05%
—
—
cases:2.94%
controls:0.04%
cases:3.75%
controls:0.49%
cases:4.85%
controls:1.59%
134
441
3668
37546
101
173
3702
37819
39
18
3764
37974
—
110
15
3632
37858
123
177
3156
36098
120
460
2354
28558
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
6.4e-01
1.2e+00
2.4e+00
4.7e+00
2.6e+00
1.2e+00
7.6e-01
cases:9.76%
controls:5.37%
cases:9.05%
controls:3.02%
cases:5.18%
controls:0.48%
cases:1.63%
controls:0.02%
cases:6.36%
controls:0.49%
cases:9.61%
controls:2.97%
cases:14.59%
controls:7.42%
371
2040
3431
35947
344
1146
3459
36846
197
183
3606
37809
62
6
3741
37986
238
186
3504
37687
315
1076
2964
35199
361
2153
2113
26865
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.2e+00
2.0e+00
3.2e+00
—
4.1e+00
1.9e+00
1.1e+00
cases:1.63%
controls:0.49%
cases:1.68%
controls:0.24%
cases:0.74%
controls:0.03%
—
—
cases:2.11%
controls:0.03%
cases:2.01%
controls:0.29%
cases:2.79%
controls:0.98%
62
186
3740
37801
64
91
3739
37901
28
12
3775
37980
—
79
13
3663
37860
66
106
3213
36169
69
283
2405
28735
Paralysis of vocal cords and larynx
J38.0 [45543265]
9.8e-01
1.9e+00
2.1e+00
—
3.5e+00
3.4e+00
2.6e+00
cases:0.32%
controls:0.12%
cases:0.37%
controls:0.06%
cases:0.16%
controls:0.02%
—
—
cases:0.43%
controls:0.01%
cases:1.40%
controls:0.05%
cases:1.58%
controls:0.12%
12
45
3790
37942
14
21
3789
37971
6
7
3797
37985
—
16
5
3726
37868
46
18
3233
36257
39
35
2435
28983
Hyperlipidaemia, unspecified
E78.5 [45537986]
1.7e+00
1.8e+00
2.8e+00
1.0e+50
3.1e+00
2.6e+00
1.5e+00
cases:2.26%
controls:0.42%
cases:1.03%
controls:0.17%
cases:0.21%
controls:0.01%
cases:0.66%
controls:0.00%
cases:0.40%
controls:0.02%
cases:1.52%
controls:0.11%
cases:2.59%
controls:0.60%
86
159
3716
37828
39
64
3764
37928
8
5
3795
37987
25
0
3778
37992
15
7
3727
37866
50
41
3229
36234
64
175
2410
28843
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.0e-01
1.2e+00
2.6e+00
4.5e+00
2.5e+00
1.5e+00
8.7e-01
cases:8.94%
controls:6.18%
cases:8.76%
controls:2.90%
cases:4.89%
controls:0.39%
cases:1.58%
controls:0.02%
cases:4.81%
controls:0.41%
cases:9.79%
controls:2.42%
cases:14.67%
controls:6.70%
340
2347
3462
35640
333
1101
3470
36891
186
147
3617
37845
60
7
3743
37985
180
157
3562
37716
321
878
2958
35397
363
1944
2111
27074
General Surgery
2 [38004447]
5.4e-01
1.2e+00
2.7e+00
4.7e+00
2.1e+00
1.4e+00
7.9e-01
cases:22.78%
controls:14.71%
cases:13.20%
controls:4.21%
cases:6.76%
controls:0.50%
cases:2.16%
controls:0.02%
cases:4.33%
controls:0.53%
cases:13.91%
controls:3.73%
cases:21.67%
controls:11.17%
866
5586
2936
32401
502
1601
3301
36391
257
190
3546
37802
82
8
3721
37984
162
199
3580
37674
456
1354
2823
34921
536
3241
1938
25777
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
1.2e+00
1.7e+00
3.0e+00
—
4.1e+00
2.1e+00
1.4e+00
cases:3.63%
controls:1.08%
cases:2.73%
controls:0.53%
cases:1.60%
controls:0.08%
—
—
cases:4.38%
controls:0.08%
cases:4.45%
controls:0.57%
cases:5.74%
controls:1.53%
138
411
3664
37576
104
203
3699
37789
61
30
3742
37962
—
164
30
3578
37843
146
206
3133
36069
142
444
2332
28574
pH of Capillary blood
2745-8 [3009343]
1.2e+00
1.6e+00
3.0e+00
—
4.0e+00
2.1e+00
1.4e+00
cases:3.60%
controls:1.07%
cases:2.63%
controls:0.53%
cases:1.60%
controls:0.08%
—
—
cases:4.30%
controls:0.08%
cases:4.36%
controls:0.55%
cases:5.66%
controls:1.48%
137
407
3665
37580
100
201
3703
37791
61
30
3742
37962
—
161
30
3581
37843
143
200
3136
36075
140
429
2334
28589
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.8e-01
1.2e+00
2.4e+00
4.6e+00
2.3e+00
1.3e+00
1.0e+00
cases:15.54%
controls:8.53%
cases:14.57%
controls:5.12%
cases:8.55%
controls:0.87%
cases:2.21%
controls:0.02%
cases:10.02%
controls:1.06%
cases:16.10%
controls:5.01%
cases:23.61%
controls:10.03%
591
3242
3211
34745
554
1944
3249
36048
325
331
3478
37661
84
9
3719
37983
375
400
3367
37473
528
1816
2751
34459
584
2910
1890
26108
General Practice
1 [38004446]
6.1e-01
1.0e+00
2.0e+00
5.3e+00
2.7e+00
1.1e+00
6.4e-01
cases:21.41%
controls:12.89%
cases:12.28%
controls:4.82%
cases:5.13%
controls:0.74%
cases:5.23%
controls:0.03%
cases:10.32%
controls:0.76%
cases:14.39%
controls:5.27%
cases:25.06%
controls:14.93%
814
4898
2988
33089
467
1831
3336
36161
195
283
3608
37709
199
10
3604
37982
386
289
3356
37584
472
1913
2807
34362
620
4332
1854
24686
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
1.2e+00
1.6e+00
2.9e+00
—
4.1e+00
2.1e+00
1.5e+00
cases:3.50%
controls:1.04%
cases:2.21%
controls:0.47%
cases:1.26%
controls:0.07%
—
—
cases:3.47%
controls:0.06%
cases:3.72%
controls:0.47%
cases:5.01%
controls:1.18%
133
394
3669
37593
84
178
3719
37814
48
27
3755
37965
—
130
23
3612
37850
122
171
3157
36104
124
341
2350
28677
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
1.0e+00
1.9e+00
3.2e+00
—
3.7e+00
2.0e+00
1.5e+00
cases:4.63%
controls:1.68%
cases:4.47%
controls:0.71%
cases:2.45%
controls:0.10%
—
—
cases:4.65%
controls:0.12%
cases:5.06%
controls:0.75%
cases:8.37%
controls:1.96%
176
637
3626
37350
170
270
3633
37722
93
37
3710
37955
—
174
45
3568
37828
166
272
3113
36003
207
568
2267
28450
Treatment plan or consultation
WZC00 [2001310885]
5.7e-01
1.2e+00
2.0e+00
5.0e+00
2.4e+00
1.4e+00
6.8e-01
cases:11.20%
controls:6.65%
cases:7.68%
controls:2.39%
cases:2.63%
controls:0.36%
cases:2.63%
controls:0.02%
cases:3.50%
controls:0.31%
cases:8.26%
controls:2.18%
cases:13.22%
controls:7.16%
426
2528
3376
35459
292
907
3511
37085
100
135
3703
37857
100
7
3703
37985
131
119
3611
37754
271
791
3008
35484
327
2079
2147
26939
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.7e-01
1.1e+00
2.3e+00
4.7e+00
2.4e+00
1.3e+00
9.3e-01
cases:20.31%
controls:12.59%
cases:19.93%
controls:7.31%
cases:11.28%
controls:1.24%
cases:2.97%
controls:0.03%
cases:13.82%
controls:1.40%
cases:21.23%
controls:7.12%
cases:31.12%
controls:15.19%
772
4784
3030
33203
758
2779
3045
35213
429
470
3374
37522
113
11
3690
37981
517
529
3225
37344
696
2583
2583
33692
770
4407
1704
24611
erythropoietin; parenteral
B03XA01 [21601133]
2.8e+00
3.8e+00
—
—
—
3.7e+00
3.0e+00
cases:0.58%
controls:0.04%
cases:0.60%
controls:0.01%
—
—
—
—
—
—
cases:0.79%
controls:0.02%
cases:0.73%
controls:0.04%
22
14
3780
37973
23
5
3780
37987
—
—
—
26
7
3253
36268
18
11
2456
29007
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
5.7e-01
1.1e+00
2.3e+00
4.6e+00
2.4e+00
1.3e+00
9.3e-01
cases:20.25%
controls:12.56%
cases:19.85%
controls:7.33%
cases:11.18%
controls:1.23%
cases:2.92%
controls:0.03%
cases:13.68%
controls:1.40%
cases:21.13%
controls:7.11%
cases:31.16%
controls:15.17%
770
4771
3032
33216
755
2783
3048
35209
425
468
3378
37524
111
11
3692
37981
512
531
3230
37342
693
2579
2586
33696
771
4402
1703
24616
oxycodone; oral, parenteral
N02AA05 [21604260]
1.1e+00
1.7e+00
2.6e+00
2.4e+00
2.7e+00
1.8e+00
9.6e-01
cases:5.13%
controls:1.75%
cases:5.57%
controls:1.11%
cases:4.36%
controls:0.34%
cases:0.24%
controls:0.02%
cases:5.34%
controls:0.38%
cases:7.53%
controls:1.30%
cases:8.29%
controls:3.35%
195
663
3607
37324
212
422
3591
37570
166
131
3637
37861
9
8
3794
37984
200
144
3542
37729
247
473
3032
35802
205
971
2269
28047
Basophils/Leukocytes in Blood
30180-4 [3022096]
5.7e-01
1.1e+00
2.3e+00
4.6e+00
2.4e+00
1.3e+00
9.2e-01
cases:20.17%
controls:12.52%
cases:19.83%
controls:7.30%
cases:11.20%
controls:1.23%
cases:2.81%
controls:0.03%
cases:13.71%
controls:1.41%
cases:21.32%
controls:7.11%
cases:31.20%
controls:15.26%
767
4755
3035
33232
754
2772
3049
35220
426
467
3377
37525
107
11
3696
37981
513
533
3229
37340
699
2579
2580
33696
772
4428
1702
24590
Emergency Medicine
93 [38004510]
5.0e-01
9.9e-01
2.3e+00
6.1e+00
1.9e+00
9.8e-01
4.3e-01
cases:25.57%
controls:17.31%
cases:20.27%
controls:8.61%
cases:10.18%
controls:1.12%
cases:17.80%
controls:0.05%
cases:7.38%
controls:1.21%
cases:21.01%
controls:9.08%
cases:34.20%
controls:25.28%
972
6574
2830
31413
771
3271
3032
34721
387
425
3416
37567
677
18
3126
37974
276
458
3466
37415
689
3293
2590
32982
846
7335
1628
21683
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.3e-01
1.1e+00
2.3e+00
4.7e+00
2.4e+00
1.2e+00
9.0e-01
cases:19.99%
controls:12.85%
cases:20.12%
controls:7.49%
cases:11.28%
controls:1.23%
cases:2.97%
controls:0.03%
cases:13.84%
controls:1.44%
cases:21.41%
controls:7.31%
cases:31.33%
controls:15.70%
760
4881
3042
33106
765
2847
3038
35145
429
469
3374
37523
113
11
3690
37981
518
546
3224
37327
702
2652
2577
33623
775
4556
1699
24462
Urinary tract ultrasound examination
KH1AE [2001306329]
1.3e+00
2.1e+00
3.3e+00
1.0e+50
2.4e+00
2.4e+00
1.7e+00
cases:1.84%
controls:0.53%
cases:1.34%
controls:0.17%
cases:0.71%
controls:0.03%
cases:1.68%
controls:0.00%
cases:0.37%
controls:0.03%
cases:1.52%
controls:0.14%
cases:2.59%
controls:0.48%
70
201
3732
37786
51
65
3752
37927
27
10
3776
37982
64
0
3739
37992
14
13
3728
37860
50
49
3229
36226
64
140
2410
28878
prazosin; oral
C02CA01 [21600411]
2.0e+00
2.2e+00
2.2e+00
—
2.4e+00
2.3e+00
2.1e+00
cases:1.68%
controls:0.24%
cases:1.42%
controls:0.15%
cases:0.50%
controls:0.06%
—
—
cases:0.48%
controls:0.04%
cases:1.71%
controls:0.17%
cases:1.90%
controls:0.25%
64
91
3738
37896
54
58
3749
37934
19
22
3784
37970
—
18
16
3724
37857
56
63
3223
36212
47
72
2427
28946
Protein [Mass/time] in 24 hour Urine
2889-4 [3020876]
1.7e+00
2.1e+00
—
—
4.5e+00
2.7e+00
2.1e+00
cases:1.42%
controls:0.26%
cases:0.84%
controls:0.10%
—
—
—
—
cases:1.63%
controls:0.02%
cases:1.31%
controls:0.09%
cases:1.66%
controls:0.21%
54
97
3748
37890
32
38
3771
37954
—
—
61
7
3681
37866
43
32
3236
36243
41
61
2433
28957
Simple therapy of methastized malignancy with biomodifiers
WD305 [2001310685]
2.0e+00
1.7e+00
2.4e+00
—
2.2e+00
2.8e+00
2.0e+00
cases:0.60%
controls:0.08%
cases:0.42%
controls:0.07%
cases:0.21%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:1.13%
controls:0.07%
cases:0.69%
controls:0.10%
23
31
3779
37956
16
28
3787
37964
8
7
3795
37985
—
7
8
3735
37865
37
25
3242
36250
17
28
2457
28990
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.3e-01
1.1e+00
2.3e+00
4.7e+00
2.4e+00
1.2e+00
9.1e-01
cases:19.65%
controls:12.58%
cases:19.38%
controls:7.35%
cases:10.89%
controls:1.22%
cases:2.71%
controls:0.03%
cases:13.07%
controls:1.41%
cases:20.89%
controls:7.18%
cases:30.92%
controls:15.31%
747
4779
3055
33208
737
2791
3066
35201
414
463
3389
37529
103
10
3700
37982
489
535
3253
37338
685
2604
2594
33671
765
4444
1709
24574
Gas panel - Capillary blood
24337-8 [3022313]
1.1e+00
1.6e+00
3.1e+00
—
3.9e+00
2.0e+00
1.3e+00
cases:2.66%
controls:0.87%
cases:1.84%
controls:0.39%
cases:1.03%
controls:0.05%
—
—
cases:2.70%
controls:0.06%
cases:2.90%
controls:0.40%
cases:3.84%
controls:1.04%
101
331
3701
37656
70
149
3733
37843
39
18
3764
37974
—
101
21
3641
37852
95
145
3184
36130
95
302
2379
28716
sevelamer; oral
V03AE02 [21605265]
3.5e+00
3.0e+00
—
—
—
3.2e+00
3.3e+00
cases:0.63%
controls:0.02%
cases:0.37%
controls:0.02%
—
—
—
—
—
—
cases:0.58%
controls:0.02%
cases:1.05%
controls:0.04%
24
7
3778
37980
14
7
3789
37985
—
—
—
19
9
3260
36266
26
11
2448
29007
Teaching
WZC30 [2001310891]
7.4e-01
1.3e+00
2.6e+00
3.5e+00
2.4e+00
1.7e+00
8.8e-01
cases:5.08%
controls:2.49%
cases:3.94%
controls:1.09%
cases:1.66%
controls:0.13%
cases:0.50%
controls:0.02%
cases:1.28%
controls:0.12%
cases:4.91%
controls:0.96%
cases:7.03%
controls:3.04%
193
944
3609
37043
150
416
3653
37576
63
48
3740
37944
19
6
3784
37986
48
46
3694
37827
161
349
3118
35926
174
882
2300
28136
Calculus of kidney
N20.0 [45567830]
1.8e+00
2.4e+00
2.3e+00
1.0e+50
2.3e+00
2.4e+00
1.8e+00
cases:1.18%
controls:0.20%
cases:1.18%
controls:0.11%
cases:0.21%
controls:0.02%
cases:0.45%
controls:0.00%
cases:0.27%
controls:0.03%
cases:1.28%
controls:0.12%
cases:1.37%
controls:0.23%
45
77
3757
37910
45
41
3758
37951
8
8
3795
37984
17
0
3786
37992
10
10
3732
37863
42
42
3237
36233
34
67
2440
28951
Simple enzyme inhibitor or similar therapy of methastized malignancy
WD505 [2001310690]
2.0e+00
2.4e+00
2.2e+00
—
2.1e+00
2.3e+00
1.9e+00
cases:0.42%
controls:0.06%
cases:0.58%
controls:0.06%
cases:0.24%
controls:0.03%
—
—
cases:0.27%
controls:0.03%
cases:0.73%
controls:0.07%
cases:0.69%
controls:0.10%
16
21
3786
37966
22
21
3781
37971
9
10
3794
37982
—
10
12
3732
37861
24
26
3255
36249
17
29
2457
28989
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.0e+00
1.8e+00
3.2e+00
—
4.0e+00
1.9e+00
1.1e+00
cases:4.29%
controls:1.57%
cases:4.39%
controls:0.78%
cases:3.02%
controls:0.13%
—
—
cases:6.20%
controls:0.12%
cases:6.10%
controls:0.95%
cases:9.22%
controls:3.23%
163
595
3639
37392
167
295
3636
37697
115
49
3688
37943
—
232
47
3510
37826
200
346
3079
35929
228
938
2246
28080
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.1e+00
1.7e+00
3.1e+00
—
3.9e+00
1.9e+00
1.3e+00
cases:2.24%
controls:0.75%
cases:2.47%
controls:0.47%
cases:1.55%
controls:0.07%
—
—
cases:3.10%
controls:0.07%
cases:3.45%
controls:0.54%
cases:5.58%
controls:1.52%
85
286
3717
37701
94
178
3709
37814
59
27
3744
37965
—
116
25
3626
37848
113
197
3166
36078
138
442
2336
28576
naloxegol; oral
A06AH03 [43534741]
1.7e+00
2.2e+00
3.1e+00
—
3.4e+00
2.7e+00
1.6e+00
cases:0.16%
controls:0.03%
cases:0.34%
controls:0.04%
cases:0.34%
controls:0.02%
—
—
cases:0.48%
controls:0.02%
cases:0.76%
controls:0.05%
cases:0.40%
controls:0.08%
6
11
3796
37976
13
15
3790
37977
13
6
3790
37986
—
18
6
3724
37867
25
19
3254
36256
10
23
2464
28995
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
1.0e+00
1.4e+00
3.0e+00
—
4.0e+00
2.0e+00
1.5e+00
cases:2.21%
controls:0.79%
cases:1.34%
controls:0.34%
cases:0.76%
controls:0.04%
—
—
cases:2.00%
controls:0.04%
cases:2.32%
controls:0.32%
cases:2.71%
controls:0.64%
84
299
3718
37688
51
128
3752
37864
29
14
3774
37978
—
75
14
3667
37859
76
115
3203
36160
67
186
2407
28832
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
9.5e-01
1.3e+00
1.6e+00
4.7e+00
2.5e+00
1.2e+00
8.3e-01
cases:3.05%
controls:1.21%
cases:2.29%
controls:0.64%
cases:0.76%
controls:0.15%
cases:1.37%
controls:0.01%
cases:1.36%
controls:0.12%
cases:2.41%
controls:0.77%
cases:4.49%
controls:2.01%
116
459
3686
37528
87
242
3716
37750
29
58
3774
37934
52
5
3751
37987
51
45
3691
37828
79
278
3200
35997
111
582
2363
28436
Base excess in Venous blood by calculation
1927-3 [3002032]
1.0e+00
1.8e+00
3.1e+00
—
4.0e+00
1.9e+00
1.2e+00
cases:4.29%
controls:1.58%
cases:4.26%
controls:0.75%
cases:2.76%
controls:0.13%
—
—
cases:5.93%
controls:0.12%
cases:6.01%
controls:0.91%
cases:9.09%
controls:3.07%
163
599
3639
37388
162
285
3641
37707
105
51
3698
37941
—
222
44
3520
37829
197
331
3082
35944
225
891
2249
28127
pH of Venous blood
2746-6 [3012544]
1.0e+00
1.8e+00
3.1e+00
—
4.0e+00
1.9e+00
1.1e+00
cases:4.39%
controls:1.61%
cases:4.39%
controls:0.78%
cases:2.95%
controls:0.13%
—
—
cases:6.04%
controls:0.12%
cases:6.13%
controls:0.95%
cases:9.01%
controls:3.23%
167
613
3635
37374
167
298
3636
37694
112
50
3691
37942
—
226
45
3516
37828
201
346
3078
35929
223
937
2251
28081
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.4e+00
1.9e+00
2.4e+00
—
2.8e+00
2.6e+00
1.9e+00
cases:1.29%
controls:0.33%
cases:1.29%
controls:0.20%
cases:0.63%
controls:0.06%
—
—
cases:1.12%
controls:0.07%
cases:2.10%
controls:0.17%
cases:2.91%
controls:0.47%
49
124
3753
37863
49
77
3754
37915
24
21
3779
37971
—
42
26
3700
37847
69
60
3210
36215
72
135
2402
28883
Gas panel - Venous blood
24339-4 [3000991]
1.1e+00
1.7e+00
3.1e+00
—
3.7e+00
2.0e+00
1.3e+00
cases:3.79%
controls:1.35%
cases:4.00%
controls:0.73%
cases:2.16%
controls:0.10%
—
—
cases:4.41%
controls:0.11%
cases:5.15%
controls:0.73%
cases:7.48%
controls:2.16%
144
514
3658
37473
152
279
3651
37713
82
37
3721
37955
—
165
43
3577
37830
169
264
3110
36011
185
627
2289
28391
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
1.1e+00
1.7e+00
2.7e+00
1.0e+50
2.5e+00
2.7e+00
2.2e+00
cases:2.79%
controls:0.92%
cases:1.53%
controls:0.29%
cases:0.26%
controls:0.02%
cases:1.29%
controls:0.00%
cases:0.27%
controls:0.02%
cases:3.17%
controls:0.23%
cases:5.82%
controls:0.67%
106
351
3696
37636
58
109
3745
37883
10
7
3793
37985
49
0
3754
37992
10
8
3732
37865
104
82
3175
36193
144
193
2330
28825
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
9.7e-01
1.9e+00
3.1e+00
1.0e+50
4.0e+00
1.9e+00
9.1e-01
cases:2.24%
controls:0.86%
cases:1.95%
controls:0.30%
cases:1.31%
controls:0.06%
cases:1.97%
controls:0.00%
cases:2.94%
controls:0.05%
cases:2.74%
controls:0.41%
cases:4.04%
controls:1.66%
85
326
3717
37661
74
115
3729
37877
50
22
3753
37970
75
0
3728
37992
110
20
3632
37853
90
147
3189
36128
100
483
2374
28535
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
1.4e+00
1.6e+00
2.8e+00
—
3.6e+00
2.5e+00
9.5e-01
cases:0.89%
controls:0.22%
cases:0.47%
controls:0.09%
cases:0.21%
controls:0.01%
—
—
cases:0.48%
controls:0.01%
cases:0.98%
controls:0.08%
cases:0.93%
controls:0.36%
34
85
3768
37902
18
35
3785
37957
8
5
3795
37987
—
18
5
3724
37868
32
29
3247
36246
23
105
2451
28913
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
1.1e+00
2.1e+00
2.5e+00
1.0e+50
2.9e+00
2.6e+00
1.7e+00
cases:0.68%
controls:0.24%
cases:1.26%
controls:0.16%
cases:0.79%
controls:0.07%
cases:0.58%
controls:0.00%
cases:1.15%
controls:0.06%
cases:1.95%
controls:0.15%
cases:1.17%
controls:0.21%
26
91
3776
37896
48
60
3755
37932
30
25
3773
37967
22
0
3781
37992
43
24
3699
37849
64
54
3215
36221
29
61
2445
28957
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.3e+00
1.8e+00
2.2e+00
—
2.8e+00
2.8e+00
1.9e+00
cases:2.00%
controls:0.55%
cases:1.42%
controls:0.23%
cases:0.24%
controls:0.03%
—
—
cases:0.35%
controls:0.02%
cases:1.86%
controls:0.12%
cases:2.63%
controls:0.39%
76
210
3726
37777
54
88
3749
37904
9
10
3794
37982
—
13
8
3729
37865
61
43
3218
36232
65
112
2409
28906
Immunofixation for Serum or Plasma
25700-6 [3037756]
1.7e+00
2.3e+00
—
1.0e+50
5.3e+00
2.0e+00
1.6e+00
cases:1.81%
controls:0.33%
cases:1.66%
controls:0.18%
—
—
cases:0.24%
controls:0.00%
cases:2.54%
controls:0.01%
cases:1.40%
controls:0.19%
cases:2.10%
controls:0.44%
69
126
3733
37861
63
67
3740
37925
—
9
0
3794
37992
95
5
3647
37868
46
69
3233
36206
52
129
2422
28889
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.2e+00
1.7e+00
2.9e+00
1.0e+50
3.9e+00
2.0e+00
1.2e+00
cases:4.73%
controls:1.49%
cases:4.36%
controls:0.84%
cases:1.92%
controls:0.11%
cases:0.58%
controls:0.00%
cases:4.06%
controls:0.08%
cases:5.31%
controls:0.76%
cases:7.28%
controls:2.42%
180
566
3622
37421
166
320
3637
37672
73
41
3730
37951
22
0
3781
37992
152
32
3590
37841
174
275
3105
36000
180
702
2294
28316
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
1.3e+00
1.8e+00
2.7e+00
1.0e+50
3.5e+00
2.3e+00
1.2e+00
cases:1.50%
controls:0.40%
cases:0.89%
controls:0.15%
cases:0.34%
controls:0.02%
cases:0.24%
controls:0.00%
cases:0.91%
controls:0.03%
cases:1.68%
controls:0.18%
cases:1.86%
controls:0.57%
57
151
3745
37836
34
56
3769
37936
13
9
3790
37983
9
0
3794
37992
34
10
3708
37863
55
65
3224
36210
46
166
2428
28852
Medical Oncology
90 [38004507]
6.6e-01
1.2e+00
2.0e+00
4.3e+00
2.4e+00
1.4e+00
8.0e-01
cases:9.39%
controls:5.09%
cases:11.36%
controls:3.58%
cases:8.44%
controls:1.24%
cases:7.13%
controls:0.10%
cases:11.49%
controls:1.15%
cases:12.56%
controls:3.44%
cases:10.79%
controls:5.17%
357
1933
3445
36054
432
1362
3371
36630
321
473
3482
37519
271
39
3532
37953
430
435
3312
37438
412
1247
2867
35028
267
1501
2207
27517
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
1.4e+00
1.6e+00
2.9e+00
—
3.6e+00
2.3e+00
9.5e-01
cases:1.00%
controls:0.25%
cases:0.53%
controls:0.11%
cases:0.29%
controls:0.02%
—
—
cases:0.59%
controls:0.02%
cases:1.10%
controls:0.11%
cases:1.17%
controls:0.45%
38
95
3764
37892
20
41
3783
37951
11
6
3792
37986
—
22
6
3720
37867
36
39
3243
36236
29
132
2445
28886
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
1.4e+00
2.2e+00
2.6e+00
—
3.0e+00
2.5e+00
1.2e+00
cases:1.32%
controls:0.33%
cases:2.42%
controls:0.28%
cases:1.50%
controls:0.11%
—
—
cases:1.71%
controls:0.09%
cases:2.81%
controls:0.25%
cases:1.21%
controls:0.37%
50
127
3752
37860
92
106
3711
37886
57
43
3746
37949
—
64
34
3678
37839
92
90
3187
36185
30
106
2444
28912
Immunoglobulin A (IgA) nephropathy
N08.2*D89.80 [2000503126]
2.1e+00
2.6e+00
2.5e+00
1.0e+50
—
2.7e+00
2.8e+00
cases:0.47%
controls:0.06%
cases:0.53%
controls:0.04%
cases:0.26%
controls:0.02%
cases:0.47%
controls:0.00%
—
—
cases:0.64%
controls:0.04%
cases:0.77%
controls:0.05%
18
22
3784
37965
20
15
3783
37977
10
8
3793
37984
18
0
3785
37992
—
21
15
3258
36260
19
14
2455
29004
Thyroglobulin Ab [Units/volume] in Serum or Plasma
8098-6 [3025547]
1.2e+00
1.8e+00
2.3e+00
—
3.7e+00
3.2e+00
2.8e+00
cases:0.58%
controls:0.17%
cases:0.50%
controls:0.09%
cases:0.13%
controls:0.01%
—
—
cases:0.96%
controls:0.02%
cases:2.32%
controls:0.10%
cases:3.40%
controls:0.20%
22
66
3780
37921
19
33
3784
37959
5
5
3798
37987
—
36
9
3706
37864
76
35
3203
36240
84
59
2390
28959
Monocytes [#/volume] in Blood
26484-6 [3001604]
5.4e-01
1.1e+00
2.2e+00
4.4e+00
2.3e+00
1.2e+00
9.0e-01
cases:21.04%
controls:13.39%
cases:20.48%
controls:8.07%
cases:11.44%
controls:1.38%
cases:2.84%
controls:0.04%
cases:14.06%
controls:1.54%
cases:22.78%
controls:7.88%
cases:33.67%
controls:17.11%
800
5087
3002
32900
779
3066
3024
34926
435
523
3368
37469
108
14
3695
37978
526
585
3216
37288
747
2857
2532
33418
833
4965
1641
24053
Oxygen saturation in Venous blood
2711-0 [3024928]
1.2e+00
2.0e+00
3.5e+00
—
3.3e+00
1.5e+00
1.3e+00
cases:0.92%
controls:0.29%
cases:0.84%
controls:0.12%
cases:0.45%
controls:0.01%
—
—
cases:0.51%
controls:0.02%
cases:0.91%
controls:0.21%
cases:1.98%
controls:0.58%
35
111
3767
37876
32
45
3771
37947
17
5
3786
37987
—
19
7
3723
37866
30
76
3249
36199
49
167
2425
28851
tacrolimus; oral, parenteral
L04AD02 [21603925]
1.8e+00
1.8e+00
2.4e+00
—
1.9e+00
2.2e+00
2.6e+00
cases:0.63%
controls:0.11%
cases:0.63%
controls:0.11%
cases:0.42%
controls:0.04%
—
—
cases:0.37%
controls:0.06%
cases:1.13%
controls:0.12%
cases:2.06%
controls:0.16%
24
40
3778
37947
24
41
3779
37951
16
14
3787
37978
—
14
22
3728
37851
37
45
3242
36230
51
45
2423
28973
Basophils [#/volume] in Blood
26444-0 [3006315]
5.4e-01
1.1e+00
2.2e+00
4.4e+00
2.3e+00
1.2e+00
9.0e-01
cases:21.09%
controls:13.44%
cases:20.56%
controls:8.11%
cases:11.41%
controls:1.38%
cases:2.84%
controls:0.04%
cases:14.06%
controls:1.55%
cases:22.78%
controls:7.91%
cases:33.83%
controls:17.23%
802
5105
3000
32882
782
3080
3021
34912
434
524
3369
37468
108
14
3695
37978
526
587
3216
37286
747
2869
2532
33406
837
5000
1637
24018
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
4.5e-01
1.1e+00
2.6e+00
4.3e+00
2.3e+00
1.4e+00
6.2e-01
cases:16.96%
controls:11.49%
cases:12.75%
controls:4.66%
cases:6.71%
controls:0.56%
cases:1.53%
controls:0.02%
cases:5.64%
controls:0.59%
cases:12.90%
controls:3.66%
cases:20.41%
controls:12.09%
645
4364
3157
33623
485
1769
3318
36223
255
212
3548
37780
58
8
3745
37984
211
225
3531
37648
423
1328
2856
34947
505
3508
1969
25510
Eosinophils [#/volume] in Blood
26449-9 [3013115]
5.6e-01
1.1e+00
2.2e+00
4.4e+00
2.3e+00
1.2e+00
8.9e-01
cases:22.20%
controls:14.04%
cases:20.96%
controls:8.35%
cases:11.94%
controls:1.46%
cases:3.00%
controls:0.04%
cases:14.24%
controls:1.58%
cases:23.12%
controls:8.17%
cases:34.56%
controls:17.76%
844
5332
2958
32655
797
3173
3006
34819
454
553
3349
37439
114
15
3689
37977
533
598
3209
37275
758
2963
2521
33312
855
5155
1619
23863
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.5e-01
1.2e+00
2.2e+00
4.4e+00
2.2e+00
1.2e+00
8.8e-01
cases:25.14%
controls:16.21%
cases:25.90%
controls:9.89%
cases:17.64%
controls:2.37%
cases:6.44%
controls:0.08%
cases:18.36%
controls:2.34%
cases:26.50%
controls:9.69%
cases:36.66%
controls:19.42%
956
6158
2846
31829
985
3756
2818
34236
671
901
3132
37091
245
31
3558
37961
687
886
3055
36987
869
3515
2410
32760
907
5634
1567
23384
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
5.2e-01
1.1e+00
2.2e+00
4.4e+00
2.3e+00
1.2e+00
8.8e-01
cases:21.41%
controls:13.89%
cases:21.01%
controls:8.34%
cases:11.57%
controls:1.41%
cases:2.89%
controls:0.04%
cases:14.19%
controls:1.57%
cases:23.12%
controls:8.10%
cases:33.99%
controls:17.60%
814
5278
2988
32709
799
3168
3004
34824
440
535
3363
37457
110
14
3693
37978
531
596
3211
37277
758
2938
2521
33337
841
5106
1633
23912
Dietary counselling and surveillance
Z71.3 [45552101]
1.4e+00
1.7e+00
2.9e+00
—
2.6e+00
2.3e+00
1.8e+00
cases:1.45%
controls:0.37%
cases:0.82%
controls:0.15%
cases:0.39%
controls:0.02%
—
—
cases:0.35%
controls:0.03%
cases:1.37%
controls:0.15%
cases:2.10%
controls:0.35%
55
141
3747
37846
31
58
3772
37934
15
8
3788
37984
—
13
10
3729
37863
45
53
3234
36222
52
101
2422
28917
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
1.4e+00
2.1e+00
2.2e+00
—
2.2e+00
2.8e+00
1.8e+00
cases:0.45%
controls:0.11%
cases:0.71%
controls:0.09%
cases:0.26%
controls:0.03%
—
—
cases:0.32%
controls:0.03%
cases:0.79%
controls:0.05%
cases:0.49%
controls:0.08%
17
40
3785
37947
27
33
3776
37959
10
11
3793
37981
—
12
13
3730
37860
26
17
3253
36258
12
24
2462
28994
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
1.2e+00
1.7e+00
2.4e+00
1.0e+50
3.6e+00
2.3e+00
1.3e+00
cases:1.10%
controls:0.34%
cases:0.63%
controls:0.11%
cases:0.21%
controls:0.02%
cases:0.24%
controls:0.00%
cases:0.69%
controls:0.02%
cases:1.34%
controls:0.13%
cases:1.25%
controls:0.35%
42
128
3760
37859
24
43
3779
37949
8
7
3795
37985
9
0
3794
37992
26
7
3716
37866
44
48
3235
36227
31
101
2443
28917
Other malignant neoplasm of kidney, except renal pelvis
C64.88 [2000501096]
1.6e+00
2.0e+00
2.9e+00
—
3.0e+00
1.9e+00
1.2e+00
cases:1.26%
controls:0.26%
cases:1.47%
controls:0.20%
cases:0.95%
controls:0.05%
—
—
cases:1.20%
controls:0.06%
cases:1.34%
controls:0.20%
cases:0.93%
controls:0.28%
48
97
3754
37890
56
75
3747
37917
36
20
3767
37972
—
45
24
3697
37849
44
74
3235
36201
23
80
2451
28938
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.1e+00
1.7e+00
3.0e+00
1.0e+50
3.9e+00
1.5e+00
1.3e+00
cases:3.58%
controls:1.17%
cases:2.87%
controls:0.54%
cases:1.31%
controls:0.07%
cases:0.34%
controls:0.00%
cases:3.26%
controls:0.07%
cases:2.62%
controls:0.57%
cases:4.77%
controls:1.29%
136
443
3666
37544
109
205
3694
37787
50
26
3753
37966
13
0
3790
37992
122
27
3620
37846
86
207
3193
36068
118
373
2356
28645
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.0e+00
1.7e+00
2.9e+00
—
3.5e+00
1.9e+00
1.4e+00
cases:4.97%
controls:1.86%
cases:4.84%
controls:0.90%
cases:2.42%
controls:0.13%
—
—
cases:2.81%
controls:0.08%
cases:4.57%
controls:0.73%
cases:7.84%
controls:1.98%
189
705
3613
37282
184
343
3619
37649
92
50
3711
37942
—
105
32
3637
37841
150
266
3129
36009
194
575
2280
28443
End-stage renal disease
N18.0 [45601717]
2.5e+00
3.5e+00
—
1.0e+50
1.0e+50
3.2e+00
3.3e+00
cases:0.76%
controls:0.06%
cases:0.45%
controls:0.01%
—
—
cases:0.16%
controls:0.00%
cases:0.27%
controls:0.00%
cases:0.73%
controls:0.03%
cases:1.33%
controls:0.05%
29
24
3773
37963
17
5
3786
37987
—
6
0
3797
37992
10
0
3732
37873
24
11
3255
36264
33
15
2441
29003
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
1.2e+00
1.9e+00
2.9e+00
—
2.8e+00
2.1e+00
1.6e+00
cases:4.21%
controls:1.37%
cases:3.89%
controls:0.58%
cases:1.63%
controls:0.09%
—
—
cases:1.76%
controls:0.11%
cases:5.03%
controls:0.66%
cases:7.15%
controls:1.52%
160
519
3642
37468
148
220
3655
37772
62
35
3741
37957
—
66
41
3676
37832
165
239
3114
36036
177
442
2297
28576
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
4.7e-01
9.9e-01
2.2e+00
5.0e+00
2.3e+00
9.6e-01
5.4e-01
cases:10.76%
controls:6.98%
cases:8.28%
controls:3.23%
cases:3.97%
controls:0.44%
cases:2.63%
controls:0.02%
cases:4.25%
controls:0.45%
cases:8.36%
controls:3.36%
cases:15.84%
controls:9.89%
409
2651
3393
35336
315
1228
3488
36764
151
169
3652
37823
100
7
3703
37985
159
170
3583
37703
274
1220
3005
35055
392
2870
2082
26148
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
1.0e+00
1.9e+00
2.3e+00
1.0e+50
3.6e+00
2.2e+00
1.4e+00
cases:1.26%
controls:0.47%
cases:1.31%
controls:0.19%
cases:0.32%
controls:0.03%
cases:0.13%
controls:0.00%
cases:1.20%
controls:0.03%
cases:1.56%
controls:0.18%
cases:2.18%
controls:0.54%
48
177
3754
37810
50
74
3753
37918
12
12
3791
37980
5
0
3798
37992
45
13
3697
37860
51
65
3228
36210
54
156
2420
28862
Bacterial infection, unspecified
A49.9 [45590816]
9.3e-01
1.8e+00
3.1e+00
—
3.3e+00
1.9e+00
1.3e+00
cases:2.50%
controls:1.00%
cases:2.45%
controls:0.43%
cases:1.21%
controls:0.05%
—
—
cases:1.60%
controls:0.06%
cases:3.11%
controls:0.47%
cases:5.05%
controls:1.41%
95
380
3707
37607
93
163
3710
37829
46
20
3757
37972
—
60
23
3682
37850
102
169
3177
36106
125
409
2349
28609
Other and unspecified cirrhosis of liver
K74.6 [45538546]
1.3e+00
1.7e+00
2.9e+00
—
2.2e+00
2.2e+00
2.1e+00
cases:0.34%
controls:0.10%
cases:0.42%
controls:0.07%
cases:0.37%
controls:0.02%
—
—
cases:0.29%
controls:0.03%
cases:0.73%
controls:0.08%
cases:1.17%
controls:0.15%
13
37
3789
37950
16
28
3787
37964
14
8
3789
37984
—
11
12
3731
37861
24
30
3255
36245
29
43
2445
28975
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.1e+00
1.6e+00
2.7e+00
—
3.9e+00
1.9e+00
1.1e+00
cases:6.34%
controls:2.20%
cases:5.50%
controls:1.12%
cases:2.34%
controls:0.16%
—
—
cases:4.89%
controls:0.11%
cases:6.37%
controls:1.00%
cases:8.89%
controls:3.02%
241
837
3561
37150
209
425
3594
37567
89
60
3714
37932
—
183
41
3559
37832
209
364
3070
35911
220
875
2254
28143
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
1.3e+00
1.9e+00
2.1e+00
1.0e+50
3.4e+00
2.3e+00
1.3e+00
cases:1.60%
controls:0.43%
cases:1.00%
controls:0.15%
cases:0.24%
controls:0.03%
cases:0.26%
controls:0.00%
cases:0.88%
controls:0.03%
cases:1.74%
controls:0.18%
cases:1.90%
controls:0.52%
61
162
3741
37825
38
58
3765
37934
9
11
3794
37981
10
0
3793
37992
33
11
3709
37862
57
65
3222
36210
47
152
2427
28866
pH of Specimen
17433-4 [3019225]
6.4e-01
1.4e+00
3.3e+00
—
3.6e+00
1.9e+00
1.4e+00
cases:5.29%
controls:2.85%
cases:5.42%
controls:1.34%
cases:4.94%
controls:0.18%
—
—
cases:6.23%
controls:0.18%
cases:7.78%
controls:1.23%
cases:10.31%
controls:2.83%
201
1083
3601
36904
206
508
3597
37484
188
70
3615
37922
—
233
67
3509
37806
255
447
3024
35828
255
822
2219
28196
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.1e+00
2.1e+00
2.9e+00
1.0e+50
2.6e+00
2.0e+00
1.7e+00
cases:2.89%
controls:1.00%
cases:2.24%
controls:0.28%
cases:0.29%
controls:0.02%
cases:0.82%
controls:0.00%
cases:0.24%
controls:0.02%
cases:1.86%
controls:0.26%
cases:4.12%
controls:0.80%
110
378
3692
37609
85
105
3718
37887
11
6
3792
37986
31
0
3772
37992
9
7
3733
37866
61
95
3218
36180
102
232
2372
28786
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.3e+00
1.7e+00
1.9e+00
—
3.0e+00
2.6e+00
1.8e+00
cases:1.95%
controls:0.56%
cases:1.63%
controls:0.29%
cases:0.68%
controls:0.10%
—
—
cases:1.28%
controls:0.06%
cases:3.60%
controls:0.27%
cases:3.56%
controls:0.63%
74
211
3728
37776
62
110
3741
37882
26
39
3777
37953
—
48
24
3694
37849
118
98
3161
36177
88
183
2386
28835
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.2e-01
9.7e-01
2.2e+00
4.9e+00
2.4e+00
1.0e+00
4.7e-01
cases:45.50%
controls:37.76%
cases:43.91%
controls:22.96%
cases:30.06%
controls:4.36%
cases:26.48%
controls:0.28%
cases:33.99%
controls:4.39%
cases:44.77%
controls:22.58%
cases:58.49%
controls:46.88%
1730
14345
2072
23642
1670
8723
2133
29269
1143
1658
2660
36334
1007
105
2796
37887
1272
1663
2470
36210
1468
8191
1811
28084
1447
13605
1027
15413
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1.1e+00
1.5e+00
2.9e+00
—
3.6e+00
1.8e+00
1.3e+00
cases:2.63%
controls:0.90%
cases:2.42%
controls:0.54%
cases:0.97%
controls:0.05%
—
—
cases:2.27%
controls:0.06%
cases:2.62%
controls:0.44%
cases:4.89%
controls:1.38%
100
342
3702
37645
92
207
3711
37785
37
20
3766
37972
—
85
23
3657
37850
86
158
3193
36117
121
401
2353
28617
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
7.5e-01
9.5e-01
1.7e+00
5.0e+00
2.1e+00
1.1e+00
6.6e-01
cases:10.28%
controls:5.12%
cases:6.36%
controls:2.55%
cases:2.60%
controls:0.46%
cases:3.68%
controls:0.03%
cases:3.39%
controls:0.45%
cases:8.17%
controls:2.84%
cases:12.33%
controls:6.76%
391
1944
3411
36043
242
969
3561
37023
99
176
3704
37816
140
10
3663
37982
127
170
3615
37703
268
1031
3011
35244
305
1963
2169
27055
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
1.3e+00
1.7e+00
2.4e+00
—
3.5e+00
2.4e+00
9.2e-01
cases:0.87%
controls:0.24%
cases:0.58%
controls:0.11%
cases:0.26%
controls:0.02%
—
—
cases:0.67%
controls:0.02%
cases:1.13%
controls:0.10%
cases:1.13%
controls:0.45%
33
90
3769
37897
22
40
3781
37952
10
9
3793
37983
—
25
8
3717
37865
37
37
3242
36238
28
132
2446
28886
Other dialysis
Z49.2 [45576160]
2.5e+00
2.7e+00
—
1.0e+50
—
3.7e+00
3.3e+00
cases:0.55%
controls:0.04%
cases:0.37%
controls:0.02%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.64%
controls:0.02%
cases:0.73%
controls:0.03%
21
17
3781
37970
14
9
3789
37983
—
5
0
3798
37992
—
21
6
3258
36269
18
8
2456
29010
Metastasis to bone marrow
OMOP5031538 [35226074]
2.1e+00
2.3e+00
2.5e+00
—
3.1e+00
2.2e+00
6.4e-01
cases:0.95%
controls:0.12%
cases:1.34%
controls:0.14%
cases:1.05%
controls:0.09%
—
—
cases:1.60%
controls:0.07%
cases:1.37%
controls:0.15%
cases:0.53%
controls:0.28%
36
46
3766
37941
51
52
3752
37940
40
33
3763
37959
—
60
27
3682
37846
45
55
3234
36220
13
81
2461
28937
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
1.4e+00
1.9e+00
2.2e+00
—
2.2e+00
2.1e+00
2.5e+00
cases:0.37%
controls:0.09%
cases:0.58%
controls:0.09%
cases:0.45%
controls:0.05%
—
—
cases:0.43%
controls:0.05%
cases:0.73%
controls:0.09%
cases:1.78%
controls:0.16%
14
36
3788
37951
22
34
3781
37958
17
19
3786
37973
—
16
18
3726
37855
24
33
3255
36242
44
45
2430
28973
FISTULA - Fistula
FISTULA-1 [2002330212]
2.8e+00
3.0e+00
—
—
—
3.1e+00
3.2e+00
cases:1.08%
controls:0.06%
cases:0.71%
controls:0.04%
—
—
—
—
—
—
cases:0.76%
controls:0.03%
cases:1.58%
controls:0.07%
41
24
3761
37963
27
14
3776
37978
—
—
—
25
12
3254
36263
39
19
2435
28999
Metastasis to bone
OMOP4998978 [36769301]
2.0e+00
2.3e+00
2.5e+00
—
3.1e+00
2.2e+00
6.4e-01
cases:0.92%
controls:0.12%
cases:1.34%
controls:0.14%
cases:1.00%
controls:0.09%
—
—
cases:1.60%
controls:0.07%
cases:1.37%
controls:0.15%
cases:0.53%
controls:0.28%
35
46
3767
37941
51
52
3752
37940
38
33
3765
37959
—
60
27
3682
37846
45
55
3234
36220
13
81
2461
28937
Secondary malignant neoplasm of bone and bone marrow
C79.5 [45571540]
2.0e+00
2.3e+00
2.5e+00
—
3.1e+00
2.2e+00
6.4e-01
cases:0.92%
controls:0.12%
cases:1.34%
controls:0.14%
cases:1.00%
controls:0.09%
—
—
cases:1.60%
controls:0.07%
cases:1.37%
controls:0.15%
cases:0.53%
controls:0.28%
35
46
3767
37941
51
52
3752
37940
38
33
3765
37959
—
60
27
3682
37846
45
55
3234
36220
13
81
2461
28937
Segmented neutrophils/Leukocytes in Blood
26505-8 [3017354]
1.1e+00
1.5e+00
2.6e+00
—
3.2e+00
2.2e+00
1.4e+00
cases:0.47%
controls:0.16%
cases:0.47%
controls:0.11%
cases:0.18%
controls:0.01%
—
—
cases:0.53%
controls:0.02%
cases:0.98%
controls:0.10%
cases:1.13%
controls:0.28%
18
61
3784
37926
18
41
3785
37951
7
5
3796
37987
—
20
8
3722
37865
32
38
3247
36237
28
80
2446
28938
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
1.2e+00
1.7e+00
2.9e+00
—
3.0e+00
1.5e+00
1.7e+00
cases:0.89%
controls:0.27%
cases:0.74%
controls:0.13%
cases:0.42%
controls:0.02%
—
—
cases:0.43%
controls:0.02%
cases:0.67%
controls:0.15%
cases:1.46%
controls:0.26%
34
102
3768
37885
28
49
3775
37943
16
9
3787
37983
—
16
8
3726
37865
22
55
3257
36220
36
75
2438
28943
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.0e-01
8.7e-01
2.0e+00
5.1e+00
2.2e+00
8.9e-01
5.7e-01
cases:26.91%
controls:19.75%
cases:20.09%
controls:9.53%
cases:9.41%
controls:1.36%
cases:7.70%
controls:0.05%
cases:11.14%
controls:1.36%
cases:19.58%
controls:9.13%
cases:35.13%
controls:23.38%
1023
7503
2779
30484
764
3622
3039
34370
358
516
3445
37476
293
19
3510
37973
417
515
3325
37358
642
3311
2637
32964
869
6784
1605
22234
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
9.0e-01
1.6e+00
3.0e+00
—
3.9e+00
1.7e+00
9.3e-01
cases:3.16%
controls:1.31%
cases:2.81%
controls:0.59%
cases:1.81%
controls:0.09%
—
—
cases:4.33%
controls:0.09%
cases:4.03%
controls:0.77%
cases:6.87%
controls:2.82%
120
496
3682
37491
107
224
3696
37768
69
35
3734
37957
—
162
33
3580
37840
132
280
3147
35995
170
817
2304
28201
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
5.2e-01
1.2e+00
2.4e+00
4.1e+00
2.1e+00
1.1e+00
7.2e-01
cases:12.81%
controls:8.04%
cases:10.75%
controls:3.63%
cases:5.60%
controls:0.53%
cases:1.08%
controls:0.02%
cases:4.20%
controls:0.55%
cases:9.94%
controls:3.65%
cases:18.88%
controls:10.20%
487
3054
3315
34933
409
1378
3394
36614
213
202
3590
37790
41
7
3762
37985
157
207
3585
37666
326
1323
2953
34952
467
2961
2007
26057
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
1.3e+00
1.7e+00
2.5e+00
—
3.3e+00
2.3e+00
9.2e-01
cases:1.10%
controls:0.30%
cases:0.68%
controls:0.12%
cases:0.29%
controls:0.02%
—
—
cases:0.69%
controls:0.03%
cases:1.22%
controls:0.13%
cases:1.33%
controls:0.54%
42
113
3760
37874
26
47
3777
37945
11
9
3792
37983
—
26
10
3716
37863
40
46
3239
36229
33
156
2441
28862
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
8.6e-01
1.7e+00
3.0e+00
—
3.9e+00
1.6e+00
8.0e-01
cases:2.34%
controls:1.00%
cases:2.21%
controls:0.39%
cases:1.24%
controls:0.06%
—
—
cases:2.75%
controls:0.06%
cases:2.65%
controls:0.55%
cases:4.53%
controls:2.09%
89
380
3713
37607
84
149
3719
37843
47
23
3756
37969
—
103
22
3639
37851
87
198
3192
36077
112
607
2362
28411
Hypothyroidism, unspecified
E03.9 [45537945]
5.2e-01
9.8e-01
1.7e+00
4.7e+00
1.9e+00
1.2e+00
9.1e-01
cases:3.55%
controls:2.15%
cases:2.52%
controls:0.96%
cases:0.79%
controls:0.15%
cases:1.74%
controls:0.02%
cases:1.02%
controls:0.15%
cases:3.14%
controls:0.99%
cases:6.51%
controls:2.73%
135
815
3667
37172
96
366
3707
37626
30
56
3773
37936
66
6
3737
37986
38
56
3704
37817
103
360
3176
35915
161
793
2313
28225
Anaemia, unspecified
D64.9 [45600610]
1.2e+00
1.8e+00
3.0e+00
—
3.1e+00
2.0e+00
7.9e-01
cases:3.42%
controls:1.08%
cases:3.16%
controls:0.52%
cases:1.45%
controls:0.07%
—
—
cases:1.55%
controls:0.07%
cases:3.51%
controls:0.50%
cases:3.44%
controls:1.59%
130
409
3672
37578
120
197
3683
37795
55
28
3748
37964
—
58
26
3684
37847
115
182
3164
36093
85
460
2389
28558
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.0e+00
1.9e+00
3.2e+00
—
3.3e+00
1.6e+00
8.1e-01
cases:1.10%
controls:0.39%
cases:1.53%
controls:0.24%
cases:0.87%
controls:0.03%
—
—
cases:0.88%
controls:0.03%
cases:1.56%
controls:0.31%
cases:2.55%
controls:1.15%
42
150
3760
37837
58
91
3745
37901
33
13
3770
37979
—
33
12
3709
37861
51
114
3228
36161
63
335
2411
28683
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
4.1e-01
8.9e-01
2.1e+00
4.8e+00
2.1e+00
9.3e-01
6.2e-01
cases:28.75%
controls:21.09%
cases:21.46%
controls:10.08%
cases:9.97%
controls:1.40%
cases:6.26%
controls:0.05%
cases:11.33%
controls:1.47%
cases:21.65%
controls:9.87%
cases:38.04%
controls:24.83%
1093
8012
2709
29975
816
3831
2987
34161
379
530
3424
37462
238
20
3565
37972
424
558
3318
37315
710
3581
2569
32694
941
7206
1533
21812
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.1e+00
1.6e+00
2.8e+00
—
3.5e+00
1.8e+00
1.2e+00
cases:6.71%
controls:2.31%
cases:6.42%
controls:1.42%
cases:3.44%
controls:0.23%
—
—
cases:6.84%
controls:0.22%
cases:7.23%
controls:1.30%
cases:9.50%
controls:3.07%
255
878
3547
37109
244
541
3559
37451
131
86
3672
37906
—
256
85
3486
37788
237
473
3042
35802
235
892
2239
28126
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.5e-01
8.7e-01
2.2e+00
4.5e+00
2.2e+00
9.8e-01
6.6e-01
cases:16.99%
controls:11.55%
cases:19.62%
controls:9.25%
cases:14.91%
controls:1.94%
cases:7.57%
controls:0.09%
cases:15.34%
controls:2.01%
cases:21.87%
controls:9.54%
cases:28.90%
controls:17.33%
646
4387
3156
33600
746
3516
3057
34476
567
737
3236
37255
288
33
3515
37959
574
763
3168
37110
717
3461
2562
32814
715
5029
1759
23989
Metastasis to intrahepatic bile ducts
OMOP5031661 [35226180]
1.7e+00
2.4e+00
2.8e+00
—
3.1e+00
1.9e+00
5.2e-01
cases:0.63%
controls:0.12%
cases:1.24%
controls:0.11%
cases:1.00%
controls:0.06%
—
—
cases:1.20%
controls:0.06%
cases:0.88%
controls:0.14%
cases:0.44%
controls:0.27%
24
46
3778
37941
47
41
3756
37951
38
24
3765
37968
—
45
21
3697
37852
29
50
3250
36225
11
77
2463
28941
Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.7 [45595688]
1.7e+00
2.4e+00
2.8e+00
—
3.1e+00
1.9e+00
5.2e-01
cases:0.63%
controls:0.12%
cases:1.24%
controls:0.11%
cases:1.00%
controls:0.06%
—
—
cases:1.20%
controls:0.06%
cases:0.88%
controls:0.14%
cases:0.44%
controls:0.27%
24
46
3778
37941
47
41
3756
37951
38
24
3765
37968
—
45
21
3697
37852
29
50
3250
36225
11
77
2463
28941
Metastasis to liver
OMOP5000224 [36770544]
1.7e+00
2.4e+00
2.8e+00
—
3.1e+00
1.9e+00
5.2e-01
cases:0.63%
controls:0.12%
cases:1.24%
controls:0.11%
cases:1.00%
controls:0.06%
—
—
cases:1.20%
controls:0.06%
cases:0.88%
controls:0.14%
cases:0.44%
controls:0.27%
24
46
3778
37941
47
41
3756
37951
38
24
3765
37968
—
45
21
3697
37852
29
50
3250
36225
11
77
2463
28941
Protein [Mass/volume] in Urine
2888-6 [3037121]
1.1e+00
1.6e+00
2.9e+00
1.0e+50
3.5e+00
1.7e+00
1.0e+00
cases:2.24%
controls:0.78%
cases:1.76%
controls:0.36%
cases:1.13%
controls:0.06%
cases:0.13%
controls:0.00%
cases:1.76%
controls:0.06%
cases:1.92%
controls:0.34%
cases:2.10%
controls:0.75%
85
297
3717
37690
67
138
3736
37854
43
24
3760
37968
5
0
3798
37992
66
21
3676
37852
63
125
3216
36150
52
217
2422
28801
Thyrotoxicosis, unspecified
E05.9 [45586131]
1.3e+00
2.5e+00
2.5e+00
1.0e+50
2.1e+00
2.1e+00
1.2e+00
cases:0.87%
controls:0.23%
cases:1.18%
controls:0.10%
cases:0.39%
controls:0.03%
cases:0.16%
controls:0.00%
cases:0.24%
controls:0.03%
cases:0.70%
controls:0.09%
cases:0.65%
controls:0.19%
33
87
3769
37900
45
38
3758
37954
15
12
3788
37980
6
0
3797
37992
9
11
3733
37862
23
31
3256
36244
16
55
2458
28963
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
9.0e-01
1.4e+00
2.5e+00
1.0e+50
3.9e+00
1.9e+00
1.2e+00
cases:0.79%
controls:0.32%
cases:0.66%
controls:0.17%
cases:0.42%
controls:0.03%
cases:0.37%
controls:0.00%
cases:0.94%
controls:0.02%
cases:1.13%
controls:0.18%
cases:2.14%
controls:0.63%
30
123
3772
37864
25
65
3778
37927
16
13
3787
37979
14
0
3789
37992
35
7
3707
37866
37
64
3242
36211
53
182
2421
28836
T2D - yes
T2D-2 [2002330230]
2.7e+00
2.5e+00
—
—
—
3.0e+00
3.5e+00
cases:0.45%
controls:0.03%
cases:0.26%
controls:0.02%
—
—
—
—
—
—
cases:0.34%
controls:0.02%
cases:0.69%
controls:0.02%
17
11
3785
37976
10
8
3793
37984
—
—
—
11
6
3268
36269
17
6
2457
29012
Body CT examination
JN4AD [2001310897]
1.1e+00
2.0e+00
2.8e+00
—
3.1e+00
1.8e+00
1.0e+00
cases:3.37%
controls:1.13%
cases:4.76%
controls:0.70%
cases:1.87%
controls:0.11%
—
—
cases:2.03%
controls:0.10%
cases:4.21%
controls:0.73%
cases:5.09%
controls:1.89%
128
429
3674
37558
181
265
3622
37727
71
42
3732
37950
—
76
37
3666
37836
138
266
3141
36009
126
547
2348
28471
Liver transplant status
Z94.4 [45566478]
1.7e+00
1.7e+00
1.9e+00
—
2.1e+00
1.9e+00
2.6e+00
cases:0.26%
controls:0.05%
cases:0.24%
controls:0.04%
cases:0.18%
controls:0.03%
—
—
cases:0.21%
controls:0.03%
cases:0.27%
controls:0.04%
cases:0.44%
controls:0.03%
10
18
3792
37969
9
17
3794
37975
7
11
3796
37981
—
8
10
3734
37863
9
15
3270
36260
11
10
2463
29008
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
8.5e-01
1.6e+00
3.0e+00
1.0e+50
4.0e+00
1.7e+00
6.9e-01
cases:1.76%
controls:0.76%
cases:1.76%
controls:0.36%
cases:1.18%
controls:0.06%
cases:2.31%
controls:0.00%
cases:2.97%
controls:0.06%
cases:2.50%
controls:0.49%
cases:3.92%
controls:2.01%
67
289
3735
37698
67
135
3736
37857
45
23
3758
37969
88
0
3715
37992
111
22
3631
37851
82
176
3197
36099
97
583
2377
28435
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 [37019628]
1.1e+00
1.6e+00
2.7e+00
—
3.6e+00
1.8e+00
8.8e-01
cases:1.10%
controls:0.36%
cases:0.89%
controls:0.19%
cases:0.32%
controls:0.02%
—
—
cases:0.67%
controls:0.02%
cases:1.22%
controls:0.20%
cases:1.70%
controls:0.71%
42
136
3760
37851
34
71
3769
37921
12
8
3791
37984
—
25
7
3717
37866
40
71
3239
36204
42
207
2432
28811
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.0e+00
1.6e+00
2.7e+00
1.0e+50
3.5e+00
1.6e+00
1.3e+00
cases:4.63%
controls:1.67%
cases:3.97%
controls:0.85%
cases:1.89%
controls:0.13%
cases:0.39%
controls:0.00%
cases:3.87%
controls:0.12%
cases:4.12%
controls:0.85%
cases:6.43%
controls:1.90%
176
636
3626
37351
151
323
3652
37669
72
48
3731
37944
15
0
3788
37992
145
46
3597
37827
135
309
3144
35966
159
550
2315
28468
Sarcoidosis of lung with sarcoidosis of lymph nodes
D86.2 [45586127]
1.6e+00
2.1e+00
2.6e+00
1.0e+50
—
2.7e+00
2.6e+00
cases:0.42%
controls:0.09%
cases:0.37%
controls:0.04%
cases:0.18%
controls:0.01%
cases:0.26%
controls:0.00%
—
—
cases:0.64%
controls:0.04%
cases:1.01%
controls:0.07%
16
33
3786
37954
14
17
3789
37975
7
5
3796
37987
10
0
3793
37992
—
21
15
3258
36260
25
21
2449
28997
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.8e-01
8.5e-01
2.2e+00
4.7e+00
2.2e+00
8.6e-01
5.7e-01
cases:11.52%
controls:8.16%
cases:9.33%
controls:4.22%
cases:5.13%
controls:0.60%
cases:2.95%
controls:0.03%
cases:5.16%
controls:0.60%
cases:9.55%
controls:4.28%
cases:18.55%
controls:11.43%
438
3101
3364
34886
355
1604
3448
36388
195
229
3608
37763
112
11
3691
37981
193
229
3549
37644
313
1552
2966
34723
459
3317
2015
25701
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]
2.8e+00
2.7e+00
—
—
—
3.2e+00
2.9e+00
cases:0.89%
controls:0.05%
cases:0.68%
controls:0.04%
—
—
—
—
—
—
cases:1.01%
controls:0.04%
cases:1.25%
controls:0.07%
34
20
3768
37967
26
17
3777
37975
—
—
—
33
15
3246
36260
31
20
2443
28998
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
5.5e-01
9.8e-01
2.0e+00
4.4e+00
2.2e+00
1.0e+00
5.6e-01
cases:10.57%
controls:6.40%
cases:8.76%
controls:3.46%
cases:3.18%
controls:0.44%
cases:1.42%
controls:0.02%
cases:4.65%
controls:0.52%
cases:9.42%
controls:3.69%
cases:16.90%
controls:10.42%
402
2431
3400
35556
333
1316
3470
36676
121
167
3682
37825
54
7
3749
37985
174
198
3568
37675
309
1338
2970
34937
418
3023
2056
25995
Other and unspecified convulsions
R56.8 [45602033]
1.1e+00
1.2e+00
3.0e+00
1.0e+50
3.2e+00
2.1e+00
1.2e+00
cases:1.10%
controls:0.38%
cases:0.47%
controls:0.14%
cases:0.37%
controls:0.02%
cases:0.74%
controls:0.00%
cases:0.56%
controls:0.02%
cases:0.91%
controls:0.12%
cases:1.21%
controls:0.37%
42
143
3760
37844
18
55
3785
37937
14
7
3789
37985
28
0
3775
37992
21
9
3721
37864
30
43
3249
36232
30
108
2444
28910
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
1.1e+00
1.5e+00
2.9e+00
—
3.2e+00
1.6e+00
1.3e+00
cases:1.47%
controls:0.51%
cases:0.92%
controls:0.20%
cases:0.24%
controls:0.01%
—
—
cases:0.67%
controls:0.03%
cases:1.04%
controls:0.20%
cases:2.34%
controls:0.66%
56
193
3746
37794
35
77
3768
37915
9
5
3794
37987
—
25
10
3717
37863
34
73
3245
36202
58
191
2416
28827
Physiotherapy
R4110 [2001310233]
4.1e-01
9.0e-01
1.5e+00
4.9e+00
1.8e+00
1.3e+00
9.2e-01
cases:7.47%
controls:5.10%
cases:4.39%
controls:1.83%
cases:1.10%
controls:0.25%
cases:1.74%
controls:0.01%
cases:1.50%
controls:0.26%
cases:4.61%
controls:1.36%
cases:9.58%
controls:4.05%
284
1936
3518
36051
167
695
3636
37297
42
96
3761
37896
66
5
3737
37987
56
97
3686
37776
151
493
3128
35782
237
1176
2237
27842
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
1.1e+00
1.6e+00
3.2e+00
1.0e+50
3.4e+00
1.7e+00
7.2e-01
cases:1.74%
controls:0.61%
cases:1.37%
controls:0.29%
cases:0.71%
controls:0.03%
cases:1.37%
controls:0.00%
cases:1.26%
controls:0.04%
cases:1.92%
controls:0.36%
cases:2.67%
controls:1.31%
66
232
3736
37755
52
111
3751
37881
27
11
3776
37981
52
0
3751
37992
47
16
3695
37857
63
130
3216
36145
66
381
2408
28637
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
8.9e-01
1.6e+00
2.6e+00
—
4.0e+00
1.5e+00
1.1e+00
cases:1.95%
controls:0.81%
cases:1.08%
controls:0.23%
cases:0.42%
controls:0.03%
—
—
cases:1.15%
controls:0.02%
cases:0.85%
controls:0.20%
cases:2.14%
controls:0.73%
74
306
3728
37681
41
87
3762
37905
16
12
3787
37980
—
43
8
3699
37865
28
72
3251
36203
53
211
2421
28807
Essential (primary) hypertension
I10 [45591453]
5.8e-01
8.8e-01
1.5e+00
5.3e+00
1.9e+00
9.5e-01
5.4e-01
cases:29.20%
controls:18.75%
cases:20.30%
controls:9.53%
cases:6.63%
controls:1.53%
cases:11.81%
controls:0.07%
cases:9.30%
controls:1.56%
cases:22.11%
controls:9.92%
cases:35.13%
controls:24.03%
1110
7124
2692
30863
772
3619
3031
34373
252
583
3551
37409
449
26
3354
37966
348
589
3394
37284
725
3599
2554
32676
869
6972
1605
22046
Abdominal ultrasound examination
JN3AE [2001305555]
1.0e+00
1.7e+00
2.6e+00
1.0e+50
2.6e+00
2.1e+00
1.7e+00
cases:4.10%
controls:1.56%
cases:2.50%
controls:0.49%
cases:0.71%
controls:0.06%
cases:2.10%
controls:0.00%
cases:0.77%
controls:0.06%
cases:2.99%
controls:0.39%
cases:5.78%
controls:1.10%
156
591
3646
37396
95
186
3708
37806
27
21
3776
37971
80
0
3723
37992
29
22
3713
37851
98
140
3181
36135
143
320
2331
28698
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.5e-01
7.7e-01
2.3e+00
4.8e+00
2.3e+00
8.1e-01
3.6e-01
cases:49.32%
controls:43.16%
cases:50.04%
controls:31.76%
cases:37.15%
controls:5.61%
cases:28.74%
controls:0.33%
cases:37.73%
controls:5.68%
cases:51.63%
controls:32.19%
cases:64.75%
controls:56.22%
1875
16397
1927
21590
1903
12066
1900
25926
1413
2130
2390
35862
1093
127
2710
37865
1412
2150
2330
35723
1693
11677
1586
24598
1602
16314
872
12704
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
1.0e+00
1.6e+00
3.1e+00
1.0e+50
3.3e+00
1.8e+00
7.4e-01
cases:1.66%
controls:0.59%
cases:1.31%
controls:0.27%
cases:0.66%
controls:0.03%
cases:1.29%
controls:0.00%
cases:0.99%
controls:0.04%
cases:1.83%
controls:0.32%
cases:2.47%
controls:1.19%
63
223
3739
37764
50
102
3753
37890
25
11
3778
37981
49
0
3754
37992
37
14
3705
37859
60
116
3219
36159
61
345
2413
28673
Diffuse lymphoma with large B cells
C83.31 [2000501224]
8.6e-01
1.5e+00
2.5e+00
1.0e+50
3.7e+00
2.3e+00
1.7e+00
cases:0.42%
controls:0.18%
cases:0.63%
controls:0.15%
cases:0.53%
controls:0.04%
cases:0.84%
controls:0.00%
cases:1.42%
controls:0.04%
cases:1.25%
controls:0.13%
cases:1.21%
controls:0.23%
16
68
3786
37919
24
56
3779
37936
20
17
3783
37975
32
0
3771
37992
53
14
3689
37859
41
47
3238
36228
30
66
2444
28952
Severe anaemia associated with chronic renal failure
138 [2001600134]
2.8e+00
2.5e+00
—
—
1.0e+50
4.1e+00
2.2e+00
cases:1.66%
controls:0.11%
cases:0.53%
controls:0.04%
—
—
—
—
cases:0.19%
controls:0.00%
cases:0.79%
controls:0.01%
cases:0.97%
controls:0.11%
63
40
3739
37947
20
16
3783
37976
—
—
7
0
3735
37873
26
5
3253
36270
24
32
2450
28986
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.0e-01
9.5e-01
2.2e+00
4.4e+00
2.3e+00
8.9e-01
4.8e-01
cases:25.70%
controls:18.80%
cases:18.83%
controls:8.25%
cases:7.49%
controls:0.93%
cases:2.73%
controls:0.03%
cases:7.91%
controls:0.89%
cases:17.54%
controls:8.06%
cases:32.34%
controls:22.78%
977
7141
2825
30846
716
3134
3087
34858
285
354
3518
37638
104
13
3699
37979
296
336
3446
37537
575
2923
2704
33352
800
6610
1674
22408
INR in Blood by Coagulation assay
34714-6 [3032080]
6.4e-01
1.2e+00
1.7e+00
4.2e+00
1.8e+00
1.2e+00
8.1e-01
cases:21.54%
controls:12.61%
cases:18.83%
controls:6.80%
cases:10.57%
controls:2.12%
cases:7.55%
controls:0.12%
cases:12.08%
controls:2.15%
cases:18.60%
controls:6.47%
cases:27.73%
controls:14.54%
819
4792
2983
33195
716
2582
3087
35410
402
804
3401
37188
287
47
3516
37945
452
813
3290
37060
610
2347
2669
33928
686
4220
1788
24798
Immunohistochemistry procedure
117617002 [4035726]
7.7e-01
1.5e+00
3.0e+00
—
3.2e+00
1.8e+00
1.2e+00
cases:4.10%
controls:1.95%
cases:3.58%
controls:0.79%
cases:1.47%
controls:0.07%
—
—
cases:1.58%
controls:0.07%
cases:2.99%
controls:0.50%
cases:4.16%
controls:1.33%
156
740
3646
37247
136
301
3667
37691
56
27
3747
37965
—
59
25
3683
37848
98
182
3181
36093
103
385
2371
28633
Preparatory care for dialysis
Z49.0 [45571361]
2.6e+00
2.8e+00
—
1.0e+50
—
3.3e+00
2.8e+00
cases:0.76%
controls:0.06%
cases:0.53%
controls:0.03%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.76%
controls:0.03%
cases:0.89%
controls:0.06%
29
22
3773
37965
20
12
3783
37980
—
7
0
3796
37992
—
25
10
3254
36265
22
16
2452
29002
Chronic ulcer of skin, not elsewhere classified
L98.4 [45533667]
1.3e+00
2.1e+00
2.5e+00
—
2.5e+00
2.0e+00
1.2e+00
cases:0.47%
controls:0.12%
cases:0.47%
controls:0.06%
cases:0.29%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.43%
controls:0.06%
cases:0.69%
controls:0.21%
18
47
3784
37940
18
23
3785
37969
11
9
3792
37983
—
7
6
3735
37867
14
22
3265
36253
17
62
2457
28956
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.5e-01
7.6e-01
2.3e+00
4.8e+00
2.3e+00
8.0e-01
3.4e-01
cases:49.76%
controls:43.47%
cases:50.38%
controls:32.15%
cases:37.50%
controls:5.74%
cases:28.69%
controls:0.34%
cases:37.87%
controls:5.80%
cases:51.97%
controls:32.66%
cases:64.71%
controls:56.52%
1892
16512
1910
21475
1916
12213
1887
25779
1426
2179
2377
35813
1091
130
2712
37862
1417
2195
2325
35678
1704
11846
1575
24429
1601
16402
873
12616
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.0e-01
8.7e-01
2.0e+00
4.7e+00
2.2e+00
8.5e-01
4.5e-01
cases:17.86%
controls:12.77%
cases:15.22%
controls:6.98%
cases:7.23%
controls:1.03%
cases:4.34%
controls:0.04%
cases:8.12%
controls:1.00%
cases:15.61%
controls:7.33%
cases:29.06%
controls:20.69%
679
4850
3123
33137
579
2652
3224
35340
275
390
3528
37602
165
15
3638
37977
304
380
3438
37493
512
2660
2767
33615
719
6005
1755
23013
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
4.0e-01
8.7e-01
2.0e+00
4.8e+00
2.2e+00
8.3e-01
4.5e-01
cases:18.20%
controls:13.03%
cases:15.36%
controls:7.07%
cases:7.34%
controls:1.03%
cases:4.39%
controls:0.04%
cases:8.15%
controls:1.02%
cases:15.61%
controls:7.48%
cases:29.35%
controls:21.01%
692
4949
3110
33038
584
2687
3219
35305
279
393
3524
37599
167
15
3636
37977
305
385
3437
37488
512
2713
2767
33562
726
6097
1748
22921
Palliative radiotherapy
WF004 [2001310703]
1.5e+00
2.2e+00
2.7e+00
—
3.3e+00
1.8e+00
8.1e-01
cases:0.37%
controls:0.08%
cases:0.66%
controls:0.07%
cases:0.24%
controls:0.02%
—
—
cases:0.35%
controls:0.01%
cases:0.43%
controls:0.07%
cases:0.36%
controls:0.16%
14
31
3788
37956
25
28
3778
37964
9
6
3794
37986
—
13
5
3729
37868
14
26
3265
36249
9
47
2465
28971
Radical radiotherapy
WF002 [2001310701]
6.0e-01
1.4e+00
2.5e+00
3.2e+00
2.2e+00
1.5e+00
1.7e-01
cases:1.21%
controls:0.67%
cases:0.97%
controls:0.24%
cases:0.45%
controls:0.04%
cases:0.32%
controls:0.01%
cases:0.35%
controls:0.04%
cases:0.85%
controls:0.18%
cases:0.73%
controls:0.61%
46
253
3756
37734
37
92
3766
37900
17
14
3786
37978
12
5
3791
37987
13
14
3729
37859
28
67
3251
36208
18
178
2456
28840
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.2e+00
1.5e+00
2.2e+00
1.0e+50
3.1e+00
2.0e+00
1.4e+00
cases:2.42%
controls:0.71%
cases:1.24%
controls:0.29%
cases:0.42%
controls:0.04%
cases:1.29%
controls:0.00%
cases:0.99%
controls:0.04%
cases:1.77%
controls:0.25%
cases:2.55%
controls:0.64%
92
270
3710
37717
47
109
3756
37883
16
17
3787
37975
49
0
3754
37992
37
17
3705
37856
58
92
3221
36183
63
186
2411
28832
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.6e+00
1.7e+00
2.2e+00
—
1.6e+00
2.0e+00
2.2e+00
cases:1.21%
controls:0.24%
cases:1.13%
controls:0.21%
cases:0.63%
controls:0.07%
—
—
cases:0.43%
controls:0.08%
cases:1.65%
controls:0.22%
cases:2.71%
controls:0.29%
46
93
3756
37894
43
80
3760
37912
24
26
3779
37966
—
16
32
3726
37841
54
81
3225
36194
67
85
2407
28933
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
8.4e-01
1.3e+00
2.6e+00
—
3.8e+00
1.6e+00
1.2e+00
cases:1.32%
controls:0.57%
cases:0.76%
controls:0.21%
cases:0.42%
controls:0.03%
—
—
cases:0.96%
controls:0.02%
cases:0.82%
controls:0.17%
cases:1.98%
controls:0.58%
50
217
3752
37770
29
79
3774
37913
16
12
3787
37980
—
36
8
3706
37865
27
61
3252
36214
49
169
2425
28849
EKG study
11524-6 [3013512]
4.2e-01
7.1e-01
1.9e+00
5.0e+00
2.2e+00
7.7e-01
4.2e-01
cases:13.31%
controls:9.14%
cases:9.57%
controls:4.96%
cases:3.89%
controls:0.62%
cases:3.50%
controls:0.02%
cases:4.65%
controls:0.55%
cases:9.97%
controls:4.90%
cases:18.88%
controls:13.31%
506
3472
3296
34515
364
1883
3439
36109
148
234
3655
37758
133
9
3670
37983
174
209
3568
37664
327
1777
2952
34498
467
3863
2007
25155
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.9e-01
8.6e-01
2.0e+00
4.7e+00
2.1e+00
8.3e-01
4.5e-01
cases:18.41%
controls:13.25%
cases:15.41%
controls:7.15%
cases:7.31%
controls:1.04%
cases:4.42%
controls:0.04%
cases:8.23%
controls:1.04%
cases:15.65%
controls:7.46%
cases:29.47%
controls:21.05%
700
5033
3102
32954
586
2716
3217
35276
278
396
3525
37596
168
16
3635
37976
308
393
3434
37480
513
2706
2766
33569
729
6107
1745
22911
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
9.5e-01
1.9e+00
2.5e+00
—
3.7e+00
1.2e+00
1.1e+00
cases:1.05%
controls:0.41%
cases:1.53%
controls:0.23%
cases:0.63%
controls:0.05%
—
—
cases:1.10%
controls:0.03%
cases:0.76%
controls:0.24%
cases:1.66%
controls:0.55%
40
155
3762
37832
58
88
3745
37904
24
20
3779
37972
—
41
10
3701
37863
25
87
3254
36188
41
159
2433
28859
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.6e-01
8.2e-01
2.0e+00
4.8e+00
2.1e+00
8.1e-01
4.0e-01
cases:15.41%
controls:11.32%
cases:11.54%
controls:5.45%
cases:5.57%
controls:0.79%
cases:3.50%
controls:0.03%
cases:6.01%
controls:0.76%
cases:11.65%
controls:5.55%
cases:21.75%
controls:15.66%
586
4300
3216
33687
439
2072
3364
35920
212
300
3591
37692
133
11
3670
37981
225
286
3517
37587
382
2012
2897
34263
538
4545
1936
24473
Pulmonary Disease
29 [38004472]
6.4e-01
1.0e+00
1.5e+00
4.5e+00
1.5e+00
1.2e+00
9.0e-01
cases:16.44%
controls:9.36%
cases:12.23%
controls:4.78%
cases:4.08%
controls:0.90%
cases:1.68%
controls:0.02%
cases:4.04%
controls:0.93%
cases:13.94%
controls:4.70%
cases:20.41%
controls:9.44%
625
3556
3177
34431
465
1815
3338
36177
155
343
3648
37649
64
7
3739
37985
151
352
3591
37521
457
1706
2822
34569
505
2738
1969
26280
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
8.0e-01
1.7e+00
2.8e+00
—
3.9e+00
1.5e+00
6.8e-01
cases:1.71%
controls:0.78%
cases:1.71%
controls:0.31%
cases:0.92%
controls:0.06%
—
—
cases:2.27%
controls:0.05%
cases:1.95%
controls:0.46%
cases:3.40%
controls:1.76%
65
296
3737
37691
65
119
3738
37873
35
22
3768
37970
—
85
18
3657
37855
64
168
3215
36107
84
510
2390
28508
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.0e-01
1.0e+00
2.2e+00
4.0e+00
2.2e+00
8.5e-01
6.0e-01
cases:32.01%
controls:24.02%
cases:27.56%
controls:11.84%
cases:12.46%
controls:1.55%
cases:2.76%
controls:0.05%
cases:12.40%
controls:1.56%
cases:22.90%
controls:11.23%
cases:42.08%
controls:28.50%
1217
9126
2585
28861
1048
4498
2755
33494
474
587
3329
37405
105
20
3698
37972
464
589
3278
37284
751
4075
2528
32200
1041
8270
1433
20748
Secondary malignant neoplasm of lung
C78.0 [45537839]
1.4e+00
2.0e+00
2.3e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:0.42%
controls:0.10%
cases:0.79%
controls:0.11%
cases:0.58%
controls:0.06%
—
—
cases:0.69%
controls:0.04%
cases:0.61%
controls:0.12%
cases:0.57%
controls:0.19%
16
39
3786
37948
30
40
3773
37952
22
22
3781
37970
—
26
16
3716
37857
20
44
3259
36231
14
56
2460
28962
Metastasis to lung
OMOP4999962 [36770283]
1.4e+00
2.0e+00
2.3e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:0.42%
controls:0.10%
cases:0.79%
controls:0.11%
cases:0.58%
controls:0.06%
—
—
cases:0.69%
controls:0.04%
cases:0.61%
controls:0.12%
cases:0.57%
controls:0.19%
16
39
3786
37948
30
40
3773
37952
22
22
3781
37970
—
26
16
3716
37857
20
44
3259
36231
14
56
2460
28962
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.0e+00
1.5e+00
3.2e+00
—
2.5e+00
1.8e+00
1.2e+00
cases:2.52%
controls:0.90%
cases:1.66%
controls:0.36%
cases:0.82%
controls:0.03%
—
—
cases:0.53%
controls:0.04%
cases:1.95%
controls:0.34%
cases:4.24%
controls:1.30%
96
343
3706
37644
63
136
3740
37856
31
13
3772
37979
—
20
17
3722
37856
64
122
3215
36153
105
377
2369
28641
Spread to lymph node
OMOP4998263 [36768587]
1.4e+00
1.8e+00
2.9e+00
1.0e+50
2.6e+00
1.4e+00
1.1e+00
cases:0.47%
controls:0.12%
cases:0.89%
controls:0.16%
cases:0.68%
controls:0.04%
cases:0.60%
controls:0.00%
cases:0.69%
controls:0.05%
cases:0.61%
controls:0.15%
cases:0.77%
controls:0.26%
18
45
3784
37942
34
59
3769
37933
26
14
3777
37978
23
0
3780
37992
26
19
3716
37854
20
55
3259
36220
19
74
2455
28944
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
1.5e+00
1.7e+00
—
—
4.6e+00
2.0e+00
1.4e+00
cases:1.24%
controls:0.27%
cases:0.74%
controls:0.14%
—
—
—
—
cases:1.55%
controls:0.02%
cases:0.91%
controls:0.13%
cases:1.50%
controls:0.37%
47
102
3755
37885
28
52
3775
37940
—
—
58
6
3684
37867
30
46
3249
36229
37
108
2437
28910
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
7.7e-01
1.7e+00
2.8e+00
—
3.9e+00
1.5e+00
6.4e-01
cases:1.63%
controls:0.76%
cases:1.66%
controls:0.31%
cases:0.92%
controls:0.06%
—
—
cases:2.22%
controls:0.05%
cases:1.95%
controls:0.45%
cases:3.27%
controls:1.75%
62
289
3740
37698
63
118
3740
37874
35
22
3768
37970
—
83
18
3659
37855
64
165
3215
36110
81
509
2393
28509
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
9.9e-01
2.0e+00
2.5e+00
—
2.9e+00
1.7e+00
1.1e+00
cases:1.29%
controls:0.48%
cases:1.29%
controls:0.18%
cases:0.45%
controls:0.04%
—
—
cases:0.72%
controls:0.04%
cases:1.25%
controls:0.23%
cases:1.66%
controls:0.55%
49
184
3753
37803
49
67
3754
37925
17
14
3786
37978
—
27
15
3715
37858
41
84
3238
36191
41
160
2433
28858
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
5.6e-01
1.0e+00
2.0e+00
3.7e+00
2.5e+00
8.5e-01
5.5e-01
cases:16.23%
controls:9.94%
cases:12.20%
controls:4.85%
cases:3.42%
controls:0.46%
cases:0.74%
controls:0.02%
cases:5.34%
controls:0.46%
cases:11.13%
controls:5.08%
cases:24.62%
controls:15.82%
617
3776
3185
34211
464
1843
3339
36149
130
176
3673
37816
28
7
3775
37985
200
175
3542
37698
365
1841
2914
34434
609
4590
1865
24428
Short blood count panel - Blood
55429-5 [40758558]
4.0e-01
8.2e-01
1.7e+00
4.7e+00
2.0e+00
8.8e-01
5.9e-01
cases:9.86%
controls:6.82%
cases:7.89%
controls:3.62%
cases:4.65%
controls:0.85%
cases:2.05%
controls:0.02%
cases:5.29%
controls:0.73%
cases:8.23%
controls:3.59%
cases:13.86%
controls:8.18%
375
2590
3427
35397
300
1377
3503
36615
177
324
3626
37668
78
7
3725
37985
198
278
3544
37595
270
1304
3009
34971
343
2373
2131
26645
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
1.0e+00
1.5e+00
3.0e+00
1.0e+50
2.9e+00
1.8e+00
9.6e-01
cases:2.18%
controls:0.81%
cases:1.89%
controls:0.44%
cases:0.79%
controls:0.04%
cases:0.92%
controls:0.00%
cases:1.02%
controls:0.06%
cases:2.10%
controls:0.35%
cases:3.40%
controls:1.33%
83
307
3719
37680
72
169
3731
37823
30
15
3773
37977
35
0
3768
37992
38
21
3704
37852
69
126
3210
36149
84
385
2390
28633
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
1.2e+00
2.1e+00
3.0e+00
—
2.3e+00
1.4e+00
1.2e+00
cases:1.66%
controls:0.51%
cases:1.45%
controls:0.18%
cases:0.42%
controls:0.02%
—
—
cases:0.27%
controls:0.03%
cases:0.79%
controls:0.20%
cases:1.70%
controls:0.54%
63
195
3739
37792
55
67
3748
37925
16
8
3787
37984
—
10
10
3732
37863
26
72
3253
36203
42
156
2432
28862
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
7.4e-01
1.7e+00
3.0e+00
—
3.1e+00
1.6e+00
1.0e+00
cases:1.29%
controls:0.62%
cases:1.26%
controls:0.23%
cases:0.58%
controls:0.03%
—
—
cases:0.99%
controls:0.04%
cases:1.22%
controls:0.25%
cases:2.14%
controls:0.78%
49
235
3753
37752
48
89
3755
37903
22
11
3781
37981
—
37
17
3705
37856
40
92
3239
36183
53
225
2421
28793
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
1.0e+00
2.2e+00
2.5e+00
—
2.6e+00
2.0e+00
8.3e-01
cases:1.87%
controls:0.66%
cases:2.45%
controls:0.28%
cases:0.79%
controls:0.07%
—
—
cases:0.75%
controls:0.06%
cases:1.83%
controls:0.25%
cases:1.05%
controls:0.46%
71
252
3731
37735
93
105
3710
37887
30
25
3773
37967
—
28
22
3714
37851
60
91
3219
36184
26
134
2448
28884
Lactate [Moles/volume] in Blood
32693-4 [3047181]
1.1e+00
1.4e+00
3.0e+00
1.0e+50
2.9e+00
1.7e+00
9.7e-01
cases:1.60%
controls:0.54%
cases:1.00%
controls:0.25%
cases:0.42%
controls:0.02%
cases:0.71%
controls:0.00%
cases:0.53%
controls:0.03%
cases:1.16%
controls:0.21%
cases:1.98%
controls:0.76%
61
204
3741
37783
38
94
3765
37898
16
8
3787
37984
27
0
3776
37992
20
11
3722
37862
38
76
3241
36199
49
220
2425
28798
Nutritional therapy
R4190 [2001310243]
1.1e+00
1.6e+00
2.2e+00
1.0e+50
2.3e+00
2.2e+00
1.7e+00
cases:0.89%
controls:0.29%
cases:0.79%
controls:0.17%
cases:0.29%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.35%
controls:0.03%
cases:1.19%
controls:0.14%
cases:2.02%
controls:0.38%
34
109
3768
37878
30
63
3773
37929
11
12
3792
37980
5
0
3798
37992
13
13
3729
37860
39
49
3240
36226
50
111
2424
28907
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.1e+00
1.6e+00
2.6e+00
—
2.8e+00
2.0e+00
1.1e+00
cases:2.00%
controls:0.69%
cases:1.81%
controls:0.38%
cases:1.10%
controls:0.09%
—
—
cases:1.12%
controls:0.07%
cases:2.56%
controls:0.37%
cases:2.79%
controls:0.96%
76
262
3726
37725
69
144
3734
37848
42
33
3761
37959
—
42
25
3700
37848
84
133
3195
36142
69
278
2405
28740
Kidney Pathology biopsy report
65757-7 [40768446]
2.2e+00
3.3e+00
—
—
1.0e+50
3.0e+00
2.7e+00
cases:0.47%
controls:0.06%
cases:0.37%
controls:0.01%
—
—
—
—
cases:0.32%
controls:0.00%
cases:0.58%
controls:0.03%
cases:0.93%
controls:0.07%
18
21
3784
37966
14
5
3789
37987
—
—
12
0
3730
37873
19
11
3260
36264
23
19
2451
28999
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.0e+00
1.9e+00
2.5e+00
1.0e+50
2.5e+00
2.0e+00
1.2e+00
cases:5.18%
controls:1.96%
cases:3.58%
controls:0.57%
cases:0.82%
controls:0.07%
cases:1.68%
controls:0.00%
cases:0.86%
controls:0.07%
cases:3.42%
controls:0.46%
cases:5.90%
controls:1.91%
197
744
3605
37243
136
215
3667
37777
31
25
3772
37967
64
0
3739
37992
32
27
3710
37846
112
167
3167
36108
146
555
2328
28463
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
1.2e+00
2.0e+00
2.8e+00
—
2.5e+00
1.4e+00
1.1e+00
cases:1.63%
controls:0.48%
cases:1.39%
controls:0.19%
cases:0.39%
controls:0.02%
—
—
cases:0.29%
controls:0.02%
cases:0.76%
controls:0.20%
cases:1.70%
controls:0.54%
62
184
3740
37803
53
71
3750
37921
15
9
3788
37983
—
11
9
3731
37864
25
71
3254
36204
42
158
2432
28860
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16182-8 [3021952]
1.3e+00
2.0e+00
—
—
4.2e+00
2.1e+00
1.5e+00
cases:1.08%
controls:0.28%
cases:0.95%
controls:0.13%
—
—
—
—
cases:0.88%
controls:0.01%
cases:0.88%
controls:0.11%
cases:1.78%
controls:0.41%
41
108
3761
37879
36
49
3767
37943
—
—
33
5
3709
37868
29
41
3250
36234
44
120
2430
28898
Sarcoidosis of other and combined sites
D86.8 [45576423]
1.8e+00
2.2e+00
—
1.0e+50
—
3.7e+00
3.4e+00
cases:0.29%
controls:0.05%
cases:0.29%
controls:0.03%
—
—
cases:0.16%
controls:0.00%
—
—
cases:1.16%
controls:0.03%
cases:1.82%
controls:0.06%
11
18
3791
37969
11
12
3792
37980
—
6
0
3797
37992
—
38
11
3241
36264
45
18
2429
29000
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
1.5e+00
1.8e+00
2.4e+00
—
2.0e+00
2.1e+00
1.2e+00
cases:1.45%
controls:0.32%
cases:0.84%
controls:0.14%
cases:0.29%
controls:0.03%
—
—
cases:0.32%
controls:0.04%
cases:1.07%
controls:0.13%
cases:1.50%
controls:0.45%
55
122
3747
37865
32
52
3771
37940
11
10
3792
37982
—
12
16
3730
37857
35
48
3244
36227
37
131
2437
28887
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
6.1e-01
1.2e+00
2.1e+00
3.0e+00
2.5e+00
1.0e+00
5.7e-01
cases:4.39%
controls:2.44%
cases:4.73%
controls:1.49%
cases:2.34%
controls:0.29%
cases:0.32%
controls:0.02%
cases:3.07%
controls:0.25%
cases:3.72%
controls:1.35%
cases:4.77%
controls:2.77%
167
925
3635
37062
180
565
3623
37427
89
109
3714
37883
12
6
3791
37986
115
95
3627
37778
122
489
3157
35786
118
803
2356
28215
Upper gastrointestinal surgery
106 [44777669]
6.0e-01
1.2e+00
2.0e+00
3.6e+00
1.8e+00
1.2e+00
7.2e-01
cases:17.18%
controls:10.24%
cases:11.62%
controls:3.96%
cases:4.31%
controls:0.63%
cases:1.26%
controls:0.03%
cases:3.82%
controls:0.65%
cases:11.38%
controls:3.73%
cases:18.88%
controls:10.17%
653
3891
3149
34096
442
1505
3361
36487
164
240
3639
37752
48
13
3755
37979
143
248
3599
37625
373
1354
2906
34921
467
2952
2007
26066
pH of Urine
2756-5 [3015736]
3.5e-01
7.8e-01
1.9e+00
4.9e+00
2.1e+00
7.6e-01
3.5e-01
cases:14.18%
controls:10.47%
cases:10.41%
controls:5.07%
cases:4.58%
controls:0.74%
cases:2.68%
controls:0.02%
cases:5.37%
controls:0.72%
cases:10.58%
controls:5.23%
cases:20.74%
controls:15.51%
539
3978
3263
34009
396
1925
3407
36067
174
281
3629
37711
102
8
3701
37984
201
271
3541
37602
347
1896
2932
34379
513
4501
1961
24517
Postsurgical hypothyroidism
E89.01 [2000501554]
2.7e+00
3.5e+00
—
1.0e+50
1.0e+50
—
4.8e+00
cases:0.63%
controls:0.04%
cases:0.50%
controls:0.02%
—
—
cases:1.37%
controls:0.00%
cases:1.76%
controls:0.00%
—
—
cases:6.14%
controls:0.05%
24
16
3778
37971
19
6
3784
37986
—
52
0
3751
37992
66
0
3676
37873
—
152
15
2322
29003
Outpatient Visit
OP [9202]
6.1e-01
7.8e-01
1.2e+00
4.6e+00
1.5e+00
1.2e+00
1.1e+00
cases:85.69%
controls:76.53%
cases:72.86%
controls:55.27%
cases:28.16%
controls:10.93%
cases:32.63%
controls:0.48%
cases:34.85%
controls:10.65%
cases:80.42%
controls:54.27%
cases:92.52%
controls:80.62%
3258
29071
544
8916
2771
20997
1032
16995
1071
4153
2732
33839
1241
183
2562
37809
1304
4034
2438
33839
2637
19686
642
16589
2289
23393
185
5625
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
1.3e+00
1.7e+00
—
1.0e+50
4.3e+00
2.0e+00
1.6e+00
cases:1.00%
controls:0.27%
cases:0.66%
controls:0.12%
—
—
cases:0.58%
controls:0.00%
cases:1.12%
controls:0.02%
cases:0.79%
controls:0.11%
cases:1.41%
controls:0.28%
38
103
3764
37884
25
44
3778
37948
—
22
0
3781
37992
42
6
3700
37867
26
40
3253
36235
35
82
2439
28936
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.9e-01
6.8e-01
2.2e+00
4.6e+00
2.2e+00
7.5e-01
2.8e-01
cases:51.87%
controls:47.07%
cases:54.01%
controls:37.25%
cases:42.36%
controls:7.33%
cases:28.32%
controls:0.39%
cases:40.49%
controls:7.29%
cases:55.84%
controls:37.50%
cases:67.42%
controls:61.04%
1972
17879
1830
20108
2054
14152
1749
23840
1611
2785
2192
35207
1077
147
2726
37845
1515
2762
2227
35111
1831
13603
1448
22672
1668
17714
806
11304
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
8.3e-01
1.4e+00
2.7e+00
1.0e+50
3.8e+00
1.2e+00
9.7e-01
cases:2.00%
controls:0.88%
cases:1.18%
controls:0.29%
cases:0.58%
controls:0.04%
cases:0.13%
controls:0.00%
cases:1.55%
controls:0.04%
cases:0.88%
controls:0.26%
cases:2.43%
controls:0.93%
76
334
3726
37653
45
109
3758
37883
22
15
3781
37977
5
0
3798
37992
58
14
3684
37859
29
94
3250
36181
60
271
2414
28747
Lenalidomid
153 [2001600151]
2.7e+00
2.5e+00
—
—
—
3.6e+00
2.1e+00
cases:0.55%
controls:0.04%
cases:0.16%
controls:0.01%
—
—
—
—
—
—
cases:0.82%
controls:0.02%
cases:0.49%
controls:0.06%
21
14
3781
37973
6
5
3797
37987
—
—
—
27
8
3252
36267
12
18
2462
29000
tinzaparin; parenteral
B01AB10 [21600981]
9.2e-01
1.6e+00
2.7e+00
—
3.0e+00
2.0e+00
7.1e-01
cases:2.68%
controls:1.09%
cases:2.52%
controls:0.54%
cases:1.66%
controls:0.12%
—
—
cases:2.03%
controls:0.10%
cases:4.00%
controls:0.54%
cases:3.64%
controls:1.83%
102
413
3700
37574
96
206
3707
37786
63
45
3740
37947
—
76
39
3666
37834
131
195
3148
36080
90
530
2384
28488
Anion gap in Blood by calculation
41276-7 [3039000]
1.1e+00
1.7e+00
2.8e+00
1.0e+50
2.7e+00
1.8e+00
7.8e-01
cases:1.18%
controls:0.38%
cases:0.74%
controls:0.14%
cases:0.29%
controls:0.02%
cases:0.42%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.76%
controls:0.13%
cases:1.05%
controls:0.48%
45
146
3757
37841
28
52
3775
37940
11
7
3792
37985
16
0
3787
37992
12
8
3730
37865
25
47
3254
36228
26
140
2448
28878
Chloride [Moles/volume] in Blood
2069-3 [3018572]
1.1e+00
1.7e+00
2.8e+00
1.0e+50
2.7e+00
1.8e+00
7.8e-01
cases:1.18%
controls:0.38%
cases:0.74%
controls:0.14%
cases:0.29%
controls:0.02%
cases:0.42%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.76%
controls:0.13%
cases:1.05%
controls:0.48%
45
146
3757
37841
28
52
3775
37940
11
7
3792
37985
16
0
3787
37992
12
8
3730
37865
25
47
3254
36228
26
140
2448
28878
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
8.5e-01
1.4e+00
2.8e+00
—
3.3e+00
1.5e+00
8.7e-01
cases:3.13%
controls:1.36%
cases:2.71%
controls:0.68%
cases:1.29%
controls:0.08%
—
—
cases:2.67%
controls:0.10%
cases:3.05%
controls:0.69%
cases:5.25%
controls:2.26%
119
516
3683
37471
103
259
3700
37733
49
29
3754
37963
—
100
37
3642
37836
100
250
3179
36025
130
657
2344
28361
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 [40764126]
1.3e+00
2.4e+00
1.0e+50
1.0e+50
3.2e+00
2.2e+00
1.6e+00
cases:0.63%
controls:0.17%
cases:0.45%
controls:0.04%
cases:0.13%
controls:0.00%
cases:0.21%
controls:0.00%
cases:0.32%
controls:0.01%
cases:0.64%
controls:0.07%
cases:0.69%
controls:0.13%
24
65
3778
37922
17
15
3786
37977
5
0
3798
37992
8
0
3795
37992
12
5
3730
37868
21
25
3258
36250
17
39
2457
28979
Nausea and vomiting
R11 [45539317]
1.2e+00
1.6e+00
2.9e+00
—
2.2e+00
1.8e+00
1.0e+00
cases:2.21%
controls:0.67%
cases:1.31%
controls:0.26%
cases:0.68%
controls:0.04%
—
—
cases:0.37%
controls:0.04%
cases:1.59%
controls:0.26%
cases:2.83%
controls:1.04%
84
255
3718
37732
50
98
3753
37894
26
15
3777
37977
—
14
15
3728
37858
52
94
3227
36181
70
301
2404
28717
filgrastim; parenteral
L03AA02 [21603851]
1.3e+00
1.9e+00
1.9e+00
—
2.0e+00
2.6e+00
1.0e+00
cases:0.84%
controls:0.23%
cases:0.82%
controls:0.12%
cases:0.39%
controls:0.06%
—
—
cases:0.37%
controls:0.05%
cases:1.80%
controls:0.13%
cases:0.61%
controls:0.21%
32
89
3770
37898
31
45
3772
37947
15
22
3788
37970
—
14
20
3728
37853
59
47
3220
36228
15
62
2459
28956
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
7.3e-01
1.4e+00
2.6e+00
—
3.4e+00
1.7e+00
9.9e-01
cases:4.68%
controls:2.31%
cases:3.55%
controls:0.87%
cases:1.21%
controls:0.09%
—
—
cases:2.06%
controls:0.07%
cases:3.84%
controls:0.75%
cases:5.38%
controls:2.06%
178
877
3624
37110
135
332
3668
37660
46
35
3757
37957
—
77
27
3665
37846
126
273
3153
36002
133
599
2341
28419

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
985
2751
4.47
322.40
4.0
2.7
65.38
66.63
g/l
4.38
910
2518
659
1333
5.76
317.12
3.0
1.9
41.04
39.81
u/l
0.61
582
1193
973
489
26.27
307.65
2.8
1.8
5.38
4.75
mmol/24h
3.21
879
434
1695
4941
5.34
307.65
5.9
2.4
2.17
2.32
g/l
22.66
1607
4552
2828
14847
4.39
307.65
10.7
4.8
34.29
35.71
g/l
28.90
2704
13848
1637
4543
5.52
307.65
5.9
2.4
28.76
22.92
%
28.99
1556
4219
321
248
14.03
307.65
1.4
1.2
113.48
110.51
pmol/l
0.22
321
248
2111
3917
10.70
307.65
11.5
5.4
1.03
1.03
mmol/l
0.42
2019
3636
2301
9797
4.34
307.65
15.7
3.8
7.40
7.40
ph
0.26
1892
7056
3233
16723
6.77
307.65
25.4
6.3
1.24
1.21
mmol/l
16.88
2878
14291
2374
11772
3.64
307.65
6.0
3.5
2.37
2.36
mmol/l
1.95
2197
10634
2857
15120
4.43
307.65
4.8
2.3
75.97
78.72
nmol/l
4.99
2711
13526
1868
2298
14.82
307.65
6.4
3.5
87.18
85.43
ng/l
0.21
1592
1954
894
2225
4.93
307.65
3.7
2.4
—
—
—
0
0
1745
5343
5.14
307.65
5.9
2.4
15.04
13.24
umol/l
13.43
1656
4983
1005
2778
4.54
307.65
2.6
2.4
381.89
371.95
nmol/l
0.73
952
2576
234
71
35.02
307.65
1.2
1.2
4.80
14.02
pmol/l
1.66
54
29
1997
5202
6.89
307.65
7.8
3.4
0.77
0.82
mmol/l
48.73
1914
4890
588
897
7.55
307.65
4.4
3.4
6.12
3.68
ratio
0.27
333
510
1054
2726
4.94
307.65
14.9
6.7
12.20
9.34
mmol/l
25.84
1019
2614
648
1020
7.43
307.65
4.6
3.6
75.35
41.48
mg/l
0.73
539
874
653
1023
7.48
307.65
4.6
3.6
65.92
55.81
mg/l
0.45
544
873
2963
14979
5.22
307.65
20.6
5.9
1.23
1.21
mmol/l
15.93
2855
13708
486
839
6.48
274.42
2.8
2.0
14.01
11.63
mg/l
3.98
437
782
980
3099
3.90
265.68
9.0
3.6
5.85
5.82
kpa
0.45
957
3023
2883
17478
3.57
265.64
11.6
6.6
11.27
11.66
umol/l
0.75
2798
16646
972
3110
3.84
258.38
9.0
3.6
7.38
7.38
ph
0.75
655
1746
1795
8554
3.05
246.34
3.2
2.2
3.00
2.85
mg/l
1.50
1602
7390
932
3009
3.77
243.13
9.3
3.6
2.11
1.88
mmol/l
0.81
834
2638
2750
16893
3.19
232.98
9.0
6.3
0.04
0.04
e9/l
0.05
2465
14512
2798
17405
3.21
230.84
9.3
6.5
0.19
0.19
e9/l
0.68
2524
15204
2738
16836
3.16
230.34
9.0
6.3
0.62
0.58
e9/l
4.82
2455
14458
2088
11096
2.92
230.10
8.5
6.4
—
—
—
0
0
2552
15102
3.04
230.00
16.2
14.3
1.20
1.26
inr
7.26
2211
12546
1817
8990
2.93
228.54
7.4
4.1
—
—
—
0
0
2579
15394
3.04
227.92
9.5
6.6
8.92
8.92
%
0.01
2466
14389
1026
3676
3.44
226.38
3.8
2.6
1.96
1.75
%
7.36
936
3296
2568
15357
3.01
224.90
9.4
6.6
0.66
0.68
%
1.69
2450
14335
2564
15356
3.00
223.23
9.3
6.5
2.67
2.87
%
4.88
2453
14343
2762
17239
3.12
222.71
9.2
6.3
1.78
1.91
e9/l
3.74
2514
15184
873
2851
3.67
222.12
3.8
2.7
71.21
68.03
e9/l
1.40
663
2088
2533
15155
2.96
219.34
7.1
2.9
234.86
127.54
ug/l
20.82
2406
14075
2593
15761
2.97
216.99
9.4
6.5
25.62
27.90
%
19.55
2499
14886
797
2498
3.76
215.11
3.9
2.9
10.80
10.64
g/l
0.24
741
2302
2546
15441
2.91
211.73
9.0
6.4
58.86
57.15
%
9.73
2456
14727
2913
19012
3.17
211.18
15.9
9.6
4.30
4.06
e9/l
5.67
2652
16506
673
1910
4.06
209.09
2.6
2.0
1.08
1.42
g/l
4.97
613
1745
534
1299
4.61
203.22
3.5
2.3
7.49
7.31
g/l
1.25
484
1185
533
1298
4.60
202.53
3.5
2.3
3.76
3.72
g/l
0.20
483
1187
533
1298
4.60
202.53
3.5
2.3
4.13
4.21
g/l
1.10
483
1186
3487
25697
4.72
201.92
17.1
8.0
88.56
79.10
u/l
16.60
3423
24300
685
2033
3.88
199.19
6.3
3.6
7.42
7.42
ph
0.05
605
1668
902
3215
3.36
198.04
3.3
2.3
0.20
0.21
g/l
0.30
844
3022
694
2099
3.81
196.17
6.4
3.6
5.10
5.17
kpa
1.28
672
2025
362
655
6.00
193.18
2.2
1.7
—
—
—
0
0
792
2679
3.46
188.33
12.8
8.4
—
—
—
0
0
499
1223
4.54
187.53
3.6
2.3
2.90
2.91
g/l
0.04
449
1112
624
1826
3.88
184.37
4.3
3.2
4.39
4.48
pmol/l
0.78
563
1637
126
49
26.55
182.63
2.5
2.1
2.71
2.71
mmol/l
0.00
119
44
1913
10623
2.59
179.26
3.9
2.5
61.31
61.00
u/l
0.04
1814
9791
521
1379
4.21
176.65
2.0
1.7
1.57
1.51
g/l
0.62
456
1200
444
1040
4.69
176.27
4.5
2.7
24.54
25.06
mmol/l
1.54
434
1025
768
2649
3.37
176.11
7.1
3.1
4.72
4.56
kpa
1.02
742
2584
2861
19408
2.84
175.13
9.9
4.5
6.81
6.62
mmol/l
5.38
2788
18319
245
327
7.93
174.09
3.1
2.3
0.90
1.23
g/24h
0.75
182
178
412
917
4.91
174.00
5.3
4.0
1.91
1.45
mg/l
13.75
388
834
1636
8538
2.59
173.09
4.7
2.6
369.63
338.38
umol/l
22.56
1483
7494
761
2675
3.30
168.64
13.2
3.3
1.24
1.23
mmol/l
1.43
709
2259
452
1121
4.43
166.63
3.6
2.3
9.67
10.39
g/l
2.25
397
997
161
129
12.98
165.68
2.9
2.3
2109.09
1890.74
ml
1.02
154
117
579
1817
3.57
152.72
8.6
4.0
24.16
24.31
mmol/l
0.41
573
1802
223
315
7.45
150.57
2.1
1.2
59.46
69.49
mmol/l
2.26
188
249
322
655
5.27
150.55
5.5
3.7
—
—
—
0
0
1257
6124
2.56
149.25
4.3
2.7
492.96
541.39
mosm/kgh2o
12.98
1152
5345
307
615
5.34
145.96
3.9
2.9
34.99
35.09
umol/l
0.02
275
567
1327
6761
2.47
141.81
4.7
3.1
2.51
2.45
mmol/l
14.08
1193
6116
1287
6475
2.48
141.29
2.2
1.5
2.67
2.46
g/l
1.15
904
3930
1826
10744
2.33
139.97
5.3
3.1
65.82
97.91
e6/l
0.72
1501
8180
294
588
5.33
139.94
4.5
2.6
89.72
90.21
%
0.46
287
574
1822
10723
2.33
139.43
4.9
3.2
34.58
34.47
u/l
0.03
1732
10066
338
768
4.73
138.46
5.2
3.4
8.18
8.35
kpa
0.89
330
754
398
1030
4.19
137.93
6.5
3.5
7.41
7.41
ph
0.37
390
1022
205
296
7.26
135.59
2.8
2.1
—
—
—
0
0
1697
9797
2.31
134.61
2.8
2.1
268.40
214.58
u/l
0.56
1630
9232
1711
9979
2.28
131.67
4.3
3.1
—
—
—
0
0
558
1880
3.30
130.47
7.1
3.0
120.67
129.60
g/l
15.91
545
1824
1669
9683
2.28
129.51
3.7
3.0
2523.84
1183.26
ng/l
7.86
1457
8294
1003
4655
2.56
129.16
2.5
2.0
29.55
29.57
s
0.04
976
4521
712
2799
2.89
127.05
10.1
7.4
1.44
1.32
mmol/l
1.20
696
2752
136
127
11.06
126.66
7.7
6.7
5.02
162.52
ug/l
0.60
93
79
435
1276
3.72
126.00
2.6
1.9
2.53
2.61
ug/l
0.03
398
1139
1389
7532
2.32
125.86
4.3
2.5
5.13
5.69
e6/l
1.05
1300
6806
587
2083
3.14
125.59
9.9
8.5
24.68
24.98
mmol/l
0.97
578
2074
1957
12228
2.22
125.26
6.3
3.6
127.44
108.12
e6/l
0.40
1548
8608
1111
5521
2.42
122.46
2.0
1.7
1301.72
1165.98
nmol/l
3.43
877
4178
743
3060
2.77
120.95
5.5
4.3
0.91
0.93
%
0.11
346
883
1601
9327
2.23
120.81
4.9
3.0
0.58
0.41
e6/l
1.59
1263
6839
439
1341
3.57
119.42
8.6
2.9
25.49
25.43
mmol/l
0.10
424
1296
3188
24708
2.67
118.19
6.7
4.3
17.44
11.93
mm/h
44.45
3037
23008
762
3219
2.70
117.76
9.2
7.7
94.76
95.71
%
2.38
738
3116
1617
9557
2.19
116.64
2.2
1.6
19.53
20.52
nmol/l
1.31
1396
7924
825
3642
2.61
116.55
9.1
7.4
7.41
7.42
ph
0.56
471
2008
2998
22720
2.43
114.29
7.2
4.4
—
2.83
—
0
29
815
3609
2.60
114.18
9.0
7.3
0.87
0.99
mmol/l
0.27
690
2955
709
2934
2.74
113.78
5.3
4.2
0.89
0.71
%
0.73
333
845
707
2930
2.73
113.08
5.6
4.4
0.16
0.11
%
1.12
312
761
2270
15441
2.14
112.18
4.0
2.7
—
—
estimate
—
0
0
1745
10744
2.14
112.08
3.7
2.4
—
—
—
0
0
815
3653
2.56
111.04
9.2
7.4
5.06
5.13
kpa
0.99
791
3513
815
3653
2.56
111.04
9.2
7.4
11.58
12.57
kpa
6.92
792
3509
1933
12455
2.11
109.21
5.6
3.3
45.07
88.41
ng/l
0.61
1571
8734
706
2976
2.68
108.87
5.5
4.6
0.05
0.36
%
1.40
298
726
705
2976
2.68
108.37
9.9
8.3
116.08
121.42
g/l
8.26
690
2904
1505
8846
2.15
108.06
4.6
3.0
0.00
359.65
estimate
—
7
43
947
4627
2.39
106.40
2.7
2.0
—
—
—
0
0
443
1472
3.27
104.96
6.4
3.9
—
—
—
0
0
2878
21758
2.27
104.92
6.9
4.5
3841.26
1743.28
e6/l
0.49
46
258
370
1099
3.62
104.59
4.1
3.1
819.56
444.30
mg/l
0.50
208
461
160
236
7.03
103.59
7.0
4.6
68.30
92.63
u/ml
0.19
65
72
273
658
4.39
103.27
4.1
2.2
15.49
16.64
%
5.60
263
645
930
4565
2.37
102.98
1.5
1.3
438.99
531.11
titre
0.99
199
997
761
3444
2.51
100.65
2.2
1.5
—
—
—
0
0
2160
14850
2.03
98.36
2.7
2.0
95.90
96.76
pmol/l
0.34
1263
7748
1384
8150
2.09
96.35
7.0
4.0
89.90
89.47
%
0.26
1354
7964
1299
7494
2.11
95.33
7.1
4.7
—
—
—
0
0
122
146
8.60
94.51
1.7
1.6
—
—
—
0
0
2444
17743
2.03
93.30
5.7
3.8
6.83
2.66
estimate
0.51
709
3830
100
93
11.01
93.27
1.8
1.5
—
—
—
0
0
109
115
9.72
93.01
48.0
38.1
7.08
7.26
ug/l
0.26
102
104
886
4428
2.30
92.94
2.2
1.6
—
—
—
0
0
206
431
4.99
92.63
2.1
2.2
0.83
0.89
%
0.72
157
285
2421
17553
2.02
92.30
5.6
3.8
0.00
0.00
estimate
1.08
695
3721
2444
17882
2.00
89.46
5.7
3.8
0.01
0.37
estimate
0.66
678
3616
1745
11398
1.97
88.92
4.8
3.2
6.74
7.62
mmol/l
15.09
1536
9513
188
381
5.14
87.68
2.2
1.4
49.19
61.84
mu/l
0.29
168
339
672
3045
2.46
87.62
1.6
1.4
—
—
—
0
0
2128
14918
1.95
87.44
23.3
10.9
0.00
0.00
e9/l
0.43
1806
12241
2808
21703
2.08
86.56
5.4
3.2
71.37
47.04
u/l
17.91
2674
20249
388
1344
3.10
85.09
1.4
1.6
2.46
16.88
iu/ml
—
5
37
227
550
4.32
85.07
3.6
3.7
1.89
1.62
%
0.34
208
487
100
106
9.66
85.01
2.3
1.3
34.41
37.61
mmol/l
0.51
93
92
3138
25478
2.24
82.43
7.1
4.2
15.32
14.80
pmol/l
23.27
2956
23232
771
3803
2.28
82.38
2.1
1.7
—
—
—
0
0
246
652
3.96
81.65
5.6
3.9
2.94
2.65
mmol/l
0.79
191
448
246
653
3.96
81.47
5.7
3.9
5.02
5.04
kpa
0.08
238
643
435
1647
2.85
81.19
6.4
2.9
0.64
0.62
%
0.48
435
1640
247
660
3.93
81.04
5.7
4.0
8.78
8.51
kpa
1.42
239
650
110
140
8.06
80.98
2.7
1.9
—
—
—
0
0
297
903
3.48
80.52
1.3
1.2
143.06
103.69
titre
0.48
36
84
234
623
3.93
77.12
2.0
1.4
—
—
—
0
0
1243
7525
1.96
76.31
1.4
1.3
1.02
1.81
u/ml
2.61
344
2006
1640
10892
1.88
75.82
5.8
3.9
29.43
6.66
mg/mmol
1.73
1172
6502
204
501
4.24
75.02
2.7
1.6
1.78
1.67
mmol/l
0.69
196
487
1972
13920
1.85
74.72
4.7
3.4
6.27
6.24
ph
0.44
1113
7816
286
893
3.38
74.25
1.3
1.2
815.00
1163.21
titre
—
8
28
255
742
3.61
73.83
5.6
3.4
62.62
61.58
%
0.28
245
725
731
3688
2.21
73.10
4.7
2.9
9.46
8.57
umol/l
0.42
640
3243
367
1339
2.92
73.08
7.2
4.8
1.62
1.60
%
0.13
351
1258
320
1082
3.13
72.84
2.4
2.1
690.67
581.24
ug/l
0.14
302
1027
210
539
4.06
72.77
1.6
1.7
—
—
—
0
0
303
1004
3.19
71.34
1.5
1.4
247.37
280.85
ug/g
1.68
184
576
247
720
3.60
71.29
3.6
2.1
123.20
130.13
g/l
3.44
213
537
153
311
5.08
71.03
1.2
1.1
—
—
—
0
0
430
1730
2.67
71.02
11.7
10.0
15.16
16.05
%
7.14
418
1656
1605
10747
1.85
70.95
4.9
3.3
94.85
39.97
mg/l
9.99
1181
6595
918
5108
2.05
70.81
2.3
1.8
—
—
—
0
0
227
632
3.75
70.11
1.9
1.3
19.39
16.83
u/ml
—
6
11
460
1925
2.58
70.10
8.1
6.7
24.67
24.63
mmol/l
0.06
444
1842
706
3582
2.19
69.28
3.9
4.4
34.22
27.30
ug/l
0.29
593
2910
260
799
3.42
69.14
2.2
1.8
4.14
3.68
iu/l
0.35
123
292
211
565
3.89
68.90
1.9
1.4
137.19
148.79
au/ml
0.61
62
161
1168
7147
1.91
67.92
2.0
1.7
1.53
1.28
mg/l
1.77
925
5473
137
263
5.36
67.84
2.3
1.8
6.30
3.62
mg/l
6.12
128
253
149
308
4.99
67.83
1.4
1.2
69.14
60.50
u/l
0.57
139
268
322
1151
2.96
66.37
1.3
1.3
—
—
—
0
0
160
361
4.58
65.54
1.4
1.3
1087.95
289.75
pmol/l
0.65
133
312
329
1199
2.91
65.45
6.8
3.9
24.95
24.89
mmol/l
0.11
313
1125
671
3408
2.17
65.34
14.6
3.7
7.38
7.35
ph
6.18
590
2378
212
592
3.73
65.15
1.7
1.2
277.18
275.94
u/ml
0.02
129
352
332
1230
2.86
64.04
7.5
5.0
0.88
0.89
%
0.10
318
1149
891
5067
1.99
63.77
4.5
3.0
3.23
2.59
e6/l
1.02
465
2443
826
4582
2.02
63.39
1.3
1.2
—
—
—
0
0
329
1222
2.85
63.14
2.2
1.7
0.42
0.31
mg/l
1.96
174
561
505
2310
2.36
63.11
1.6
1.4
—
—
—
0
0
1493
10155
1.77
59.77
5.8
3.9
0.00
0.00
estimate
1.85
630
3477
542
2627
2.24
58.85
4.2
2.2
0.45
0.41
e6/l
0.16
527
2511
84
114
7.51
58.51
1.8
1.3
159.58
157.51
mmol/24h
0.07
84
114
1129
7110
1.83
58.31
2.0
1.7
481.79
38433460.95
pmol/l
6.53
933
5935
433
1920
2.41
57.80
5.8
4.6
—
—
—
0
0
955
5721
1.89
57.74
4.0
2.8
1.20
1.12
e6/l
0.22
533
3094
450
2037
2.37
57.32
10.7
9.3
0.64
0.65
%
0.21
445
2027
171
457
3.87
55.92
8.0
6.6
13.12
11.78
mg/l
2.97
152
422
1384
9365
1.75
55.35
5.2
3.2
0.52
0.24
estimate
0.28
600
2957
164
436
3.88
54.02
1.2
1.3
0.21
0.36
nmol/l
0.72
14
27
191
566
3.50
53.62
1.3
1.3
28.08
37.95
u/l
0.86
173
481
116
237
5.02
53.51
1.6
1.4
—
—
—
0
0
264
953
2.90
53.23
1.6
1.2
—
—
—
0
0
453
2121
2.29
53.17
10.7
9.0
1.34
1.31
%
0.23
448
2113
1826
13444
1.68
52.70
5.6
3.7
0.88
0.55
estimate
0.15
605
3083
159
421
3.90
52.67
1.2
1.3
0.66
4.82
nmol/l
0.49
153
406
120
259
4.75
51.88
1.5
1.4
277.66
285.43
mosm/kgh2o
2.34
103
193
411
1870
2.34
51.52
10.9
9.2
23.82
24.35
mmol/l
2.02
400
1833
3595
32420
2.60
50.84
37.1
14.6
25.00
24.42
mg/l
0.53
3296
26459
133
321
4.26
49.96
2.5
2.5
25.97
29.37
iu/ml
0.17
13
41
46
34
13.68
49.36
16.9
9.1
4.70
5.89
mmol/l
1.61
46
34
68
89
7.76
48.86
5.9
4.3
—
—
—
0
0
72
104
7.04
47.44
3.0
3.0
0.59
0.61
mmol/l
1.45
72
104
141
373
3.89
46.76
3.2
4.0
63.50
57.07
%
2.60
123
315
256
980
2.73
46.12
1.7
1.7
1.18
1.18
g/l
0.11
245
947
128
319
4.12
46.08
7.2
24.3
7.07
6.99
mmol/l
0.10
119
265
139
370
3.86
45.70
1.2
1.3
0.20
0.18
nmol/l
1.17
108
302
246
928
2.76
45.58
2.8
2.7
3.55
3.50
g/l
0.15
235
887
137
362
3.89
45.51
1.5
1.3
—
—
—
0
0
527
2781
2.04
45.16
5.7
3.7
—
—
—
0
0
248
946
2.73
44.97
1.7
1.7
0.25
0.23
g/l
1.36
236
914
266
1053
2.64
44.83
4.1
3.8
1.50
1.31
mmol/l
1.23
258
1046
121
296
4.19
44.66
2.5
2.5
1070.00
1143.31
e6/l
0.40
109
262
3400
30278
2.04
44.44
8.7
5.1
1.94
1.93
mu/l
0.19
3226
27791
154
451
3.52
43.99
1.1
1.1
1.56
1.51
g/l
0.67
145
408
345
1559
2.33
43.70
7.3
4.2
36.93
36.91
°c
0.46
338
1545
141
396
3.66
42.90
2.6
1.5
90.09
89.90
%
0.13
135
389
228
862
2.75
42.03
7.9
5.8
1.44
1.26
mmol/l
1.20
204
752
352
1658
2.24
40.31
1.5
1.2
—
—
—
0
0
682
4062
1.82
40.27
1.9
1.5
—
—
—
0
0
198
712
2.88
40.09
5.0
2.6
1.59
1.65
mmol/l
0.31
192
687
101
240
4.29
38.74
2.3
2.4
74.41
71.89
%
0.70
96
228
3633
33502
2.45
38.57
44.2
16.8
139.25
139.80
mmol/l
30.47
3607
32805
143
438
3.35
38.09
2.0
2.0
20.62
26.33
ug/l
0.85
136
433
211
811
2.69
37.64
3.9
3.6
1454.68
855.59
u/ml
0.31
198
738
113
299
3.86
37.48
1.2
1.1
—
—
—
0
0
3634
33569
2.43
37.47
45.1
16.9
3.97
3.97
mmol/l
0.16
3606
32801
909
6007
1.67
36.74
5.1
3.5
278.99
590.59
ng/l
1.04
739
4645
125
361
3.55
36.49
1.3
1.3
—
—
nmol/l
—
0
0
35
28
12.61
35.78
6.3
5.6
56.76
45.82
ug/min
0.23
29
23
697
4315
1.75
35.69
3.8
3.1
4.50
4.48
e9/l
0.03
582
3727
41
42
9.86
35.65
3.0
2.5
52.58
22.04
mg/l
0.71
13
15
1244
8962
1.57
34.98
4.1
2.8
0.15
0.03
0.75
27
238
1755
13651
1.52
34.74
2.4
2.1
—
—
—
0
0
45
55
8.27
34.21
5.0
3.9
—
—
—
0
0
56
92
6.16
32.68
1.0
1.0
—
—
—
0
0
114
334
3.49
32.57
3.8
4.4
—
—
—
0
0
188
737
2.63
32.23
4.5
3.2
60.29
57.74
%
1.82
188
737
670
4232
1.71
31.54
2.5
2.4
150.97
134.13
ug/g
0.73
534
3320
55
92
6.05
31.53
1.1
1.1
—
—
—
0
0
88
225
3.98
30.65
1.7
1.3
0.92
1.24
promille
1.07
72
179
1345
10102
1.51
30.19
10.7
6.1
—
—
—
0
0
50
80
6.32
29.95
1.1
1.1
—
—
—
0
0
132
450
3.00
29.43
2.7
3.1
—
—
—
0
0
64
134
4.84
28.75
28.0
24.6
102.76
119.32
ug/l
1.00
51
109
388
2140
1.90
28.63
1.2
1.2
177.17
130.79
u/ml
0.97
150
793
62
128
4.91
28.32
2.3
2.0
38.97
28.77
%
3.52
62
128
505
3033
1.77
28.24
4.1
2.4
40.70
55.39
u/l
0.43
428
2551
611
3884
1.68
27.79
1.5
1.4
—
—
—
0
0
67
152
4.47
27.32
1.5
1.2
—
—
—
0
0
273
1377
2.06
25.99
1.9
1.8
7.77
7.03
iu/ml
0.14
58
326
168
693
2.49
25.93
1.3
1.2
—
—
—
0
0
1236
9370
1.47
25.44
1.6
1.4
—
—
—
0
0
147
575
2.62
25.33
3.2
1.9
1.02
0.82
nmol/l
2.12
119
489
434
2578
1.77
25.07
1.2
1.2
—
—
—
0
0
149
593
2.57
24.79
5.7
2.8
7.33
7.38
mmol/l
0.07
144
573
186
825
2.32
24.44
1.7
1.4
11.74
10.18
u/l
0.59
148
663
437
2639
1.74
23.77
2.6
2.2
5.04
7.26
ug/l
3.29
370
2333
89
273
3.31
23.73
1.2
1.2
65.00
166.81
titre
—
6
47
94
299
3.20
23.63
1.1
1.2
—
—
—
0
0
148
605
2.50
23.30
9.9
6.9
11.81
11.19
mmol/l
1.15
137
532
148
606
2.50
23.22
9.9
6.9
104.61
105.11
mmol/l
0.46
137
533
139
553
2.57
23.16
1.6
1.7
0.73
0.81
g/l
0.31
99
435
230
1142
2.08
22.83
2.3
2.1
21.12
20.90
s
0.33
208
1003
241
1218
2.04
22.80
2.8
3.7
926.68
1513.75
u/ml
0.25
213
1041
72
199
3.67
22.53
2.4
2.5
0.51
0.66
e9/l
1.58
66
192
64
163
3.98
22.48
2.5
2.5
14.79
16.37
%
2.47
64
163
72
200
3.65
22.37
2.6
2.8
493.79
494.11
e6/l
0.00
56
163
313
1742
1.87
22.32
3.0
2.1
0.00
0.48
estimate
0.51
93
526
57
134
4.30
22.26
1.3
1.7
3.04
6.69
nmol/l
0.51
49
106
55
126
4.41
22.20
2.4
1.7
38.03
40.47
g/l
1.90
55
126
100
347
2.93
21.67
1.5
1.2
—
—
—
0
0
72
206
3.54
21.42
2.8
2.9
213.85
223.27
e6/l
0.12
61
177
60
154
3.94
20.87
2.4
2.1
7.65
8.43
mmol/l
0.76
60
154
65
177
3.72
20.81
2.9
2.9
39.36
40.69
%
0.21
45
99
161
722
2.28
20.64
1.3
1.3
3.88
3.66
mmol/l
1.39
151
680
149
650
2.34
20.37
3.4
2.2
239.71
109.18
ug/min
1.12
97
373
103
376
2.79
20.36
1.1
1.1
—
—
—
0
0
58
148
3.96
20.34
3.3
2.0
503.37
493.45
min
0.27
46
104
127
517
2.51
20.21
1.1
1.1
—
—
—
0
0
846
6201
1.47
19.84
1.4
1.3
44.10
31.56
iu/ml
1.10
244
1831
77
243
3.21
19.66
1.1
1.1
—
—
—
0
0
41
82
5.04
19.48
1.8
1.4
14.57
15.22
pmol/l
0.37
35
71
107
410
2.66
19.28
1.7
1.4
—
—
—
0
0
107
410
2.66
19.28
1.7
1.4
—
—
—
0
0
107
410
2.66
19.28
1.7
1.4
—
—
—
0
0
107
410
2.66
19.28
1.7
1.4
—
—
—
0
0
69
206
3.39
19.26
3.0
2.1
725.87
655.21
ml
0.67
52
129
1045
8010
1.42
19.13
5.1
3.8
1.40
0.62
—
5
95
75
237
3.21
19.12
1.3
1.3
2.21
2.15
mmol/l
0.11
69
224
240
1290
1.92
19.02
1.3
1.2
0.32
1.17
u/ml
1.67
14
104
390
2430
1.67
18.75
3.7
2.8
255.47
184.52
ng/l
1.40
350
2214
173
832
2.13
18.69
1.3
1.4
464.49
563.54
mg/l
2.79
163
788
3651
34813
1.91
18.35
47.4
19.1
98.18
76.47
umol/l
57.55
3633
34366
780
5753
1.45
17.42
1.4
1.3
9.64
10.90
u/ml
0.23
297
2244
3619
34476
1.81
17.34
23.0
11.6
26.42
25.92
u/l
0.97
3568
33372
184
934
2.02
17.22
2.0
1.7
309.95
295.28
mu/l
0.28
168
862
651
4657
1.48
17.00
1.3
1.3
—
—
—
0
0
2928
26747
1.39
16.58
43.7
18.0
14.16
13.62
%
63.44
2915
26347
418
2750
1.58
16.06
2.6
2.2
13.06
13.73
nmol/l
0.84
371
2504
28
47
5.99
16.04
2.5
1.5
1.19
1.18
mmol/l
0.27
28
47
139
657
2.16
15.73
1.4
1.5
—
—
—
0
0
46
121
3.84
15.54
2.0
2.5
161.13
133.58
umol/l
0.15
15
66
146
707
2.11
15.53
1.4
1.5
16.56
29.79
e6/l
0.51
107
537
119
531
2.28
15.51
1.1
1.1
—
—
—
0
0
71
247
2.91
15.42
1.3
1.1
—
—
—
0
0
218
1217
1.84
15.37
2.2
2.7
—
—
—
0
0
86
332
2.63
15.34
1.3
1.3
2.67
2.99
g/l
0.77
56
242
86
332
2.63
15.34
1.3
1.3
0.48
0.41
g/l
0.29
55
239
86
332
2.63
15.34
1.3
1.3
7.10
6.87
g/l
0.18
57
240
268
1592
1.73
15.32
1.1
1.1
1.18
0.88
u/ml
—
5
19
84
322
2.64
15.20
1.3
1.3
—
—
—
0
0
147
720
2.08
15.18
1.4
1.5
1056.43
1363.04
e6/l
0.15
119
578
55
166
3.35
15.16
4.2
2.2
15.20
31.40
umol/l
—
5
12
47
128
3.70
15.12
1.2
4.3
3569.64
61.76
mg/l
0.49
39
90
31
61
5.12
15.03
1.6
1.3
171.58
44.87
mu/l
0.89
21
48
38
89
4.30
14.99
1.7
1.5
3395.25
22875.59
e6/l
0.50
16
54
161
827
1.99
14.61
4.2
3.1
2.70
1.97
index
0.47
86
425
36
83
4.37
14.49
1.4
1.3
85.92
157.50
nmol/24h
0.45
36
83
189
1030
1.88
14.39
1.3
1.3
47.83
31.43
u/ml
0.24
11
60
104
456
2.32
14.15
1.5
1.4
31.40
33.26
g/l
0.70
95
421
92
383
2.44
14.06
1.3
1.4
31.85
28.75
u/l
0.30
78
317
32
69
4.67
13.98
1.2
1.2
405.42
289.73
pmol/l
0.53
24
52
3287
30895
1.43
13.67
8.8
5.9
39.96
38.76
mmol/mol
10.28
3074
28664
479
3358
1.49
13.65
2.8
2.0
0.03
0.01
estimate
0.43
108
659
101
449
2.28
13.33
2.9
2.7
—
—
—
0
0
40
107
3.77
13.23
1.8
1.9
916.60
648.13
e6/l
0.19
25
79
54
176
3.10
13.18
1.1
1.4
17.97
5.81
u/l
0.45
43
155
141
718
2.00
13.14
5.0
4.3
—
—
—
0
0
3342
31572
1.44
12.90
6.4
5.0
6.10
5.88
mmol/l
13.98
3073
28757
89
384
2.35
12.60
2.1
1.6
69.85
58.52
%
2.12
65
244
19
11
17.35
12.50
2.4
1.9
—
—
—
0
0
21
34
6.20
12.46
3.6
1.8
1.37
1.38
umol/l
0.03
21
22
17
7
24.37
12.45
1.2
1.1
28.99
45.66
mg/24h
—
17
7
175
976
1.83
12.42
1.3
1.3
3.18
5.83
u/ml
1.26
21
161
76
308
2.50
12.34
1.9
1.5
378.67
351.50
mu/l
0.20
66
246
42
123
3.44
12.19
1.2
1.1
—
—
—
0
0
173
972
1.82
12.00
1.3
1.3
2.84
5.86
u/ml
—
9
96
42
125
3.39
11.90
3.7
2.8
—
—
—
0
0
276
1767
1.61
11.85
3.2
3.7
55.01
80.51
u/ml
1.00
266
1710
156
854
1.86
11.76
2.0
1.6
16337.01
11183.51
e6/l
0.86
116
599
22
21
10.53
11.74
1.8
1.4
316.59
341.57
umol/24h
0.20
22
21
89
397
2.27
11.70
1.5
1.4
1729.44
2829.93
e6/l
0.78
61
279
48
157
3.08
11.68
1.3
1.2
130.60
133.98
nmol/l
0.21
48
157
85
372
2.31
11.68
2.0
1.6
—
1729.23
—
0
13
50
169
2.98
11.51
1.9
1.4
1.28
1.19
nmol/l
0.23
42
120
39
115
3.42
11.22
2.2
2.9
7.97
10.67
%
0.84
34
107
16
8
20.08
11.12
1.4
1.3
—
—
—
0
0
122
632
1.96
10.89
2.0
1.5
—
1.00
—
0
5
78
340
2.32
10.84
1.5
1.5
—
—
—
0
0
32
85
3.79
10.74
1.5
1.3
11.75
13.79
g/l
0.50
20
61
75
324
2.34
10.65
1.4
1.4
—
—
—
0
0
316
2150
1.51
10.36
1.4
1.3
245.65
228.13
u/ml
0.07
296
1991
957
7830
1.30
10.30
5.6
4.0
1.02
1.21
kg/l
0.50
685
5113
92
440
2.12
10.23
1.4
1.3
—
—
—
0
0
96
468
2.08
10.16
1.3
1.1
38.85
1317.31
iu/ml
0.53
17
102
151
859
1.79
10.10
1.4
1.2
—
—
—
0
0
148
846
1.78
9.75
2.9
2.2
3983.16
4768.57
u/l
0.11
53
347
33
96
3.46
9.73
1.7
1.7
—
—
—
0
0
31
87
3.58
9.64
1.8
2.9
0.29
0.21
e9/l
0.29
12
39
134
748
1.82
9.56
1.3
1.2
50.37
41.50
u/ml
—
10
86
23
52
4.44
9.54
1.1
1.0
—
—
—
0
0
216
1375
1.60
9.52
1.6
1.4
26.92
28.58
iu/l
0.27
183
1181
75
343
2.21
9.36
1.1
1.1
—
—
—
0
0
136
770
1.79
9.27
1.1
1.1
3.73
6.74
eliau/ml
—
7
86
77
358
2.17
9.23
1.3
1.5
—
—
—
0
0
41
141
2.93
9.22
1.5
1.3
55.80
69.31
%
—
5
13
13
7
18.63
8.92
1.5
1.3
2.12
1.89
mmol/24h
—
13
7
75
352
2.15
8.80
1.5
1.6
—
—
—
0
0
43
156
2.78
8.79
1.0
1.1
1542.07
1504.26
miu/ml
0.08
43
156
34
108
3.17
8.76
1.3
1.2
—
—
—
0
0
3657
35544
1.56
8.47
54.7
22.5
250.45
249.74
e9/l
0.23
3620
34797
75
359
2.11
8.39
1.4
1.4
13184.54
57600.97
e6/l
1.22
41
198
3657
35550
1.55
8.39
54.4
22.4
92.04
91.21
fl
20.26
3639
35124
3657
35551
1.55
8.38
54.4
22.4
30.52
30.36
pg
5.86
3639
35125
3657
35554
1.55
8.34
55.6
22.9
38.71
40.70
%
20.93
3638
35110
3657
35554
1.55
8.34
54.6
22.5
4.27
4.49
e12/l
95.36
3613
34682
3657
35556
1.55
8.31
54.7
22.5
7.06
6.67
e9/l
17.14
3614
34672
3657
35560
1.55
8.26
55.1
22.6
128.78
135.54
g/l
97.44
3639
35148
327
2362
1.42
7.89
2.5
2.5
21.94
22.37
au/ml
0.03
22
235
58
258
2.27
7.80
1.3
1.1
—
—
—
0
0
67
318
2.13
7.69
3.4
2.5
—
—
—
0
0
304
2180
1.43
7.64
1.3
1.3
67.21
56.24
au/ml
0.20
14
162
86
449
1.94
7.62
1.3
1.5
0.33
0.31
nmol/l
0.08
63
339
330
2408
1.41
7.52
1.9
1.7
—
—
—
0
0
23
63
3.67
7.45
4.4
2.5
4.43
120.09
ug/l
0.98
23
63
69
337
2.07
7.37
1.8
1.4
110569.67
86513.55
e6/l
0.15
46
227
247
1717
1.47
7.33
2.7
2.4
—
—
—
0
0
24
69
3.49
7.26
2.9
1.9
—
—
—
0
0
45
185
2.45
7.24
1.1
1.1
7.65
16.20
nmol/l
—
8
44
35
127
2.77
7.21
1.7
1.3
66.17
63.77
%
0.14
30
101
10
5
20.05
7.13
4.9
5.2
409.20
380.60
umol/l
—
10
5
19
47
4.06
7.07
2.1
1.2
—
—
—
0
0
40
158
2.55
7.00
3.4
3.3
26.51
23.74
mu/l
0.16
40
152
111
646
1.74
6.98
3.6
3.2
0.86
0.80
nmol/l
0.57
85
519
241
3383
0.69
6.97
2.0
2.0
3.66
3.50
ratio
1.22
194
2634
64
316
2.04
6.68
2.1
1.5
21.20
30.20
%
1.61
49
189
61
300
2.05
6.45
1.3
1.3
1.67
1.53
nmol/l
0.39
54
268
24
75
3.21
6.41
1.2
1.3
23.38
26.83
g/l
0.34
17
60
78
421
1.87
6.32
1.3
1.3
90.16
47.10
u/ml
—
9
26
85
472
1.82
6.30
1.3
1.3
2.86
3.31
u/ml
0.29
36
210
9
5
18.04
6.26
6.0
2.2
2.19
2.70
g/l
—
9
5
53
252
2.12
6.13
1.2
1.2
38.34
36.52
mg/l
0.16
44
206
75
404
1.87
6.12
6.1
5.3
341.49
354.20
umol/l
0.31
68
352
51
239
2.15
6.12
1.2
1.1
269.84
255.73
mg/l
0.24
43
208
19
53
3.60
6.03
1.1
1.1
0.78
0.69
umol/24h
—
9
25
51
241
2.13
6.00
1.3
1.1
—
—
—
0
0
3179
30504
1.24
5.93
5.1
4.1
1.42
1.26
mmol/l
29.62
2892
27820
126
798
1.60
5.80
1.2
1.1
—
—
—
0
0
38
161
2.37
5.79
2.1
1.4
1.60
4.41
%
—
10
34
19
55
3.47
5.72
1.4
1.8
—
—
—
0
0
39
170
2.31
5.59
1.4
1.3
7.40
7.41
ph
0.08
33
112
9
7
12.88
5.58
1.2
1.4
27.70
45.79
umol/24h
—
9
7
175
1205
1.47
5.52
1.6
1.6
29.23
14.17
u/ml
1.66
38
266
196
2729
0.70
5.43
1.2
1.4
—
—
—
0
0
174
2474
0.69
5.42
1.7
1.7
3.51
3.50
mmol/l
0.06
122
1734
25
90
2.79
5.30
1.8
1.6
22.36
49.42
u/l
0.72
25
85
23
79
2.92
5.29
1.8
1.3
17.27
33.51
%
1.97
15
59
218
1583
1.40
5.18
5.0
3.2
1.02
1.02
ratio
0.08
203
1433
8
6
13.36
5.07
1.0
1.7
498.62
363.83
mg/24h
—
8
6
34
147
2.32
5.00
1.1
1.1
15.18
208.30
ng/l
—
5
33
15
41
3.67
4.92
1.3
1.6
—
—
—
0
0
18
56
3.22
4.89
1.7
1.4
—
—
—
0
0
13
25
5.21
4.76
1.2
1.2
—
361.50
—
0
6
134
905
1.50
4.70
1.3
1.3
177.74
216.61
miu/ml
0.57
36
417
14
30
4.68
4.67
1.1
1.1
—
—
—
0
0
48
246
1.96
4.63
4.3
2.7
259.41
17.79
mg/l
1.86
41
179
26
103
2.53
4.62
1.8
1.4
208.44
119.05
nmol/l
0.35
18
73
331
2608
1.29
4.60
3.8
2.6
6.03
6.07
ph
0.26
231
1757
45
226
2.00
4.59
1.5
1.4
18.36
12.51
u/l
2.07
45
218
12
22
5.47
4.59
1.1
1.0
—
—
—
0
0
34
153
2.23
4.59
1.1
1.1
—
—
—
0
0
48
247
1.96
4.58
1.1
1.1
372.65
367.96
nmol/l
0.05
37
218
56
304
1.85
4.56
1.1
1.1
—
—
—
0
0
21
75
2.81
4.54
6.1
5.6
25.07
24.86
mmol/l
0.07
21
68
8
8
10.02
4.52
1.1
1.1
—
—
mmol/l
—
0
0
56
308
1.83
4.39
3.4
2.1
10.57
7.10
umol/l
0.32
45
225
11
20
5.51
4.28
1.1
1.0
—
—
—
0
0
7
6
11.68
4.27
3.0
1.5
4.47
4.33
mmol/l
—
7
6
1196
10783
1.16
4.19
5.3
5.5
4.11
3.29
ug/l
0.62
1076
9759
298
2347
1.29
4.17
1.3
1.2
—
—
—
0
0
73
441
1.67
4.16
2.9
2.3
29.44
21.55
mg/l
0.66
32
160
21
79
2.67
4.15
1.3
1.2
—
—
—
0
0
37
180
2.07
4.14
1.5
1.2
0.54
0.56
ratio
0.17
23
103
16
52
3.09
4.08
1.2
1.2
0.75
2.50
mmol/l
—
10
37
38
188
2.03
4.08
1.2
1.1
1.08
1.06
ratio
0.52
31
149
92
592
1.57
4.07
1.9
1.8
—
—
—
0
0
17
58
2.94
4.00
9.7
6.9
6.54
4.91
kpa
1.21
17
58
81
509
1.60
3.97
1.1
1.1
3.58
16.67
au/ml
4.17
12
120
72
441
1.64
3.91
2.0
2.7
—
—
—
0
0
520
4396
1.21
3.89
5.6
4.7
32.28
32.54
%
0.21
380
2837
47
256
1.85
3.84
1.7
2.0
1.97
1.53
u/field
0.39
29
134
10
19
5.27
3.82
1.1
1.1
—
—
—
0
0
39
203
1.93
3.67
1.8
1.4
80.67
79.26
umol/l
0.11
39
203
71
1107
0.63
3.60
1.1
1.2
1.52
1.54
g/l
0.26
71
1107
3291
32021
1.19
3.55
5.9
4.8
1.41
1.49
mmol/l
20.92
3037
29532
25
111
2.26
3.54
2.7
2.2
45.17
54.34
umol/l
0.43
20
98
13
36
3.62
3.49
1.0
2.8
—
—
—
0
0
120
846
1.43
3.48
1.4
1.4
—
—
—
0
0
67
1047
0.63
3.44
1.1
1.1
0.59
0.63
ratio
—
8
140
10
22
4.55
3.42
2.0
2.4
27.60
55.12
%
—
5
17
202
1554
1.32
3.41
1.3
1.2
—
—
—
0
0
14
47
2.99
3.41
1.6
1.9
1.49
2.24
mmol/l
—
6
36
17
64
2.66
3.39
9.7
6.7
5.75
6.00
kpa
0.58
17
58
11
27
4.08
3.39
1.4
1.2
—
—
—
0
0
24
107
2.25
3.38
1.2
1.3
38.88
39.94
g/l
—
8
57
114
804
1.43
3.31
2.3
1.8
210.53
209.86
pmol/l
0.02
100
770
27
128
2.12
3.29
1.1
1.2
—
—
—
0
0
32
162
1.98
3.28
1.7
1.6
2.51
3.85
u/field
0.41
26
110
11
28
3.94
3.28
1.4
1.2
—
—
—
0
0
3307
32239
1.18
3.23
5.9
4.9
4.49
4.69
mmol/l
25.31
3063
29927
13
39
3.34
3.22
10.6
10.6
0.21
0.36
umol/l
1.84
13
39
12
34
3.54
3.19
1.3
1.4
75.00
67.89
%
0.35
12
29
57
350
1.64
3.14
2.0
2.3
—
—
—
0
0
14
50
2.81
3.08
2.1
1.3
16.00
6.05
%
—
9
21
17
68
2.51
3.04
1.6
1.4
—
—
—
0
0
21
93
2.26
3.03
1.7
1.3
—
—
—
0
0
50
300
1.68
3.02
4.9
2.6
13.18
12.69
index
0.13
38
167
63
401
1.58
3.01
1.1
1.1
1.44
2.95
eliau/ml
1.32
14
177
12
36
3.34
3.01
1.0
1.1
—
—
—
0
0
63
403
1.57
2.96
1.3
1.2
—
—
—
0
0
144
1081
1.34
2.92
1.1
1.1
—
—
—
0
0
9
22
4.10
2.88
1.7
1.1
—
—
—
0
0
9
23
3.92
2.77
1.0
2.1
—
—
—
0
0
50
308
1.63
2.76
1.3
1.8
—
—
—
0
0
5
6
8.34
2.75
2.8
1.7
23.22
31.83
umol/l
—
5
6
5
6
8.34
2.75
1.0
1.0
—
—
—
0
0
38
218
1.75
2.72
1.3
1.2
—
—
—
0
0
13
49
2.66
2.62
1.1
1.1
—
—
—
0
0
9
25
3.61
2.57
1.0
1.1
1.71
1.90
umol/24h
—
9
25
5
7
7.15
2.55
12.0
2.7
—
—
—
0
0
33
186
1.78
2.52
1.1
1.5
7.67
7.96
ug/l
0.07
28
168
8
21
3.81
2.46
1.5
3.7
—
—
—
0
0
11
38
2.90
2.41
1.4
1.5
—
—
—
0
0
123
935
1.33
2.36
1.7
2.1
—
—
—
0
0
8
22
3.64
2.36
1.0
2.1
—
—
—
0
0
65
444
1.47
2.33
1.1
1.2
—
—
—
0
0
14
59
2.38
2.29
1.4
1.4
—
—
—
0
0
39
238
1.65
2.28
3.9
2.4
40.61
31.26
mg/l
0.61
23
168
3339
32738
1.15
2.27
6.5
5.5
2.58
2.75
mmol/l
23.00
3087
30213
132
1021
1.30
2.25
1.7
2.0
—
—
—
0
0
131
1016
1.30
2.20
1.7
2.0
—
—
—
0
0
24
131
1.84
2.07
1.7
1.7
4480.00
3960.00
titre
—
7
22
131
1027
1.29
2.05
1.7
2.0
—
—
—
0
0
105
799
1.32
2.04
1.8
2.1
—
—
—
0
0
11
44
2.50
2.01
1.2
1.3
65.45
64.23
ug/l
0.04
11
44
128
1008
1.28
1.95
1.6
2.0
—
—
—
0
0
5
11
4.55
1.94
1.0
1.6
557.40
2181.09
nmol/l
—
5
11
52
355
1.47
1.92
1.2
1.2
—
—
—
0
0
39
254
1.54
1.81
1.5
1.3
0.34
1.29
u/ml
1.34
22
148
50
344
1.46
1.80
1.2
1.3
7.46
7.39
mmol/l
0.06
41
306
24
139
1.73
1.75
1.9
1.8
0.00
0.02
estimate
0.50
24
139
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
35
226
1.55
1.70
2.1
1.9
7.80
6.53
mmol/l
1.13
24
144
19
104
1.83
1.67
1.7
1.7
10.57
8.87
ug/l
0.78
19
104
187
1569
1.20
1.64
2.2
1.9
—
—
—
0
0
19
105
1.81
1.62
1.2
1.3
129.56
492.93
ug/l
—
9
50
40
270
1.49
1.61
1.7
1.6
2.62
4.03
ug/l
0.61
32
227
28
174
1.61
1.60
1.7
1.6
—
—
—
0
0
6
20
3.00
1.58
1.2
1.1
—
—
—
0
0
11
50
2.20
1.56
2.1
1.2
—
—
—
0
0
11
50
2.20
1.56
2.0
1.2
—
—
—
0
0
11
50
2.20
1.56
2.1
1.2
—
—
—
0
0
170
1423
1.20
1.55
1.1
1.1
—
—
—
0
0
2627
26913
0.93
1.48
44.3
19.0
331.25
332.21
g/l
5.58
2618
26746
19
109
1.75
1.46
1.5
1.3
61.11
55.72
%
0.27
19
91
15
80
1.88
1.44
1.1
1.1
—
—
—
0
0
5
16
3.13
1.44
1.2
1.1
0.16
0.16
umol/l
—
5
16
5
16
3.13
1.44
1.2
1.0
230.60
282.38
nmol/l
—
5
16
66
502
1.32
1.38
1.2
1.2
—
—
—
0
0
61
461
1.33
1.34
1.3
1.2
—
—
—
0
0
33
224
1.48
1.33
2.1
2.1
1.96
2.25
ug/l
0.38
25
185
22
137
1.61
1.29
2.1
2.1
212.88
100.18
ug/min
—
8
33
56
421
1.34
1.28
1.1
1.1
3.16
5.20
u/ml
0.39
23
192
5
19
2.63
1.21
1.2
1.2
—
—
—
0
0
1460
14034
1.06
1.13
2.1
1.9
1.46
1.32
mmol/l
6.64
1206
11613
28
401
0.70
1.12
1.5
1.5
1.28
1.27
mm
0.03
17
292
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
16
97
1.65
1.06
1.2
1.0
—
—
—
0
0
16
97
1.65
1.06
1.2
1.0
—
—
—
0
0
16
97
1.65
1.06
1.1
1.1
—
—
—
0
0
16
97
1.65
1.06
1.2
1.0
—
—
—
0
0
29
408
0.71
1.06
1.4
1.5
—
—
—
0
0
82
669
1.23
1.04
1.1
1.1
0.79
1.94
u/ml
2.24
46
381
30
417
0.72
1.03
1.5
1.6
—
—
—
0
0
76
912
0.83
0.87
1.4
1.6
1041.44
1009.79
mu/l
0.08
60
760
57
459
1.25
0.86
1.1
1.1
2.07
3.96
u/ml
0.83
30
232
6
31
1.94
0.84
1.2
1.1
0.02
0.02
u/ml
—
6
31
6
33
1.82
0.79
1.5
1.5
—
—
—
0
0
76
638
1.20
0.78
5.1
3.4
27.03
27.75
mg/l
0.06
55
431
11
66
1.67
0.78
1.5
3.9
103.20
103.12
ng/l
—
5
33
284
3090
0.91
0.78
1.4
1.4
—
—
—
0
0
44
352
1.25
0.73
3.0
2.3
—
—
—
0
0
53
643
0.82
0.71
1.3
1.7
—
—
—
0
0
26
194
1.34
0.71
1.1
1.1
—
—
—
0
0
16
110
1.46
0.68
1.4
1.9
—
—
—
0
0
5
28
1.79
0.66
1.4
1.7
—
—
—
0
0
17
237
0.72
0.66
1.4
1.4
223.99
217.11
pmol/l
0.04
17
237
26
199
1.31
0.62
1.2
1.1
—
—
—
0
0
5
30
1.67
0.61
3.0
2.1
0.20
0.73
u/field
—
5
30
0
20
0.00
0.60
0.0
1.1
—
0.60
—
0
12
8
51
1.57
0.60
3.5
2.2
13.89
18.85
umol/l
—
8
51
31
246
1.26
0.58
1.0
1.0
890.18
743.94
ng/l
0.65
22
159
21
158
1.33
0.57
1.0
1.1
0.16
4.78
u/ml
—
6
49
11
74
1.49
0.53
1.0
1.0
—
—
—
0
0
6
39
1.54
0.53
1.0
1.8
10.55
4.07
nmol/l
—
6
39
1213
12450
0.96
0.52
3.7
3.0
—
—
—
0
0
7
48
1.46
0.46
1.6
1.4
—
—
—
0
0
80
714
1.12
0.44
1.3
1.2
—
—
—
0
0
30
247
1.22
0.44
1.0
1.0
343.95
337.74
ng/l
0.04
21
165
62
546
1.14
0.42
1.1
1.1
0.98
1.14
u/ml
0.10
25
263
5
32
1.56
0.42
1.4
2.3
1.22
1.49
mg/l
—
5
25
114
1046
1.09
0.39
14.3
9.4
—
—
—
0
0
46
400
1.15
0.39
1.1
1.1
0.06
0.30
u/ml
1.74
17
149
5
37
1.35
0.37
1.4
1.1
96.00
84.76
titre
—
5
37
13
99
1.31
0.35
2.9
2.6
32.50
29.55
umol/l
—
6
73
10
134
0.75
0.34
1.1
1.2
13.90
10.41
mm/h
—
10
134
20
163
1.23
0.34
4.9
3.5
—
—
—
0
0
7
52
1.35
0.31
2.4
3.4
—
—
—
0
0
62
561
1.11
0.31
1.1
1.1
2.08
3.94
u/ml
1.13
28
313
11
84
1.31
0.30
1.9
2.3
—
—
—
0
0
48
531
0.90
0.26
1.4
1.6
70.64
61.01
ug/l
0.42
37
448
21
182
1.15
0.21
1.0
1.1
0.42
1.62
u/ml
—
10
74
6
52
1.15
0.19
2.8
7.5
14.83
8.12
mmol/l
—
6
52
57
535
1.07
0.16
1.1
1.1
2.66
1.59
u/ml
0.38
29
283
20
178
1.12
0.15
4.9
3.4
—
—
—
0
0
15
132
1.14
0.13
1.1
1.1
9.80
6.75
u/ml
—
5
15
58
550
1.06
0.12
1.3
1.1
—
—
—
0
0
25
231
1.08
0.10
1.1
1.0
—
—
—
0
0
57
548
1.04
0.08
1.3
1.1
—
—
—
0
0
655
6501
1.01
0.07
3.2
3.3
0.89
0.77
ug/l
0.96
447
4291
11
102
1.08
0.03
1.1
1.3
30.09
27.95
s
0.53
11
102
149
1476
1.01
0.02
1.7
1.7
—
—
—
0
0
45
442
1.02
0.01
1.4
1.8
—
—
—
0
0
22
214
1.03
0.00
1.1
1.2
13.79
18.39
u/ml
—
7
88
18
175
1.03
0.00
1.0
1.1
0.40
1.23
u/ml
—
6
56
0
9
0.00
0.00
0.0
2.0
—
276.44
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.96
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
0.34
—
0
6
7
77
0.91
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
6.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
3320.00
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_MINERAL_MET and mortality.

Females

Parameter HR [95% CI] p-value
E4_MINERAL_MET 2.617 [2.34, 2.93] < 0.001
Birth year 0.996 [0.99, 1.0] 0.322

During the follow-up period (1.1.1998 — 31.12.2019), 3027 out of 8828 females with E4_MINERAL_MET died.

Males

Parameter HR [95% CI] p-value
E4_MINERAL_MET 3.794 [3.25, 4.43] < 0.001
Birth year 0.988 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 2295 out of 5987 males with E4_MINERAL_MET died.

Mortality risk

Mortality risk for people of age

years, who have E4_MINERAL_MET.

N-year risk Females Males
1 0.258% 0.65%
5 1.569% 4.37%
10 4.004% 10.145%
15 7.557% 18.812%
20 12.678% 31.367%

Relationships between endpoints

↥

Index endpoint: E4_MINERAL_MET – Disorders of mineral metabolism

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data